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Abstract
The programmable self-assembly facilitated by DNA nanotechnology provides unparalleled
capabilities to construct functional devices at the nanoscale. Recently, DNA nanostructures
have been developed to interact with biological membranes and serve as artificial counterparts
of natural ion channels, or membrane bending, scaffolding, or fusion proteins. In this thesis,
we design a synthetic DNA-built enzyme that facilitates rapid lipid mixing between the two
leaflets of a lipid bilayer. It thereby mimics the function of yet another class of membrane
proteins – lipid scramblases. Characterising this DNA nanostructure with gel electrophoresis,
dynamic light scattering, atomic force and transmission electron microscopy, we find that
the cholesterol groups required for membrane insertion, also induce clustering. Hence, we
establish an easy-to-implement strategy to control hydrophobically mediated aggregation
thereby introducing a solution to a common problem of amphiphilic DNA constructs. With a
combination of fluorescence microscopy experiments and molecular dynamics simulations,
we identify the mechanism behind the scrambling activity. The spontaneous membrane
insertion of our DNA scramblase induces a toroidal pore that is lined by the lipid headgroups.
This DNA-stabilised pore connects the inner and outer bilayer leaflet thereby facilitating
diffusive lipid transport that rapidly equilibrates the membrane’s lipid composition. In good
agreement between experiments and simulations, we find the scrambling rate catalysed by our
DNA-made enzyme to exceed 107 lipids per second, orders of magnitude faster than natural
scramblase proteins. We thereby pioneer the use of self-assembled DNA nanostructures
for controlling the lipid composition of biological membranes, opening new avenues for
applications of membrane-interacting DNA systems in biophysical research and medicine.
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Chapter 1
Introduction & Motivation
As we go down in size, there are a number of interesting
problems that ... we will have to be ready to design for.
But I am not afraid to consider the final question as to
whether, ultimately – in the great future – we can arrange
the atoms the way we want; the very atoms, all the way
down! What would happen if we could arrange the atoms
one by one the way we want them?
– Richard P. Feynman
On December 29th in 1959, theoretical physicist and Nobel laureate Richard Feynman voiced
these words in his famous lecture “There’s plenty of room at the bottom” given at the annual
meeting of the American Physical Society at Caltech, California [1]. In his speech, he invited
the audience to consider a new field of physics – a physics at the smallest of scales. He
illustrated the tremendous opportunities that lie in studying the “problem of manipulating and
controlling things on a small scale”. With his vision of arranging atoms and molecules one
by one, he is today considered to be the father of the modern-day history of nanotechnology.
Presumably unbeknownst to Feynman, the material that made his dream become a reality,
was deoxyribonucleic acid – or DNA. In 1982, crystallographer Nadrian Seeman laid the
theoretical groundwork for creating large, periodic networks made from DNA, thereby
pioneering the field of ‘DNA nanotechnology’ [2]. DNA is hereby taken out of its biological
context of storing the genetic information of an organism. Instead, the DNA sequence is used
to direct the assembly of structural motifs and connect them with each other. DNA molecules
themselves are composed of 0.34 nm long nucleotides that assemble into polymer chains,
the DNA strands. In contrast to the self-assembly of amino acid chains into highly ordered
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protein structures, the interactions of DNA strands with each other are well understood.
These characteristics of having ångström-scale building blocks, each individually addressable
due to the known DNA sequence, and a profound understanding of how these blocks interact
with each other, make DNA an ideal building material at the nanoscale.
Of considerable interest in recent years, was the use of DNA nanotechnology for biological
and biophysical applications [3, 4]. Notably, the study of biophysical processes at cell
membranes or model lipid bilayers has become a prominent and successful area in DNA
nanotechnology [5]. Rather than a top-down approach of, for example, modifying natural
proteins, DNA allows us to build synthetic counterparts ourselves from the bottom up, just
like in Feynman’s vision. This approach enables us to develop an understanding of which
features are essential to reproducing biological function. The feasibility of the bottom-up
assembly of synthetic protein analogues has already successfully been demonstrated by
mimicking natural protein ion channels with a variety of rationally-designed, DNA-built
counterparts. Since the first DNA-made ion channel introduced by Langecker et al. in
2012 [6], several designs have been developed spanning multiple orders of magnitude in
conductance, similar to natural ion channel proteins [7].
However, only recently the interface between the membrane-inserted DNA and the lipids the
membrane is composed of, has become the focus of attention. In parallel to the beginning of
this thesis work, we have shown that a hydrophobically modified and membrane-inserted,
single DNA duplex induces the formation of a toroidal, water-filled lipid pore surrounding
the duplex [8]. This observation sparked the idea that such a DNA-induced, toroidal pore
could potentially allow lipids to translocate between the two bilayer leaflets. Such so-called
‘lipid flipping’ events are an important mechanism for cells to modulate the lipid composition
in their cell membrane. As the two leaflets of a mammalian cell’s plasma membrane are
made up from chemically distinct mixtures of phospholipids, the lipid distribution across
bilayer leaflets is typically asymmetric [9]. A loss of the asymmetry can trigger unregulated
apoptosis [10] and could lead to the development of Alzheimer’s disease [11]. Therefore,
controlling this lipid distribution is critically important to the cell’s health and functions.
Three protein families – flippases, floppases and scramblases [12, 13] – can move lipids
between the bilayer leaflets. While flippases and floppases require energy in the form of ATP
(adenosine triphosphate) to maintain the asymmetric lipid composition, scramblase proteins
can be activated to passively dismantle the lipids’ asymmetric distribution at scrambling rates
of up to 104 lipids per second [14–17]. Cells use this as a signalling mechanism typically
required during critical events such as cell activation, blood coagulation and apoptosis [18–
21]. Defective enzyme-catalysed, phospholipid scrambling activity in blood cells has been
shown to hinder thrombin formation leading to a bleeding disorder called Scott syndrome [22].
3Controlled lipid scrambling activity is a crucial process in marking cells as apoptotic which,
if impaired, has been linked to weaken the immune system and induce autoimmune responses
by exposing self antigens [23]. Therefore, the development of biocompatible and controllable
synthetic counterparts to repair and/or regulate lipid scrambling activity in cell membranes is
of considerable medical interest.
In this doctoral thesis, we will introduce the novel and innovative application of using DNA
nanotechnology to modulate the lipid composition in biological membranes. We will devise
a DNA nanostructure design that is able to self-insert into lipid membranes and mix lipids
between the bilayer leaflets at extraordinary high rates, significantly outperforming natural
lipid scramblase proteins. To the best of our knowledge, we thereby pioneer the application
of DNA nanotechnology to build a synthetic lipid scramblase.
Throughout this dissertation we will progressively increase the complexity of the DNA
nanostructure design and the experimental methods to analyse lipid scrambling activity. In
Chapter 2, we will first provide a brief introduction to the design and assembly principles
of DNA nanostructures. Previous work focussing on interfacing DNA constructs with
lipid membranes will be reviewed with special emphasis on membrane-spanning DNA
nanostructures. Our current understanding about the interactions between membrane-inserted
DNA constructs and the lipids of a lipid bilayer will be summarised and how this relates to
the aim of this dissertation to build an artificial lipid scramblase. The chapter will furthermore
provide an overview of natural lipid scramblases and their biological role, as well as previous
attempts to create artificial counterparts. Lastly, we will discuss an experimental method,
termed ‘dithionite reduction assay’ [24], that will be key in determining the lipid scrambling
activity of our artificial DNA scramblase.
In Chapter 3, we will introduce the design of the DNA scramblase and provide an in-
depth analysis of its assembly and structural characteristics. Gel electrophoresis will be
employed as a cost-efficient and rapid bulk analysis method to gauge the assembly yield of
the DNA nanostructures. Using single-molecule techniques such as atomic force (AFM)
and transmission electron microscopy (TEM), we will verify the correct assembly and
geometry of the folded constructs. Several new designs will be introduced and compared
against existing layouts. We will ultimately highlight the advantages of our particular DNA
nanostructure design that will be employed to demonstrate its lipid scrambling activity.
As the lipid bilayer’s hydrophobic core presents a high energetic barrier for the negatively
charged DNA [25], hydrophobic modifications are required for the stable membrane inser-
tion of DNA nanostructures. Although there are several tags applicable, the commercial
availability in a variety of modification options made cholesterol the most prominent of them.
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However, a common issue of hydrophobically modified DNA constructs is their tendency
to aggregate. In order to understand and avoid this problem, we will study the aggregation
behaviour of cholesterol-modified ssDNA, dsDNA, and of our DNA nanostructure design
introduced in the previous chapter. In a collaboration with the group of Aleksei Aksimen-
tiev from the University of Illinois at Urbana-Champaign, we will employ a combination
of all-atom molecular dynamics (MD) simulations, gel electrophoresis and dynamic light
scattering to study the aggregation depending on the DNA sequence, and the number and
modification position of the cholesterol groups. Our results reveal an interaction of ssDNA
with cholesterol that can be exploited to shield the hydrophobic group. We thereby introduce
an easy-to-implement mechanism to control aggregation of DNA nanostructures simply by
design.
Building up on this acquired knowledge, we will investigate the DNA constructs’ interaction
with lipid membranes in Chapter 5. Electrophysiology experiments verify that our cholesterol-
modified DNA structure self-inserts into a lipid bilayer and induces an ionic current across
it. However, the insertion efficiency will prove to be very low. We will then employ
the dithionite reduction assay where scrambling activity is assessed from the fluorescence
reduction of dye-labelled lipids located in the membrane of artificial lipid vesicles. After
characterising and optimising several assay parameters, different cholesterol-modified DNA
nanostructures will be tested for their lipid scrambling activity. We will demonstrate that
the conventional dithionite assay of using ~200 nm-sized vesicles and bulk fluorescence
spectroscopy measurements, is not sensitive enough to measure scrambling activity of the
DNA nanostructures as their insertion efficiency is most likely too low to induce a detectable
signal.
In Chapter 6, we will again employ atomistic simulations with the help of Aleksei Aksimen-
tiev’s group to verify that the DNA nanostructure indeed scrambles lipids when membrane-
insertion is assured. The results will not only reveal the stable formation of a toroidal pore
but also that this DNA-induced pore allows lipids to translocate between bilayer leaflets at
rates on the order of 107 lipids per second. To experimentally complement these results,
we will adapt the dithionite reduction assay to giant unilamellar vesicles thereby compen-
sating for the DNA structures’ low insertion efficiency and allowing us to directly trace
lipid scrambling activity at the single-vesicle level using confocal fluorescence microscopy.
Strikingly, experiments indicate similarly high scrambling rates as demonstrated by the simu-
lations. Our de novo designed DNA-built lipid scrambling enzyme can thereby outperform
any known biological scramblase by several orders of magnitude. This demonstrates the
enormous power and still unexplored opportunities of controlling lipid homeostasis using
DNA nanotechnology.
Chapter 2
DNA nanotechnology & lipid scrambling
Parts of this work previously appeared in:
A. Ohmann, K. Göpfrich, H. Joshi, R. F. Thompson, D. Sobota, N. A. Ranson, A. Aksimen-
tiev, and U. F. Keyser. ‘Controlling aggregation of cholesterol-modified DNA nanostructures.’
Nucleic Acids Research, 47(21):11441–11451 (2019).
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2.1 Folding DNA into 3D shapes
Some people see a DNA robot and say,
‘You can build a robot.’
Some people see a robot and say,
‘You can build anything.’
– William M. Shih
DNA is an organic molecule composed of nucleotides that, via covalent bond formation,
arrange into long polymers – the DNA single strands. Nucleotides contain one of four
nitrogenous bases: adenine (A), cytosine (C), guanine (G), or thymine (T) (Fig. 2.1a). The
number of nucleotides (nt) determines the length and their order determines the sequence
of a DNA strand. Due to the formation of hydrogen bonds between complementary bases
(A with T and G with C), a process called ‘hybridisation’, stable ‘base pairs’ are formed,
turning single-stranded DNA (ssDNA) into double-stranded DNA (dsDNA). This dsDNA
then typically adopts the characteristic double-helical structure as first proposed by Watson
and Crick in 1953 [26] based on X-ray scattering experiments by Franklin et al. [27]. While
DNA is used in living cells to store genetic information, with a distance between base pairs of
0.34 nm and a diameter of 2 nm, DNA is ideally suited as a building material at the nanoscale.
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Fig. 2.1 Development of DNA nanotechnology. (a) Structure of B-form dsDNA with Watson-
Crick base pairing [26] and an axial rise per base pair (bp) of 0.33 nm [28]. (b) Seeman’s
design of branched DNA junctions (top), 2D latices (middle) and a DNA cube (bottom).
Adapted with permission [29]. Copyright 2003, Springer Nature. (c) Rothemund’s DNA
origami constructs shown with their scaffold pathways (top half) and AFM images (bottom
half). Scale bars are 1 µm (left) and 100 nm (middle and right). Adapted with permission [30].
Copyright 2006, Springer Nature. (d) DNA origami structures of a stick figure, a bottle and a
version of the Stanford bunny designed from 3D meshes (top half) and analysed with TEM
(bottom half). Scale bars are 50 nm. Adapted with permission [28]. Copyright 2015, Elsevier
Ltd. Entire figure adapted with permission [31]. Copyright 2019, Elsevier Ltd.
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After laying the theoretical groundwork for DNA nanotechnology in 1982, Nadrian Seeman
further developed the technique experimentally, demonstrating the successful self-assembly
of structured materials out of DNA (see Fig. 2.1b) [29, 32, 33]. Other researchers followed
with increasingly complex shapes like an octahedron by Shih et al. in 2004 [34]. Another
milestone in the history of DNA nanotechnology was the introduction of the ‘DNA origami’
technique by Paul W. K. Rothemund in 2006 (see Fig. 2.1c) [30]. The method is based
on directing the folding of a kilobase-long, viral ssDNA strand (termed ‘scaffold’) into a
desired, pre-programmed geometry through the specific hybridisation of ~200 synthetic
ssDNA strands (termed ‘staples’), each typically between 20 to 50 nt long [35].
A crucial step in the simplification of designing DNA constructs was the development of
the open-source programme ‘caDNAno’ by Douglas et al. in 2009 [36]. Desired shapes are
designed graphically and the software calculates the necessary staple strand sequences which
can then be synthesised by a company. This considerably sped up the design process while re-
ducing the error rate facilitating the move from 2D to complex 3D shapes [35]. Another major
step towards the analysis of DNA structures was made in 2011 with the web-based tool CanDo
that can simulate 3D DNA origami shapes and provide an idea about their flexibility and
stability [37]. Multiple design and modelling tools have been developed in recent years and
many are still under active development [28, 38–42]. The advances in experimental expertise
and design software have led to a vast range of applications of DNA nanostructures [3, 43],
particularly regarding nanofabrication with synthetic nanomaterials [44], arranging pathways
for chemical reactions [45, 46], biomolecule- [47] and force-sensing [48, 49], drug deliv-
ery [50, 51] and creating higher order structures (Fig. 2.1d) [28, 52].
In 2012, an alternative technique to DNA origami emerged, where the scaffold is omitted
and only short synthetic ssDNA strands are employed [53]. This enabled the assembly
of significantly more complex shapes than previously demonstrated solely based on short
oligonucleotides. Still, the assembly of scaffolded DNA origami and non-scaffolded DNA
constructs have certain common experimental characteristics. As the melting temperature of
the DNA strands depends on their length and sequence, the folding reaction usually happens
by mixing the DNA strands, heating them to above 90 ◦C to ensure complete separation,
and then cooling them down slowly to room temperature (Fig. 2.2). This thermal annealing
protocol can take from a few minutes up to several days depending on the complexity of
the design [37, 54]. To overcome the repulsive electrostatic forces between the negatively
charged DNA strands, this one-pot reaction typically takes place in a salt buffer with diva-
lent ions such as 10 to 20 mM magnesium chloride (MgCl2) [35], although folding with
only monovalent ions at higher concentration, such as 1 to 2 M sodium chloride, has been
successfully demonstrated as well [55].
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Fig. 2.2 Comparison of DNA origami assembly techniques. Snapshots of folding animations
of scaffolded (a) and non-scaffolded (b) DNA nanostructure assembly during a temperature
gradient typically from > 90 ◦C down to room temperature (a is adapted from [56, 57]).
For the aim of this dissertation to design a synthetic DNA-built mimic of a lipid scram-
blase, using only chemically synthesised oligonucleotides rather than employing the DNA
origami technique has several advantages:
1. Iteration steps in design optimisation are much shorter and more cost-efficient as much
fewer staple strands are needed.
2. As DNA origami structures are generally folded with an excess of staple strands over
the scaffold strand, they require a post-assembly purification step [58]. Non-scaffolded
structures, being assembled at equimolar concentrations of the DNA strands, generally
do not require purification.
3. The design space can be expanded to smaller DNA constructs, as not the entire usually
~7,000 to 8,000 nt long scaffold strand needs to be incorporated into the structure.
This facilitates the creation of designs with a molecular weight more similar to their
protein-based counterparts.
4. Smaller DNA structures allow for significantly longer all-atom MD simulations, as
the computing time required for large DNA origami constructs is very costly and time-
consuming, and therefore typically not feasible. This advantage will be particularly
beneficial in Chapter 6 of this dissertation.
5. Not being limited by the scaffold strand, purely staple-based designs can easily be
produced at micromolar concentrations. This is several orders of magnitude higher
than the nanomolar concentration range typically yielded for DNA origami structures.
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While the larger, scaffolded DNA origami constructs allow for the incorporation of a higher
number of functional groups in the design, we will see in this thesis that an impressive amount
of modifications can be included already in structures made from a few ssDNA strands. This
is also facilitated by the advantage that every DNA strand can be modified while, in contrast,
modifications cannot easily be placed on the viral scaffold DNA. Furthermore, particularly
the scalability of the DNA nanostructure folding concentrations, while maintaining low
production costs, is the most striking benefit of the non-scaffolded design approach. It does
not only broaden the spectrum of experimental opportunities but is a crucial requisite for
possible medical applications in the future. Due to these advantages, this dissertation will
employ non-scaffolded DNA nanostructures rather than the DNA origami technique.
In summary, the versatility, programmability and possibility to design and modify shapes
with nanoscale precision, make DNA nanotechnology an ideal approach to build controllable
structures that could potentially mimic the function of natural proteins.
2.2 Interfacing DNA nanostructures with lipid bilayers
Due to the immense structural control, the biocompatibility of DNA, and the ease of precisely
modifying DNA with functional groups, interfacing DNA constructs with biology has gained
significant importance in recent years [3, 4, 59]. Particularly, the targeted interaction of DNA
with lipid bilayers has become a popular application of DNA nanotechnology [5, 60].
Negatively charged DNA interacts with cationic lipids, particularly under low salt condi-
tions [61], as well as zwitterionic lipids in the presence of divalent cations such as Mg2+ or
Ca2+ [62–64]. However, for a targeted and stable interface without significant dependence
on the lipid composition, and to control the directionality of the insertion, DNA is typically
conjugated to lipids or hydrophobic molecules. While a variety of membrane anchors such as
azobenzene [65], porphyrin [8, 66, 67], ethyl phosphorothioate [68, 69], or tocopherol [70]
have been employed, cholesterol is by far the most prominent [6, 54, 65, 71–84]. Its abun-
dance in natural cell membranes and the commercial availability of cholesterol-tagged DNA
with a variety of linker chemistries render it an ideal functional group to interface DNA
nanostructures with biological and artificial lipid membranes.
Lipophilic DNA-conjugates have been used to functionalise polymersomes [73], microfluidic
droplets [85] and, most prominently, lipid vesicles and planar lipid bilayers [86]. Herein,
lipid-DNA linkers have been employed for drug delivery [87], biosensing [88] and to as-
semble size-controlled liposomes [89] or stimuli-responsive liposome networks [65, 71].
DNA-built mimics of membrane bending [76, 77], membrane scaffolding [90] and fusion
proteins [91, 92] are other prominent classes of membrane-interacting DNA constructs.
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Of particular interest and success has been the application to design DNA nanostructures
that can spontaneously self-insert into lipid membranes and induce ionic currents across
them, thereby mimicking the function of natural protein ion channels [6]. An impressively
large variety of designs across multiple scales ranging from a single DNA duplex [8], via
small non-scaffolded constructs [66–68, 72, 73, 93], to large-conductance DNA origami
transmembrane porins [70, 74] has been devised in recent years.
Interestingly, our work on the smallest of these structures, a porphyrin-modified DNA du-
plex, was of particular importance for this dissertation [8]. This membrane-inserted DNA
nanostructure did not possess a hollow, ion-conducting cavity. Yet it still induced stable ionic
currents across a lipid bilayer suggesting an ionic current flow at the DNA-lipid interface
(see schematic in Fig. 2.3a). MD simulations showed that the lipid headgroups rearrange
towards the amphiphilic transmembrane part of the DNA duplex thereby forming a water-
and ion-filled toroidal lipid pore. However, no efforts investigating the movement of lipid
molecules between the bilayer leaflets were made at that point.
a bIon conduction Lipid scrambling
Fig. 2.3 Schematics of membrane-inserted DNA duplex and DNA scramblase. (a) DNA
duplex (blue) modified with porphyrin (red ellipses) and its envisioned placement inside
a lipid bilayer inducing a toroidal DNA-lipid pore that facilitates an ionic current flux
across the lipid bilayer (grey arrows). Adapted with permission [8]. Copyright 2016,
American Chemical Society. (b) Schematic of the membrane-inserted DNA scramblase
design employed in this dissertation and its envisioned lipid scrambling mechanism. Lipids
initially residing at opposite bilayer leaflets (purple and green) can translocate between the
leaflets via the DNA-induced toroidal pore (indicated by white arrows).
In this dissertation, we hypothesise that such a DNA-induced toroidal pore can not only
conduct ions, as demonstrated previously, but also connects the bilayer leaflets such that lipid
molecules can translocate between them (see Fig. 2.3b). It can thereby mimic the function of
natural lipid scramblase proteins to equilibrate the lipid composition across bilayer leaflets.
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2.3 Lipid scrambling in biological membranes
Living cells use membranes for numerous physiological processes such as compartmentali-
sation of functions, segregation and protection, cell-cell interaction and many others [94].
One way to control these functions and to communicate with the extracellular environment is
to specifically modulate the lipid composition of the plasma membrane. In all animal cells,
there is an asymmetric distribution of phospholipids between the inner and outer leaflet of
the cell’s lipid bilayer [95]. A crucial step in controlling the lipid composition is to overcome
the high energetic barrier of the bilayer’s hydrophobic core. To translocate a phospholipid
headgroup from one bilayer leaflet to the other through the hydrophobic core, a process
called ‘lipid flip-flop’ [96], an energy barrier of > 20 kcal mol−1 must be overcome [97]. The
rates of spontaneous lipid flipping events depend on the chemistry of the lipid headgroup,
their fatty acid chains, the membrane composition and its physical state [98]. However,
spontaneous translocation of phospholipids is generally a very slow process happening at
time scales of several hours to days [96–99]. Nevertheless, lipid flip-flop at rates significantly
faster than passive lipid translocations is essential for a cell’s health. It is required for cell
growth, cellular responses to physiological stimuli, membrane homeostasis, and to cooperate
with proteins in creating intracellular vesicles [97]. Therefore, a transbilayer lipid flipping
mechanism is essential to actively control the lipid composition of the plasma membrane.
Mainly three protein families facilitate lipid flipping: flippases, floppases and scramblases
(Fig. 2.4) [97]. While flippases and floppases are ATP-dependent and work against a concen-
tration gradient to establish and maintain lipid asymmetry, scramblases are ATP-independent
working along concentration gradients to equilibrate the lipid composition [100].
Flippase Floppase Scramblase
Facilitate asymmetry
ATP dependent
Lipid specific
Facilitate symmetry
ATP independent
Non-specific
Extracellular
Intracellular
Fig. 2.4 Comparison of lipid-flipping proteins. Flippases flip lipids from the extracellular
to the intracellular leaflet (flippases flip to the inside), floppases flip lipids the other way
(floppases flip to the outside). Scramblases flip lipids in both directions. While flippases and
floppases flip/flop only specific lipids, scramblases scramble lipids non-specifically [97].
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Cell function, differentiation and growth depend on the precise modulation of the lipid
distribution between bilayer leaflets [98]. To exert control over the equilibration of the
lipid composition induced by lipid scramblases, their activity needs to be regulated. This
is typically mediated by caspases (a family of cysteine proteases) or by adjusting the con-
centration of Ca2+ ions in the cell [95, 98, 101]. As phosphatidylserine (PS) and phos-
phatidylethanolamine (PE) lipids are primarily found in the intracellular (cytoplasmic) leaflet
of the plasma membrane [102], activation of scramblase activity results in their increased
concentration in the extracellular (exoplasmic) leaflet. Particularly the exposure of PS lipids
to the cell surface is connected to critical events such as marking cells as apoptotic to trigger
their removal by macrophages [103]. PS exposure has also been linked to the activation of
blood platelets to regulate blood coagulation by enhancing thrombin production [104], cell
fusion [105] and aiding bone mineralisation [106, 107]. This demonstrates that controlling
the lipid composition is essential for a broad spectrum of physiological processes. Particu-
larly uncontrolled scrambling activity has been linked to severe illnesses such as sickle cell
disease [108] or Scott syndrome, a rare bleeding disorder [109].
Although already in 1985, Rosing et al. demonstrated that impaired scramblase activity
causes Scott syndrome, only in 2010, Suzuki et al. were able to identify a specific molecule,
transmembrane protein 16F (TMEM16F), as a calcium-dependent phospholipid scram-
blase [95, 110]. In 2014, Brunner et al. then obtained the X-ray structure of a TMEM16
fungal homologue from Nectria haematococca (nhTMEM16) (see Fig. 2.5) [111].
90°
ba c
In
Out
Ca2+
Fig. 2.5 Structure of nhTMEM16 scramblase. Side view from the membrane (indicated
by black horizontal lines) using a cartoon (a) or a surface representation (b). Yellow and
blue illustrate the two subunits of the homodimeric protein. Red indicates the position of
bound calcium ions. (c) Rotated view of b with a white double-headed arrow indicating the
hydrophilic groove. Images were created using VMD [112] and structure 4WIT [111] from
the Protein Data Bank [113].
The TMEM16 protein family consists of Ca2+-activated Cl− channels as well as Ca2+-
dependent channels that are at the same time also lipid scramblases [114, 115]. Particularly
the fungal homologues afTMEM16 and nhTMEM16, and human TMEM16E and TMEM16F
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proteins, have been shown to possess this dual function [115], with TMEM16F being the
one that has been studied the most and its physiological role understood best [21, 116–120].
When fully activated by Ca2+ ions, lipid transport rates of scramblases have been estimated
to be ≥ 104 lipids per second [14, 115, 121]. A more detailed discussion on scrambling rates
will be presented in Section 6.3.6 in Chapter 6.
Unregulated scramblases, such as the G protein-coupled receptor opsin [15], that constitu-
tively scramble lipids exist as well which is thought to be mediated by a transient hydrophilic
groove opened through a conformational change [17]. Oligomerisation of single-helix
peptides, such as antimicrobial peptides [122] or the pore-forming protein perforin [123],
have been shown to form toroidal pores that can facilitate phospholipid flip-flop. But also
monomeric single-helix peptides, typically with several repeated sequences in the hydropho-
bic core and decorated by positively charged residues at both termini [120], have also been
demonstrated to induce constitutive, unregulated phospholipid scrambling activity [124, 125].
Despite ample research, the precise mechanism how scramblases translocate lipid molecules
is still poorly understood [120]. The generally accepted ‘credit card’ model (see Fig. 2.6)
suggests that scramblases possess a membrane-exposed hydrophilic cavity, or a groove (see
Fig. 2.5c), which phospholipid headgroups can move through [97, 115, 126].
ba ‘Credit card’ model ‘Out-of-the-groove’ model
Phospholipid PEG-conjugatedphospholipid
Fig. 2.6 Models for lipid scrambling mechanism. (a) Schematic illustration of the credit
card model in which a lipid translocating through the hydrophilic groove of a scramblase
protein is envisaged as a credit card being swiped through a card reader. Adapted with
permission [17]. Copyright 2018, Elsevier Ltd. (b) Comparison of ‘credit card’ (left) and
‘out-of-the-groove’ model (right). While in the credit card model lipids only translocate
through the groove, together with ion permeation, in the out-of-the-groove model local
membrane deformation (indicated by blue arrows) facilitates lipid transfer outside the groove.
Adapted with permission [127].
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Nevertheless, the question if the ion permeation and lipid scrambling pathways are always
the same or can be separate is an ongoing debate [127]. In 2013, a study concluded a separate
pathway for ions and lipids of afTMEM16 [14]. A more recent publication suggested that
ion and lipid conduction pathways are physically the same [128] which had subsequently
been confirmed for the fungal scramblase nhTMEM16 [129]. However, translocations of
lipids with headgroups much larger than the cavity width have been observed which suggests
an additional ‘out-of-the-groove’ transport mechanism (see Fig. 2.6b) [115]. This hypothesis
is supported by a recent structural study of TMEM16F using electron cryo-microscopy
with results indicating that an additional mechanism based on membrane distortion could
independently scramble lipids without requiring a hydrophilic groove [130]. This ongoing
controversy and particularly the still poorly understood mechanism of how lipids enter the
hydrophilic groove make this subject a particularly interesting area of active research.
Although a few previous studies were able to create artificial lipid scramblases via synthesised
cationic steroids [131] or synthetic peptides [125, 132], reported scrambling rates were
generally rather low. Efforts involving the insertion of DNA nanostructures in a lipid bilayer
have so far only been focused on creating ion channels. No results have been reported on
designing an artificial scramblase using DNA making it a highly interesting and innovative
approach. The important biological role and the prevailing controversy about the lipid
translocation mechanism make scrambling activity a particularly intriguing area of study.
2.4 Determining lipid scrambling activity
As the lipid translocation between bilayer leaflets cannot be observed directly, several indirect
detection methods using chemically modified lipid probes have been developed [133]. A
common factor among them is that an asymmetry between the inner and outer bilayer leaflet
is established first. Scrambling activity is then assessed by monitoring how this asymmetry
returns back to a uniform distribution over time [98]. To study lipid scrambling under
controlled conditions, model membrane systems present an ideal environment as they avoid
the complex interplay of active processes found in natural systems.
Scrambling activity has been investigated by electron paramagnetic resonance of spin-
labelled [96], by proton nuclear magnetic resonance of isotopically labelled [134, 135], or
by extraction (using BSA [14] or liposomes [136]) or reduction of fluorescently labelled
lipids [133]. Herein, the most established assay to determine scrambling activity in model
membrane systems is the ‘dithionite reduction assay’ [14, 24, 115, 131, 132, 137–142].
Artificial lipid vesicles are prepared containing a low proportion (~0.5 %) of lipids chemically
modified with the fluorescent dye nitrobenzoxadiazole (NBD). While only weakly fluorescent
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in water, its fluorescence intensity and lifetime increases when located in a hydrophobic
environment [142]. The fluorescence intensity of such NBD-containing lipid vesicles is then
monitored, typically in bulk, using fluorescence spectroscopy. Sodium hydrosulfite Na2S2O4,
also termed ‘sodium dithionite’, which dissociates in aqueous solution into 2 Na+ and S2O2−4
(dithionite), is then added to the vesicle suspension. In the presence of dithionite, the nitro
group (-NO2) on the NBD dye is irreversibly reduced to an amino group (-NH2) forming the
non-fluorescent derivative aminobenzoxadiazole (ABD; see Fig. 2.7).
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Fig. 2.7 Chemical reaction of dithionite reduction. Sodium hydrosulfite dissociates in aqueous
solutions into 2 Na+ and S2O2−4 (dithionite) [24]. Dithionite then irreversibly bleaches NBD
fluorescence by reducing the NBD’s nitro group (-NO2) to an amino group (-NH2). R denotes
a chemical group the NBD is attached to, for example a lipid tail.
A fundamental feature of this assay is that due to the double negative charge, dithionite
does not permeate through membranes [15, 24]. This means that in the absence of scrambling
activity, only NBD-labelled lipids in the outer bilayer leaflet are reduced in their fluorescence.
Assuming an equal distribution of labelled lipids in the inner and outer bilayer, the normalised
fluorescence per vesicle thereby exhibits an intensity reduction to half of the initial value over
time (see Fig. 2.8a). This typically occurs at a time scale of a few minutes where spontaneous
lipid flip-flop is negligible. Thus, the fluorescence reduction establishes an asymmetric lipid
distribution between the bilayer leaflets, a fundamental characteristic of lipid scrambling
assays mentioned at the beginning of this section.
To test the scrambling activity of a scramblase protein or, in our case, a membrane-inserting
DNA nanostructure, prior to addition of dithionite the vesicles are either formed with the
lipid-scrambling complex or are incubated with it to allow membrane insertion to take
place. The same dithionite reduction assay is then performed. If lipid scrambling activity is
induced, NBD-labelled lipids on the inner bilayer leaflet that were previously inaccessible
to be bleached by dithionite, are now transported to the outer bilayer leaflet where their
fluorescence can be irreversibly reduced. Given a complete exchange of lipid molecules
between both bilayer leaflets, the fluorescence intensity should then over time approach 0
(Fig. 2.8b). Example traces of lipid vesicles constituted without or with a calcium-regulated
afTMEM16 scramblase obtained via fluorescence spectroscopy are shown in Fig. 2.8c.
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Fig. 2.8 Dithionite reduction assay to experimentally verify scrambling activity. (a,b) Scheme
of lipid vesicles containing a low percentage of NBD-labelled lipids (green) which are fluo-
rescently reduced (black) upon addition of dithionite. (a) In the absence of lipid scrambling
activity the normalised fluorescence is reduced to 0.5 over time. (b) If lipid flip-flop is
induced by a scramblase, the fluorescence intensity is eventually reduced to 0. (c) Example
traces of fluorescence reduction obtained via fluorescence spectroscopy [14]. Upon addition
of dithionite (asterisk) the normalised fluorescence approaches a value of ≈ 0.5 without a
scrambling protein present (green trace). If vesicles were constituted with the afTMEM16
scramblase the fluorescence intensity rapidly decreases below 0.5 at a calcium-dependent rate
(black and red traces). The fluorescence does not approach 0 as not all lipid vesicles contain
scramblase proteins. Adapted with permission [14]. Copyright 2013, Springer Nature.
For the dithionite assay, lipids can be labelled with NBD at different positions: either
at their headgroup or at their fatty acid tails typically via a hexane (C6) or a dodecane
(C12) linker (see Fig. 2.9). A previous study employed differential spin-label quenching to
determine the position of the NBD dye within the lipid membrane [143]. Interestingly, the
location of the NBD group of tail-labelled (6-NBD-PC and 12-NBD-PC) and headgroup-
labelled lipids (NBD-PE) was found to be very similar (see Fig. 2.9) [144, 145]. This also
provides an explanation why NBD can at the same time exhibit enhanced fluorescence due
to the hydrophobic environment but still be accessible for reduction by the dithionite anion.
An important aspect for the interpretation of the results is to ascertain that through all
stages of the assay, membrane-impermeability of the dithionite is maintained. This will be
discussed more in detail in Section 6.3.5 in Chapter 6. Furthermore, as the signal indicative
of scrambling activity is assessed from the translocation of NBD-labelled ‘reporter’ lipids,
there is an uncertainty of how representative the determined scrambling rates are for the
unlabelled lipids the vesicles are composed of. Due to the presence of the fluorescent tag on
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Fig. 2.9 Schematic diagram of one bilayer leaflet illustrating the location of NBD-labelled
lipids as determined by differential spin-label quenching. Bottom line refers to the centre of
the lipid bilayer. Adapted with permission [144]. Copyright 1990, Elsevier Ltd.
the lipid, its flipping kinetics could differ from the kinetics of the general, unlabelled lipid
composition [133]. However, a recent study employed a perdeuterated variant of 1-palmitoyl-
2-oleoyl-sn-glycero-3-phosphatidylcholine (POPC) as the labelled reporter lipid [135]. The
difference compared to unlabelled POPC is minimal as only some of the hydrogen atoms
were replaced with deuterium. Using proton nuclear magnetic resonance (H1-NMR) as a
readout method, they determined flip-flop rates comparable to a previous study that used
lipids tail-labelled with NBD [146]. This suggests that the presence of the NBD dye at the
lipid tail might not significantly affect the measured scrambling kinetics which agrees with
another report stating that the lipid headgroup charge is a more significant determining factor
for lipid flip-flop than a modification on the fatty acid chain [133].
One drawback of the dithionite reduction assay is that the observed intensity traces are a
superposition of two processes: (a) scrambling of NBD-labelled lipids between the bilayer
leaflets, and (b) their fluorescence reduction by dithionite. If the lipid translocation occurs
very rapidly, the dithionite reduction will be the rate-limiting process. Therefore, estimating
the lipid scrambling rate from the trace of fluorescence reduction can underestimate the
actual rate of lipid flip-flop. We will discuss this in more detail in Section 6.3.6 in Chapter 6.
However, the comparative ease of performing the dithionite reduction assay, the ample
previous research published on it, and the existing equipment and expertise to form and
analyse model lipid bilayer systems in our group, render this assay the ideal choice in this
thesis to determine the scrambling activity of our synthetic, DNA-built lipid scramblase.
Chapter 3
DNA nanostructure design and assembly
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3.1 Introduction
Part of it is DNA and getting DNA to form
interesting and exciting and useful shapes ...
– Nadrian C. Seeman
In this chapter, we will introduce the DNA nanostructure design which will later be employed
as an artificial lipid scramblase. Optimising the folding yield of monomeric structures and
performing an in-depth structural analysis will lay the foundation for subsequent experiments
focusing on the effects of cholesterol modifications, studying lipid membrane insertion, and
lipid scrambling activity.
Polyacrylamide gel electrophoresis will initially be employed as a rapid and cost-efficient
tool to study the folding yield of the DNA nanostructure. It will allow to verify the correct
assembly of the DNA nanostructure in bulk by providing insight on the amount of formed
monomers, dimers and aggregates. This method will then be utilised to optimise the folding
yield depending on the MgCl2 concentration in the assembly buffer. We will furthermore
discuss the influence of ssDNA overhangs at the ends of the design, particularly which
nucleotides prevent stacking interactions best and how many are needed.
While gel electrophoresis is the ideal tool to verify folding yields, it does not allow to deter-
mine the actual size and geometry of the assembled nanostructures at a single-molecule level.
After optimising the folding yield, we will therefore employ atomic force and transmission
electron microscopy, two prevalent techniques in the field of DNA nanotechnology [3], to
confirm that the most prominent band in the gel actually represents monomeric structures
approximately matching the expected design both in shape and size.
Lastly, the optimised design will be compared to previously reported nanostructures able
to insert into lipid membranes and alternative designs devised in this thesis work. We will
compare them regarding the pathways of the ssDNA staple strands and the distribution of
crossovers providing structural stability. Using the computational tool ‘CanDo’ the rigidity
will be analysed to identify undesirable fluctuations or instabilities in the design. Gel elec-
trophoresis will furthermore allow for a quick estimate of their respective folding yields. The
designs will also be compared regarding their ease and flexibility to introduce modifications
at various positions. This will become specifically important later on for the incorporation
of cholesterol tags to facilitate membrane insertion and fluorescent dyes to track the DNA
nanostructures with fluorescence microscopy.
A fundamental comprehension and optimisation of the design is a crucial step as these aspects
need to be kept in mind when designing future experiments and interpreting their results.
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3.2 Materials & Methods
3.2.1 DNA nanostructure assembly
DNA nanostructures were designed using caDNAno software [36]. In order to maximise
specificity of the different strands, sequences were optimised using the web-based analysis
tool NUPACK [38]. DNA oligonucleotides were purchased from Integrated DNA Technolo-
gies, Inc. (IDT) using standard desalting and delivery at 100 µM in IDTE buffer (10 mM
Tris, pH 8.0, 0.1 mM EDTA). If not stated otherwise, required DNA strands for a specific
construct were mixed at a final concentration of 1 µM in TE20 buffer (10 mM Tris, 1 mM
EDTA, 20 mM MgCl2, pH 8.0). DNA nanostructure assembly was performed as described
previously [54]. Briefly, the mixture was heated to either 85 or 95 ◦C for 5 min, subsequently
cooled to 25 ◦C over 18 hours and finally stored at 4 ◦C. Heating to 95 ◦C reduced the visible
aggregation of the folded DNA nanostructures upon analysis with PAGE and was therefore
the superior protocol. For the assembly it was important that all DNA strands were at the
same concentration. Therefore, the minimum final amount of assembly mix was 100 µl
in order to not pipette less than 1 µl per DNA strand. Furthermore, the concentration of
purchased DNA strands was measured using UV-vis spectroscopy (NanoDrop 2000, Thermo
Fisher Scientific) to verify that it is indeed approximately 100 µM.
3.2.2 Polyacrylamide gel electrophoresis
Gel electrophoresis, a well-established experimental technique in molecular biology, is one
of the most cost-efficient and powerful tools for the characterisation of DNA nanostruc-
tures. Upon applying an electric field across a gel formed from cross-linked polymers, the
negatively-charged DNA migrates through the porous gel matrix against the direction of the
field. When keeping the applied voltage, the pore size of the gel, and the buffer conditions
constant, the migration distance of the DNA nanostructure primarily depends on its size and
shape [147]. Thereby information can be gained about the different structural conformations
of the DNA sample, e.g. folded and misfolded populations can be separated. To maximise the
separation resolution, the average pore size of the gel matrix needs to be chosen appropriately
regarding the size of the molecule to be analysed. As a macromolecule separation method,
agarose gel electrophoresis is best suited for analysing large DNA constructs, such as DNA
origami. The size of the here designed DNA nanostructures is on the order of ~10 nm. This
makes non-denaturing (native) polyacrylamide gel electrophoresis (PAGE) with pore sizes in
the low nanometre range (depending on the acrylamide concentration [148, 149]) the optimal
tool, as used previously for a DNA structure of similar size [54].
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Gel preparation, running conditions & staining
All chemicals were acquired from Sigma-Aldrich and all gel equipment from Bio-Rad. Gels
were hand-cast at a concentration of 10 % polyacrylamide supplemented with 0.5x Tris-
borate-EDTA and 11 mM MgCl2, as described previously [54]. The detailed recipe is listed
in Table 3.1.
Table 3.1 Recipe for casting one 10 % PAGE gel. For two gels all amounts are doubled.
Gel mixture recipe Amount Concentration Order #
Acrylamide/Bis-acrylamide, 30 % solution 5 ml 10 % A3699
10x Tris-Borate-EDTA (TBE) pH 8.3 750 µl 0.5x T4415
0.5 M MgCl2 330 µl 11 mM M2393
H2O 8.92 ml
Total volume 15 ml
Polymerisation initiators
10 % (w/v) ammonium persulfate (APS) 150 µl 0.1 % A3678
N,N,N’,N’-Tetramethylethylenediamine (TEMED) 10 µl 0.07 % T9281
Mini-PROTEAN® spacer plates with 1.0 mm integrated spacers (1653311, Bio-Rad) were
used together with Mini-PROTEAN® short plates (1653308), clamped together, and mounted
in a Mini-PROTEAN® Tetra Cell casting stand. Once assembled, APS and TEMED were
added to the 15 ml gel mixture. The mixture was then immediately vortexed, poured between
the spacer plates using a glass Pasteur pipette, and the gel comb was inserted. The gel was
left to polymerise for 1 to 2 hours.
Gels were run in a Mini-PROTEAN® Tetra Cell (Bio-Rad) which was embedded in crushed
ice a few minutes prior. The gel was run for 90 min at 100 V in running buffer containing
0.5x TBE and 11 mM MgCl2 (for recipe see Table 3.2). DNA was stained by immersing the
gel slab for 10 min in GelRed® 3x in water (Biotium). Subsequent imaging was performed
on a GelDoc-ItTM (UVP) using UV excitation.
Table 3.2 Recipe for PAGE running buffer sufficient for one run.
Running buffer recipe Amount Concentration
10x Tris-Borate-EDTA (TBE) pH 8.3 40 ml 0.5x (44.5 mM Tris-borate, 1 mM EDTA)
0.5 M MgCl2 17.6 ml 11 mM
H2O 742.4 ml
Total volume of running buffer 800 ml
A detailed collection of advice and troubleshooting guidance for performing PAGE with
DNA nanostructures can be found in Appendix A.1.
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Sample loading & DNA ladder
2 µl of DNA nanostructures at 1 µM were mixed with 0.4 µl custom-made 6x orange loading
dye (for detailed recipe see Table 3.3). The loading dye was prepared using TE20 (10 mM
Tris, 1 mM EDTA, 20 mM MgCl2, pH 8.0) as the main buffer and stored at room temperature.
2 µl of the mixture were loaded into the well using 0.5 mm thick Corning® gel-loading tips
(CLS4853, Sigma-Aldrich).
Table 3.3 Recipe for 6x orange loading dye. Amount of Orange G can be approximate as it is
only used to add visibility for sample handling (typically the tip of a spatula is sufficient). For
loading DNA nanostructures the dye was made with TE20 buffer. Note that the concentration
of this buffer should not be at 6x even though the recipe is for the 6x loading dye.
6x loading dye recipe Amount Concentration Order #
Ficoll®-400 150 mg 15 % (w/v) F2637
Orange G 9 mg 0.9 % (w/v) O3756
Buffer solution fill to 1 ml
Total volume of 6x loading dye 1 ml
Reference DNA markers were either L: GeneRuler Low Range DNA Ladder (SM1191,
Thermo Fisher Scientific), or L*: 50 bp DNA ladder (N3236, New England Biolabs). With
the loading dye described above diluted in TE20 buffer, DNA ladder L can be prepared
ready-to-load using the recipe listed in Table 3.4. The ladder was stored at 4 ◦C and between
1.2 and 2 µl were typically loaded onto the gel.
Table 3.4 Recipe for preparing 120 µl of ready-to-load DNA ladder L.
DNA ladder recipe Amount
GeneRuler Low Range DNA Ladder, 0.5 µg µl−1 12 µl
6x orange loading dye (prepared with TE20 buffer) 20 µl
TE20 buffer 88 µl
Total volume of ready-to-load DNA ladder L 120 µl
Image analysis
Gel images were analysed using Fiji [150]. Images were cut, the colour scale was inverted
and the background was subtracted using the integrated rolling ball method at a radius of
300 pixel (> 30 % of the shortest image dimension). Using the gel analyser tool intensity plots
per lane were generated. The background for each lane was again subtracted by drawing
a line from the intensity level before the gel pocket to the level after the furthest band.
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Monomer, dimer and multimer peaks were identified, and approximated by lines following
the contour of the peak from the full width half maximum downwards. The areas under these
approximated monomer, dimer and multimer peaks was then measured using the wand tool.
The obtained values were normalised to the sum of their respective lane which compensated
for a possible variation in sample loading volume and therefore allowed the comparison of
folding yields between different lanes.
3.2.3 Atomic force microscopy of DNA nanostructures
5 µl of DNA nanostructures (typically at a concentration of 10 nM) in TE20 buffer were
deposited on a freshly cleaved mica surface (Agar Scientific) and incubated for 90 s. To
remove excess sample the surface was rinsed three times with 1 ml Milli-Q water and
blow-dried with nitrogen. Imaging was carried out by M. Ricci using a Cypher S AFM
(Oxford Instruments) in amplitude modulation in air and at room temperature using AC240TS
cantilevers (Olympus) with a nominal spring constant of 2 N m−1. The set-point to free
amplitude ratio was generally kept at around 70 % with a free oscillation amplitude of 20 nm.
The frequency of excitation was set close to the resonance of the first flexural mode (around
70 kHz) and a repulsive mode was preferred. The scan speed was set to either 1 or 2 Hz
obtaining an image of 256 × 256 pixels. Images were flattened and band-pass filtered using
Gwyddion [151]. For analysis of DNA nanostructure dimensions, a height mask was applied
and an ellipse was automatically fitted to these areas approximating major and minor axes
which was interpreted as length and width of the nanostructures, respectively.
3.2.4 Transmission electron microscopy of DNA nanostructures
3 µl of DNA nanostructure solution (1 µM in TE20 buffer) were deposited onto an electron
microscopy grid (Agar) with a continuous carbon layer treated by glow discharge before use
(30 s, 10 mA). Sample was blotted away and the surface of the grid was washed twice with
water and once with 1 % (w/v) uranyl acetate staining solution. 3 µl staining solution was
then incubated on the surface of the grid for 30 s. Subsequently the excess was blotted away.
Grids were imaged by R. F. Thompson with an FEI Spirit G2 12 BioTWIN transmission
electron microscope with a Gatan US1000XP 2k x 2k CCD camera.
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3.3 Results & Discussion
3.3.1 Design overview
An overview of the design of the DNA nanostructure used throughout this thesis work is
presented in Fig. 3.1. The structure consists of eight ssDNA strands (Fig. 3.1a) that, in the
presence of Mg2+ ions and subject to a thermal annealing protocol, self-assemble into four
interconnected DNA duplexes giving the design an overall cuboid shape (Figs. 3.1b-d). The
required DNA strands range from 23 to 47 nt in length and are listed in Table 3.5.
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Fig. 3.1 Design of DNA nanostructure. (a) 2D illustration highlighting the pathways of the
ssDNA strands as well as the crossover positions. Complementary strands are displayed
in light and dark grey. Black arrows indicate DNA nicks that facilitate the incorporation
of modifications on the DNA 3’ and 5’ terminal ends. View from side (b), top (c) and
perspective (d) of a 3D representation of the folded nanostructure. The 3D model was created
by converting the caDNAno file to a protein data bank (PDB) file format using an open-source
online tool [42] and then depicted using a surface representation in VMD software [112].
The assembled DNA construct has a length of ≈ 13.1 nm and a width of ≈ 5.0 nm,
assuming an axial rise per bp of 0.33 nm [28], a mean distance between two bases of
0.43 nm for ssDNA [152], a dsDNA diameter of 2.25 nm [37], and an interhelical distance of
2.7 nm [153]. The layout follows the caDNAno design rules which suggest DNA crossovers
at specific locations when neighbouring DNA strands are close to each other with respect
to their helical rotation [36]. In the central region there are four DNA nicks (see Fig. 3.1a)
which allow the incorporation of cholesterol modifications on the 3’ or 5’ terminal ends
which will facilitate the insertion of the DNA nanostructure into a lipid bilayer. These nicks
are strategically placed at positions that face away from the nanostructure to the outside as
the helical pitch of the DNA is taken into account. This will be discussed more in detail in
Chapter 4 and is specifically highlighted in Fig. 4.10.
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Table 3.5 DNA sequences and strand names used to assemble DNA nanostructures.
Name Sequence (5’ to 3’) Length (nt)
sc1 CCTTTCCACGAACACAGGGTTGTCCGATCCTATATTACGACTCCTTT 47
sc2 TTTGGGAAGGGGTTCGCAAGTCGCACCCTAAACG 34
sc3 TCTTATCCTGCATCGAAAGCTCAATCATGCATCTTT 36
sc4 TTTATGTTGAAGGCTCAGGATGC 23
st1 TTTATCGGACATTCAACATGGAGTCGTGGTGCGACT 36
st2 TGCGAACAGGATAAGACGTTTAGAATATAGGTTT 34
st3 TTTTTCGATGCCCCTTCCCGATGCATGAAGGGCATCCTGAGCCACCC 47
st4 TGTGTTCGTGGAATTGAGCTTTT 23
The square-lattice arrangement of the four DNA duplexes leads to a small, central lumen along
the long axis of the nanostructure (see Fig. 3.1c). While this cavity would be large enough
to allow ions to pass [154, 155], we have previously demonstrated that ion permeation can
also occur at the DNA-lipid interface [8]. It is therefore anticipated that this DNA construct
creates a passage for ions when inserted into a lipid bilayer. This can be exploited to verify the
insertion capabilities of the DNA nanostructure design by performing single-molecule current
recordings across lipid bilayers, as typically employed to verify the successful membrane
insertion of DNA constructs [6, 66, 68]. This aspect will be focused on in Chapter 5.
Lastly, the design is composed of a dsDNA core section (≈ 10.6 nm / 32 bp) flanked at both
ends by eight ssDNA overhangs (see Fig. 3.1a) to prevent stacking interactions between the
nanostructures which will be discussed in detail in the following section.
3.3.2 Single-stranded overhangs to avoid stacking
An initial hurdle to overcome was to optimise the yield of monomeric DNA nanostructures.
A crucial design element are four single-stranded DNA overhangs at each end of the design
(blue in Figs. 3.2a,b). PAGE analysis of the folded structures shows that without any
ssDNA overhangs (–) the DNA nanostructures formed clusters that remained in the gel
pocket (see Fig. 3.2c). This is caused by stacking interactions between the blunt double-
strand ends [156, 157] and enhanced by the presence of the divalent Mg2+ ions in the
buffer solution [158]. Introducing four, single-nucleotide ssDNA overhangs at either end of
the nanostructure resulted in the appearance of two additional bands in the gel which are
interpreted as DNA nanostructure monomers and dimers (see Fig. 3.2c). While cytosine
overhangs (C) do not mitigate clustering, a monomer band appears for both guanine (G)
and adenine (A) overhangs. However, the highest monomer band intensity was observed for
thymine overhangs (T). This makes thymine nucleotides most efficient at preventing stacking
interactions consistent with calculations on free stacking energies [159]. Further extension of
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the overhangs to up to three thymine nucleotides (TTT) almost entirely eliminated aggregation
leaving an intense monomer band with low presence of dimers.
Although the structure is formed from 128 bp and 24 nt of ssDNA overhangs, the monomer
band appears slightly below the 400 bp mark. As DNA ladders are composed of pieces of
double-stranded DNA of various lengths, they can only be used as a relative comparison for
DNA nanostructures, for example across different gels, as the geometry of the nanostructure
is different from dsDNA which alters its running behaviour in the gel. To verify that this most
intense band indeed refers to monomeric nanostructures, transmission electron microscopy
was employed which will be discussed in Section 3.3.4.
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Fig. 3.2 Dependence of inter-structural stacking on the ssDNA overhang type. (a) 2D layout
of the nanostructure design including strand names. Single-stranded DNA overhangs are
highlighted in blue. (b) 3D representation illustrating the position of the ssDNA overhangs.
(c) PAGE analysis of DNA nanostructures folded with various overhanging ssDNA bases
on all eight ends ranging from single nucleotides (C, G, A, or T) to multiple thymines (TT
and TTT). Specific DNA sequences for each design are listed in Table A.1 in the Appendix.
The amount of monomeric structures increases while aggregation in the pocket decreases the
more thymine overhangs are employed. L denotes a DNA ladder (see Section 3.2). Samples
and ladder were run on the same gel but space between them was omitted as indicated by the
dashed line. (d) Histogram plotting the intensities of monomer, dimer, and multimer bands
normalised to their sum per lane.
Determining the band intensity of monomers, dimers and multimers normalised per lane,
results in a quantitative analysis of their respective yield (see Fig. 3.2d). The optimised
structure with TTT overhangs yields a band intensity of 66 % for monomers, 18 % for dimers,
and 16 % for multimers. However, it needs to be pointed out that larger DNA structures
result in more intense bands as the signal is determined by the number of dye molecules that
intercalate into the DNA, which is larger for bigger structures. Therefore, simply judging by
3.3 Results & Discussion 29
the intensity of the dimer and multimer bands, their actual share in the sample mixture will
be overestimated thereby underestimating the monomer yield. Assuming a linear relationship
between DNA nanostructure size and intercalating number of dye molecules, Equation 3.1
can be used to achieve a more representative estimate:
%Monomer = 100−%Dimer−%Multimer
= 100− IDimer
2
− IMultimer
n
(3.1)
where n≥ 3 is the number of monomeric structures the multimers are formed of, and IDimer
and IMultimer are the percental proportion of dimers and multimers judging by their respective
band intensity (as plotted in Fig. 3.2d). For n = 3, to gauge a lower limit of the monomer
yield, Equation 3.1 results in a monomer folding yield of ≈ 86 %. This means that in a
solution of folded DNA nanostructures with TTT overhangs, roughly 86 % can be assumed
as being monomeric. Following the trend of increasing monomer band intensity with higher
number of thymine ssDNA overhangs, this yield could possibly be even more improved by
adding a fourth thymine nucleotide to the overhangs. Interestingly, the same trend is not
observed in the dimer band intensities (12 % for T, 19 % for TT and 18 % for TTT). This
could mean that dimer formation is not caused by stacking interactions but rather due to
misfolding.
Studying the number of single TTT extensions on each side of the design revealed that
all eight overhangs (four on each side) are necessary to effectively reduce clustering (see
Fig. 3.3). Including overhangs on only one side of the construct resulted in a mixture of
clustering and a pronounced band at a shorter run length (4 |0 in Fig. 3.3). As this design
favours dimer formation of DNA nanostructures via stacking interactions of the blunt double-
stranded DNA ends on one side, the intense, slow migrating band can be identified as DNA
nanostructure dimers, confirming the initial interpretation.
Due to the results of these experiments, the DNA nanostructure will always be folded with
eight TTT overhangs, unless stated otherwise.
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Fig. 3.3 Dependence of inter-structural stacking on the number of TTT overhangs. (a) PAGE
analysis of DNA nanostructures folded with gradually increasing numbers of TTT overhangs
on each side of the nanostructure. (b) Histogram plotting the intensities of monomer, dimer,
and multimer bands normalised to their sum per lane. (c,d) 2 % agarose gel of samples
analysed in a shown as greyscale (c) and false colours (d) to highlight changes in band
intensities. Ladder refers to 1 kb DNA ladder (New England Biolabs). For an overview of the
stepwise introduction of DNA strands with TTT overhangs, see Table A.2 in the Appendix.
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3.3.3 Folding yield dependence on magnesium concentration
In the previous section, the DNA nanostructures were folded in 1x TE and 20 mM MgCl2.
This buffer was chosen as a starting point as it has previously been successfully employed to
fold a DNA construct of similar geometry [54]. To explore how our particular design folds
at different Mg2+ concentrations, the DNA nanostructure has been assembled at various
concentrations of MgCl2 and analysed with PAGE (see Fig. 3.4a).
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Fig. 3.4 Influence of loading dye on DNA nanostructure analysis. DNA nanostructures were
folded at varying concentrations of MgCl2 between 0 and 30 mM and loaded into the gel
pocket either using blue (a) or orange (b) loading dye each at 1x final concentration (for
buffer contents see Table 3.6). L* refers to a 50 bp DNA ladder (New England Biolabs).
The gel shows that even without additional Mg2+ ions during the assembly, a certain
amount of structures fold to form monomers. This could be explained by the fact that the
DNA nanostructure is very small and electrostatic repulsion of the DNA strands does not
impair folding as much as it would for larger DNA origami constructs. However, for MgCl2
concentrations up to 10 mM a significant portion of structures remains as clusters in the
gel pocket. From 12 mM onwards, these clusters are suddenly reduced and the results are
comparable to previous ones obtained when studying single-stranded overhangs. While this
suggests that this DNA nanostructure design only folds well for MgCl2 concentrations above
10 mM, the result is actually an artefact of the loading dye used to load the samples into
the gel pockets. At the final 1x concentration used for loading, the employed, commercially
available blue loading dye still contains 11 mM EDTA in it (for dye contents see Table 3.6).
EDTA is a chelator for metal ions with the following hierarchy in binding affinity:
Fe3+ > Cu2+ > Pb2+ > Zn2+ > Cd2+ > Co2+ > Fe2+ > Mn2+ > Ca2+ > Mg2+ [160].
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Table 3.6 Comparison of blue and orange loading dye contents at 1x concentration. Orange
dye was prepared using TE20 buffer. As DNA nanostructure samples are already in TE20
buffer, the 6x orange dye only needs to match it but does not need to be more concentrated.
1x Blue loading dye 1x Orange loading dye Unit
Dye Bromophenol blue Orange G
0.015 0.15 % (w/v)
Ficoll®-400 2.5 2.5 % (w/v)
EDTA 11 0.17 mM
Tris-HCl 3.3 1.7 mM
SDS 0.017 — %
MgCl2 — 3.3 mM
pH 8.0 8.0
While its affinity is higher for other metal ions, EDTA is still a very effective chelator for
Mg2+ ions. This means that loading the sample with the commercially available blue dye
results in a reduction of free Mg2+ ions as they are captured by EDTA in a 1:1 ratio [161].
Although this reduction is post-assembly and only during the gel sample preparation and
loading, EDTA could even chelate Mg2+ ions that are already bound to the DNA. The
magnitude of this effect can be highlighted by loading the same exact samples onto a gel
using a custom-made gel loading dye with only 0.17 mM EDTA (see Table 3.6 for orange
dye contents). The resulting gel reveals that DNA nanostructure aggregation only occurs at
very low MgCl2 concentrations and is already significantly reduced from ~6 mM onwards
(Fig. 3.4b). This means, that the EDTA-containing blue loading dye affected the interpre-
tation at which MgCl2 concentrations the DNA constructs fold well. The sudden change
between assembly at 10 mM and 12 mM supports this interpretation as this exactly bridges
the 11 mM threshold of EDTA. It also shows that depletion of Mg2+ ions leads to DNA
nanostructure aggregation, even after they have been correctly assembled beforehand.
It should be noted that the custom-made 6x loading dye (orange dye) contains 20 mM MgCl2.
However, this is not expected to significantly interfere with the results as this change in
MgCl2 concentration only happens after the folding process. If the assembly was successful,
it should not reduce the yield. If the assembly was not successful, it will not significantly
increase the yield as most structures aggregate without proper thermal annealing (Fig. 4.12b).
For these reasons, the custom-made dye will be used exclusively from here on.
For large DNA origami nanostructures, typically a rather narrow range of MgCl2 concentra-
tion yields successfully folded structures [35, 55]. To determine if there is such an optimal
concentration for this nanostructure design, the band intensities of monomers, dimers and
multimers have been analysed as illustrated in Fig. 3.5. From approximately 6 mM MgCl2
onwards, monomer band intensities dominate compared to aggregates. Increasing the MgCl2
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concentration to 20 mM further enhances the monomer intensities from 54 % to 68 %,
while both dimer and multimer formation decrease from 29 % to 20 % and 18 % to 12 %,
respectively. Even though 30 mM improves the monomer yield even slightly more, some
experiments require a low amount of MgCl2, which would be more difficult to achieve after
assembly without diluting the DNA nanostructures too much. Furthermore, a number of
protocols have been established previously on DNA nanostructures folded at 20 mM in our
group. For these reasons, the optimal MgCl2 concentration to fold this design at was chosen
to be 20 mM and, if not stated otherwise, was used from here onwards.
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Fig. 3.5 Dependence of DNA nanostructure folding yield on the concentration of MgCl2
in the folding mix. (a) Same PAGE analysis of DNA nanostructures folded at different
concentrations of MgCl2 as shown in Fig. 3.4b. Coloured sections highlight monomer, dimer,
and multimer bands, as well as a small population of misfolded nanostructures at low MgCl2
concentrations. (b) Graph showing the normalised intensity of bands referring to monomeric,
dimeric, multimeric, or misfolded nanostructures as shown in a. For the analysis, care was
taken that none of the band intensities were saturated.
3.3.4 Size verification of DNA nanostructures with AFM & TEM
AFM measurements
In the previous sections we have applied gel electrophoresis to analyse the different size
populations of the folded DNA nanostructures which allowed us to optimise the design and
folding protocol to maximise the amount of monomeric structures. However, DNA reference
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ladders cannot be used to judge the absolute size and geometry of the DNA nanostructures.
Atomic force microscopy (AFM) has previously been applied successfully to measure the
size and geometry of assembled DNA nanostructures [30, 45, 54, 74, 162, 163]. To determine
the dimensions of this particular design, assembled structures were deposited on a mica
surface and imaged in air. The recorded AFM images shown in Figs. 3.6a,b reveal a relatively
homogeneous distribution of elevated spots resembling the DNA nanostructures.
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Fig. 3.6 Atomic force microscopy analysis of DNA nanostructures. (a,b) Topographic
AFM images showing DNA nanostructures deposited on a mica surface and imaged dry.
Arrows indicated likely monomeric structures. Images were acquired by M. Ricci. (c) Graph
depicting the lengths and widths derived from ellipses fitted to the nanostructures shown in a.
The dashed line indicates circularly shaped structures. Blue area highlights data most likely
referring to monomeric nanostructures. The model of the DNA nanostructure in the lower
left corner is scaled to the theoretical dimensions. Inset shows a 2D density plot peaking at
≈ 12.8 nm and ≈ 10.3 nm length and width, respectively. (d) Histogram of the maximum
height distribution of DNA constructs. Red line represents a Gaussian fit. Data in c,d was
obtained from 136 structures identified in a.
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The dimensions, measured from ellipses automatically fitted to the structures, show a clear
asymmetry due to the deviation from the dashed line which would indicate a circular shape
(see Fig. 3.6c). The majority of data points is localised at the low end of the size spectrum
between ~10 and 20 nm which most likely represent monomeric DNA nanostructures (see
blue area and inset in Fig. 3.6c). The low number of determined larger structures could refer
to dimeric or multimeric structures. The fact that the larger measured constructs increase
in asymmetry could indicate that the dimeric and multimeric DNA constructs might be
connected longitudinally on their short edge. However, due to the sample density the larger
sizes could also be monomers located too close to each other to be successfully resolved.
The average length (ama jor) and width (aminor) for monomeric DNA nanostructures (blue
shaded area in Fig. 3.6c) was determined to be 13.2 ± 2.3 nm and 9.9 ± 2.1 nm (mean ± SD),
respectively. The length matches very well with the theoretical value of ≈ 13.1 nm given
that tip convolution could cause the structures to appear larger [164]. The width, however,
amounts to roughly double of the expected value of ≈ 5.0 nm which could have several
reasons. The dimensions of the nanostructures might be smaller or on the order of the size
of the AFM tip which would represent a measurement of the tip geometry rather than the
actual sample. Another possibility for the constructs approximately doubling in width could
be that they might have adhered onto the surface due to the positive Mg2+ ions present
during the sample deposition. Lastly, sample deformation could occur due to the applied
forces onto the DNA constructs by the oscillating, probing AFM tip. The latter explanation
would agree with the maximum height distribution averaging only at zmax = 0.72 ± 0.08 nm
(mean ± SD; Fig. 3.6d). Such a height has previously been reported for DNA embedded in a
salt layer imaged in air together with the observation that DNA height was always less than
the theoretical value when determined with AFM (even without a salt layer) due to elastic
deformation caused by the interaction of the tip with the sample [165].
TEM measurements
Although atomic force microscopy did provide some more information about the size and
geometry of the DNA nanostructures, the determined dimensions only matched in length
with the expected value but not in width. While these results could eventually be the actual
sizes of the DNA nanostructures, meaning that it did not assemble as expected, multiple
reasons were presented why and how the AFM measurement method inherently could have
influenced the result to cause the increased width. A further improvement of measuring the
dimensions of the DNA constructs could be expected by performing transmission electron
microscopy (TEM). TEM imaging has frequently been employed to determine the dimensions
of assembled DNA nanostructures [35, 36, 166–168]. By applying this technique, the lowest
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resolvable, structural feature is not related to a tip size and no elastic deformations due to
compression forces would bias the measurements.
Figure 3.7 summarises the results obtained from TEM analysis of positively stained DNA
nanostructures. Heavy ions in the uranyl acetate staining solution accumulate on the DNA
constructs which results in an increased scattering probability for electrons in the beam due
to the larger cross-section of the uranium ions. Therefore, areas with higher contrast are
associated with the DNA constructs (Figs. 3.7a,b,d).
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Fig. 3.7 Transmission electron microscopy analysis of DNA nanostructures. (a) Example
TEM micrograph of positively stained DNA nanostructures. A magnified view (b) shows
the monomeric DNA nanostructures as dark, rectangular shapes. White scale bars denote
50 nm. (c) Histogram of the length and width distribution of monomeric DNA nanostructures
obtained from 211 structures. (d) TEM micrographs used for size distribution analysis.
White scale bars denote 100 nm. Images were acquired by R. F. Thompson.
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In agreement with the PAGE results, only a small amount of multimeric structures is observed.
The magnified view in Fig. 3.7b illustrates that the majority of structures is of similar size
and rectangular geometry which is consistent with monomeric nanostructures laying flat on
the TEM grid. The images in Fig. 3.7d also show that aggregates predominantly adopt chain-
or ring-like structures which could represent multimers caused either by stacking interactions
or incorrect strand hybridisation. However, these were not observed with AFM analysis so
they could also be an artefact emerging from the sample preparation, for example due to
uranyl acetate staining.
Analogously to the analysis of the AFM data, images were flattened, an intensity mask
was applied and ellipses were automatically fitted to obtain the dimensions of the DNA
structures. As predominantly the size and geometry of monomeric constructs were of interest,
masked regions of aggregated structures were excluded. The lengths and widths of over 200
monomeric DNA nanostructures were measured from the images shown in Fig. 3.7d yielding
an average length of 11.7 ± 1.2 nm and width of 5.4 ± 0.6 nm (mean ± SD; Fig. 3.7c). The
length matches well with the expectations given that only the central 10.6 nm of the DNA
constructs consist of double-stranded DNA. While the overhanging TTT ssDNA bases extend
the total length to ≈ 13 nm, their reduced contrast is likely to bias the measurement towards
shorter dimensions. An explanation for the slightly wider than expected ≈ 5 nm width
could be electrostatic repulsion between the DNA strands of the structure. Cryo-electron
microscopy of larger DNA origami structures has shown that the distance between the
midpoints of neighbouring duplexes can vary between 1.85 nm (at DNA crossover positions)
and 3.6 nm [168]. Furthermore, as the structures were positively stained, the slightly larger
width could result from uranyl atoms predominantly binding to the DNA backbone [169]
making the DNA structures appear wider without affecting their length.
In summary, while AFM measurements provided some insight into the size and geometry,
particularly the width of the DNA nanostructures significantly differed from the expected
value possibly due to tip-sample interaction. Analysis with TEM, however, introduced
fewer possible biases and provided results closer to the theoretically expected ones. The
currently applied method of determining dimensions by fitting ellipses to the structures might
have introduced some deviation as well. A most likely more accurate approach would be
to perform class-averaging on a large sample size of imaged structures and measure the
geometry from this. Furthermore, negatively stained nanostructures could yield even more
representative dimensions as well. Nevertheless, we could conclude from these results that
the DNA nanostructures fold correctly with approximately the expected size and geometry.
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3.3.5 Comparison to alternative DNA nanostructure designs
Figure 3.8 presents an overview of different DNA nanostructure designs comparing previous
ones to the ones devised in this work. Each design is accompanied by a mechanistic
simulation using the web-based tool CanDo [37] which provides a rapid computational
feedback on the 3D structure and flexibility (right in Fig. 3.8). All of these structures were
designed to be used for insertion into lipid bilayers. The ones devised in our group (CP
= Cambridge Pore) are all based on a 4-helical architecture differing in length and strand
layout. While CP1 was designed previously [54], CP2 to CP4 were created within this thesis
work. The 6HP design has been devised and studied extensively by another group [72].
In order to compare the designs, all structures have been assembled at 1 µM in TE20 buffer
using the 18 hour folding protocol described in Section 3.2. The necessary sequences to fold
each structure are summarised in Table A.3 in the Appendix. These sequences were also
used to determine the molecular weights of the nanostructures. The folded constructs have
then been analysed with PAGE (see Fig. 3.9a).
The gel shows clear monomer bands for all designs while the amount of dimer and multimer
formation varies between them. Although the DNA ladder cannot be used as a direct size
reference, the nanostructures themselves could. The graph in Fig. 3.9b plots the molecular
weight of the DNA nanostructures over their run length in the gel. For dimer structures,
simply double the monomer weight was assumed. The linear fit to both monomers and
dimers agrees very well with the linear fit to only the monomers, which further confirms
that the often observed upper intensity band in the gel refers do dimeric nanostructures.
Interestingly, the designs CP1, CP2, CP3 and 6HP have very similar molecular weights
yet quite different run lengths. This could be explained by their varying structural rigidity.
The CanDo simulations show that CP3 is the most rigid, followed by CP2, then CP1, and
6HP being the most flexible. As additional flexibility increases the hydrodynamic radius,
more flexible designs will travel slower through a gel matrix and more rigid designs will
travel faster. The fact that these differences are confirmed in the gel in turn verifies that the
simulated mechanical properties of the DNA nanostructures could indeed indicate realistic
design-specific characteristics. In the following section the advantages and disadvantages of
each design will be discussed.
CP1. This design has previously been employed in our group and demonstrated lipid
membrane insertion and ion conduction with gating and voltage-switching behaviour [54].
The staple pattern follows a previously introduced DNA tiles principle to form arbitrary
two-dimensional DNA shapes [53]. While this design yields a distinctive monomer band
in the gel with little clustering in the pocket, some additional bands between the monomer
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Fig. 3.8 Overview of different DNA nanostructure designs. CP1 and 6HP have been pub-
lished previously [54, 72]. All other designs have been devised in this work. Lengths are
approximated similarly as for the design presented in Fig. 3.1 in Section 3.3.1.
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Fig. 3.9 Analysis of different DNA nanostructure designs. (a) PAGE analysis of different,
assembled DNA nanostructure designs together with their CanDo simulations at the top.
Samples were run on the same gel but space between them was omitted as indicated by the
dashed line. (b) Graph displaying the run length of the monomer and dimer bands from the
gel shown in a over the respective molecular weight of the different DNA nanostructures.
Dimer molecular weights were simply assumed to be double the monomer weight. Run
lengths were measured in pixel with respect to the particular well of each lane. Linear fits
are either to all data points (solid) or to monomers only (dashed).
and dimer band are visible. These indicate the formation of some intermediate structures of
unknown size and geometry. Furthermore, the design has a significant asymmetry regarding
the distribution of crossovers that interconnect the helices. The caDNAno design shows
that the first crossover appears after 14 nucleotides, approximately one third of the total
design length. The CanDo simulations confirm that this asymmetric crossover distribution
leads to an asymmetry in the rigidity of the structure showing increased noise on the left
end of the construct. Lastly, the design does not follow the suggested crossover positions
in the caDNAno software. While the crossover pattern works well for a large 2D plane, it
could induce torsional stress in this design as the DNA strands are not close to each other
at the crossover position due to their helical pitch. It also makes it less clear which way
incorporated modifications would face in the design.
CP3. In this design, the previously discussed asymmetric crossover distribution of CP1 has
been remedied simply by switching the orientation of four staples strands (red in Fig. 3.8).
This creates a balanced distribution of crossovers and overall homogenises the noise and
rigidity of the structure which is also visible in the CanDo simulations. However, the
design still does not follow the typical pattern to place crossovers where the helical pitches
of adjacent DNA strands are closest, similar to CP1, possibly inducing torsional stress.
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Furthermore, the gel reveals a very prominent dimer band and some clustering. This could
possibly be remedied by choosing different staple sequences.
CP3 short. This layout is based on CP3 but shortened by one section. Interestingly, this
almost completely diminishes dimer or multimer formation, leaving the cleanest monomer
band for all designs. However, this comes again at the cost of an asymmetric rigidity. While
the small size of this construct could aid its membrane insertion potential, a significant
downside is that it limits the amount of modifications that can be incorporated in the design.
For DNA strands with a single modification, only two modifications can be placed in the
central region which limits the options to place cholesterol tags to facilitate membrane
insertion. Although it is possible to add two modifications to a single DNA strand, typically
this increases the price while the yields are very low.
CP4. This is the second design with barely any tendency to form multimeric structures. The
monomer band shows a slight smear which could be due to the floppy ssDNA loops on one
end of the design. The advantage of this layout is that multiple cholesterol modifications can
be placed in the central region. They can also be added slightly off-centre, adjacent to the
ssDNA loop. This would allow the cholesterol to be shielded by the presence of the ssDNA,
a feature which will be discussed more detailed in Chapter 4. While the design presents an
asymmetry in the rigidity, the distribution of crossovers is rather homogeneous and they also
follow the caDNAno design rules, which should avoid torsional stress.
6HP. While this 6-helical design is significantly different to the other designs, it is presented
here as it has been the subject of multiple publications [72, 73, 78, 79, 93, 170, 171]. The
six helices are interconnected by ssDNA loops, composed of four thymines each, which
make this structure the least rigid which is also reflected in the CanDo simulations (note the
different size range of the colour scale). This flexibility could pose a problem for example
for single-molecule current measurements as it could add to the noise and induce a variety of
conductances. The design allows for placing multiple cholesterol modifications in the central
region. However, it does not easily facilitate the incorporation of fluorescent dyes as they
would also have to be placed in the central region, possibly interfering with the membrane
interaction, or modified internally to a DNA strand which is typically more expensive. Lastly,
as it is a 6-helical pore, the hollow central lumen allows for transport of molecules. While
this could be exploited, in this work it is a disadvantage as it creates a passage for dithionite
which is undesirable in the lipid scrambling assay that will be discussed more in depth in
Chapters 5 and 6.
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CP2. In this direct comparison, many advantages of this design become apparent. Due
to the array of DNA nicks around the central region, it can be equipped with up to eight
modifications at once while still only using single-modified DNA strands. Alternatively,
modifications can be placed on the outer edges of the design which is ideal to separate
functional parts. For example cholesterol modifications to facilitate membrane insertion can
be placed in the central part while fluorescent dyes to track the structures can be positioned
at the ends, thereby not interfering with the membrane-inserted middle region. Furthermore,
the design follows the crossover rules of caDNAno which should minimise torsional stress.
It also allows to place the central nicks at positions where modifications on the 3’ and 5’
ends are diagonally facing away from the structure. Although the PAGE results do show
some dimer and slight multimer formation, it is comparable to previously employed designs.
Lastly, the layout is point symmetric to the centre, giving it no preferred directionality
and homogeneous rigidity throughout as confirmed by the CanDo simulations. The design
therefore strikes a balance between homogenous structural properties that follow caDNAno
crossover rules, high yield of monomeric structures, and large customisability with chemical
modifications. This is why it was chosen as the basic structure to create a synthetic lipid
scramblase.
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In this chapter, the fundamental design of the DNA nanostructure was presented that will be
used throughout this work. PAGE was employed for the initial analysis to optimise the yield
of folded monomeric structures. A folding buffer with 1x TE and 20 mM MgCl2 yielded the
highest amount of monomers without using excessive amounts of MgCl2 which could cause
problems in later experiments. Overhanging ssDNA strands were incorporated at the ends of
the design to reduce nanostructure aggregation caused by base pair stacking interactions. It
was shown with PAGE that overhangs composed of three thymines reduced aggregation best,
leading to a monomer yield of ≈ 86 %. Possibly four thymines could improve the folding
yield slightly further and could be implemented in future experiments using the CP2 design.
While AFM measurements could roughly confirm the length of the DNA nanostructure,
the width was wider than expected. This could be explained by the AFM tip being of a
similar size as the DNA nanostructure and possible deformation of the DNA constructs
due to sample-tip interaction. TEM analysis remedied these measurement artefacts and
indeed yielded a length of 11.7 ± 1.2 nm and width of 5.4 ± 0.6 nm which are very close to
the expected values. A further improvement in determining the precise dimensions could
be to use negatively-stained DNA nanostructures rather than positively-stained ones. In
summary, gel electrophoresis confirmed a high proportion of monomeric structures, and
TEM measurements verified that these monomers are of the expected size and geometry.
Compared to previous and alternative DNA nanostructure layouts, the CP2 design stood
out due to its balance of homogeneous rigidity, structural symmetry, comparatively high
folding yield, and the advantageous location and high number of modification positions, and
will therefore be used for further applications in this work. However, the smaller CP3 short
design, despite the limited number of modification positions, could still be interesting as it
formed almost exclusively monomers and its small form factor could aid membrane insertion.
Also the CP4 design could potentially be used in future experiments as it had a high folding
yield and cholesterol modifications could be adjacent to ssDNA loops which could shield
their hydrophobicity and reduce aggregation (a method discussed further in Chapter 4).
The gained information from the in-depth analysis of the CP2 design presented in this chapter
will provide an important basis for judging the results of further experiments involving
cholesterol modifications, membrane insertion, and the application of this nanostructure as
an artificial DNA scramblase.

Chapter 4
Controlling aggregation of cholesterol-
modified DNA nanostructures
Parts of this work previously appeared in:
A. Ohmann, K. Göpfrich, H. Joshi, R. F. Thompson, D. Sobota, N. A. Ranson, A. Aksimen-
tiev, and U. F. Keyser. ‘Controlling aggregation of cholesterol-modified DNA nanostructures.’
Nucleic Acids Research, 47(21):11441–11451 (2019).
A. Ohmann, C. Y. Li, C. Maffeo, K. Al Nahas, K. N. Baumann, K. Göpfrich, J. Yoo, U. F.
Keyser, and A. Aksimentiev. ‘A synthetic enzyme built from DNA flips 107 lipids per second
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... and the other part of it is to modify DNA. But
to do things with modified DNA is very hard –
that takes a lot of work by talented people.
– Nadrian C. Seeman
The previous chapter focused exclusively on understanding and optimising the DNA nano-
structure itself. With the CP2 design having shown the most promising characteristics, the
next step is to equip it with the capability to self-insert into a lipid bilayer such as a cell
membrane. The key to inserting the negatively charged DNA into lipid membranes are hy-
drophobic groups specifically positioned on the DNA constructs. As outlined in Section 2.2
in Chapter 2, cholesterol is the most prominent hydrophobic modification to facilitate the
insertion of DNA nanostructures into lipid bilayers. However, a fundamental challenge is
the strong tendency of DNA-cholesterol conjugates to aggregate [70, 79–81, 172]. While
aggregation can be exploited as a switching mechanism [80] or to grow DNA crystals [173],
it is undesirable for most applications as a precise structure-function relationship requires
well-defined monomeric components. Krishnan et al. designed a large DNA-built channel
decorated with 57 hydrophobic anchors which demonstrated increased membrane interaction
but aggregated in solution [70]. Johnson-Buck et al. reported reduced hybridisation kinet-
ics by ~6 to 9 times of cholesterol-modified ssDNA compared to unmodified ssDNA [81].
They also observed clustering of DNA-cholesterol nanostructures forcing them to use fewer
cholesterol modifications to reduce aggregation. Already two cholesterol moieties have been
shown to induce oligomerisation in the assembly of DNA origami blocks [172]. Cholesterol-
mediated aggregation was also observed to cause extremely low binding efficiencies to
artificial lipid vesicles [174]. Even after successful insertion, DNA nanostructures with three
cholesterol moieties have been reported to form aggregates in a lipid bilayer [78].
Nevertheless, higher numbers of cholesterol tags on a DNA construct are desirable and often
necessary to facilitate spontaneous membrane insertion [70]. Their collective free energy
gain upon membrane incorporation reduces the energy barrier for DNA nanostructures to
self-insert into a lipid bilayer [74, 175], thereby facilitating more efficient membrane inter-
action. This intricate balance between an increased number of hydrophobic moieties while
keeping aggregation at a minimum is typically only found by time-consuming trial and error.
To overcome this long-standing challenge, this chapter will provide systematic insight into
the factors that govern the aggregation of cholesterol-modified ssDNA, dsDNA and DNA
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nanostructures. With non-denaturing (native) PAGE and all-atom molecular dynamics (MD)
simulations, we initially analyse the aggregation of cholesterol-tagged ssDNA (chol-DNA).
We then establish a mechanism to reduce cholesterol-mediated interactions of a DNA duplex
by incorporating ssDNA overhangs adjacent to the hydrophobic group. Using transmission
electron microscopy, PAGE and dynamic light scattering (DLS), we characterise our devised
DNA nanostructure and its aggregation behaviour depending on the cholesterol number,
modification position and linker type. Finally, we show that ssDNA overhangs adjacent
to the cholesterol can be applied as a universal mechanism to control the aggregation of
hydrophobically modified DNA nanostructures.
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4.2.1 DNA nanostructure assembly
DNA nanostructures were designed using caDNAno software [36]. In order to maximise
specificity of the different strands, sequences were optimised to minimise secondary structure
and unwanted base pairing using the web-based DNA analysis tool NUPACK [38]. Un-
modified DNA oligonucleotides were purchased from Integrated DNA Technologies, Inc.
(IDT), purified by standard desalting or PAGE, and delivered at 100 µM in IDTE (10 mM
Tris, pH 8.0, 0.1 mM EDTA). Required DNA strands for a specific construct were mixed
at a final concentration of 1 µM in TE20 buffer (10 mM Tris, 1 mM EDTA, 20 mM MgCl2,
pH 8.0). The mixture was heated to 85 ◦C or 95 ◦C for 5 min, subsequently cooled to 25 ◦C
over 18 hours and finally stored at 4 ◦C, as described previously [75]. If not stated otherwise,
3’-modified cholesterol strands were purchased from IDT with a triethylene glycol (TEG)
linker, while 5’-modified strands were acquired from biomers.net with either a TEG or a
C6 linker. Chol-DNA strands were HPLC-purified, delivered dry, and only then diluted in
Milli-Q water (Merck Millipore) to a concentration of 100 µM and stored at 4 ◦C. Prior
to addition to the assembly mix, chol-DNA strands were vortexed briefly, spun down in a
tabletop centrifuge and heated to 55 ◦C for 10 min. Chol-DNA was incorporated into the
DNA nanostructure by adding it to the assembly mix at 1 µM final concentration (1:1 ratio
towards unmodified strands) while the respective unmodified oligonucleotide with the same
sequence was omitted.
4.2.2 Non-denaturing polyacrylamide gel electrophoresis
Chemicals were acquired from Sigma-Aldrich and gels were run in a Mini-PROTEAN
Tetra Cell (Bio-Rad). Gels were hand cast at a final concentration of 10 % polyacrylamide
supplemented with 0.5x Tris-borate-EDTA (TBE) and 11 mM MgCl2. Per 15 ml gel mixture,
150 µl 10 % (w/v) ammonium persulfate solution (aliquots kept at −20 ◦C and freshly thawed
each time) and 10 µl N,N,N’,N’-Tetramethylethylenediamine (TEMED) were added to start
the polymerisation which was typically left to set for at least 1 hour before running the
gel. 2 µl of assembled DNA nanostructures at 1 µM were mixed with 0.4 µl custom-made
6x loading dye (6x: 15 % Ficoll 400, 0.9 % Orange G diluted in TE20) and 2 µl of the
mixture were loaded into the well, as described in Chapter 3. For chol-DNA only, 1 µl
of 100 µM chol-DNA solution (pre-heated as described in DNA nanostructure assembly)
was mixed with 9 µl Milli-Q water and 2 µl of custom loading dye (this time prepared in
Milli-Q water instead of TE20) and between 1 and 3 µl of this mixture were loaded. For
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duplexes of DNA and chol-DNA, strands were mixed at a 1:1 stoichiometric ratio in 50 mM
NaCl and left at room temperature for 30 min before loading. GeneRuler Low Range (L;
Thermo Fisher Scientific Inc.) or a 50 bp DNA ladder (L*; New England Biolabs) were
employed as reference DNA ladders. Gels were run in 0.5x TBE supplemented with 11 mM
MgCl2 at 100 V for 90 min on ice which are typical conditions for the analysis of DNA
nanostructures [36, 55]. DNA was stained by immersing the gel slab for 10 min in 3x GelRed
(Biotium). Subsequent imaging was performed on a GelDoc-ItTM (UVP). Image analysis was
performed as described in Section 3.2.2 in Chapter 3. All operations were homogeneously
applied to the whole image.
4.2.3 MD simulations of cholesterol-modified ssDNA and dsDNA
All-atom MD simulations described in this chapter were carried out by H. Joshi and A.
Aksimentiev at the University of Illinois at Urbana-Champaign. The simulations were per-
formed using the NAMD2 programme [176]. Initial atomistic ssDNA and dsDNA models
were constructed using AMBERTOOLs [177] and the cholesterol was covalently linked
to the DNA backbone [75]. CHARMM General Force Field (CGenFF) parameters [178]
were used to describe the cholesterol-TEG’s bonded and non-bonded interaction with sur-
rounding atoms of DNA, water, and ions. The DNA’s negative charge was compensated
by Mg2+ hexahydrates, as used in experiment, and the system was submersed in water and
100 mM NaCl using VMD software [112]. Subsequently, the system was subjected to energy
minimisation and equilibration at constant number of atoms, pressure, and temperature.
The particle mesh Ewald (PME) method was used to calculate the long-range electrostatic
interactions in NAMD2 [176], the Nose-Hoover Langevin piston [179, 180] and Langevin
thermostat [181] were used to maintain the system’s constant pressure and temperature.
CHARMM36 force field parameters [182, 183] along with NBFIX modifications for non-
bonded interaction [184, 185] were used to describe interatomic potential among water, ions,
and nucleic acids. SETTLE [186] algorithm was applied to maintain rigid water molecules
and RATTLE [187] algorithms were used to constrain all other covalent bonds involving
hydrogen atoms. 500 ns equilibrium MD simulations were performed for each system using
periodic boundary conditions. To improve sampling of the conformational space, two sets of
simulations for each system were performed. Analysis and post-processing of simulation
trajectories were performed using VMD [112] and CPPTRAJ [188].
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4.2.4 Lipid membrane attachment of DNA duplex and nanostructure
Membrane attachment experiments were performed by K. Göpfrich, Max Planck Institute for
Medical Research, Germany. Small unilamellar vesicles (SUVs) were formed as described
previously [189]. Briefly, 99.5 mol% 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphatidylcholine
(POPC, Avanti Polar Lipids, USA) and 0.5 mol% Atto488-labelled 1,2-dioleoyl-sn-glycero-
3-phosphoethanolamine (Atto488-DOPE, ATTO-TEC GmbH, Germany) were mixed in
chloroform. The lipid mixture was dried under a gentle stream of nitrogen and subsequently
placed in a desiccator for 2 hours. Lipids were resuspended in 10 mM Tris, pH 8.0, 1 mM
EDTA at a concentration of 2.2 mM, vortexed for 10 min and extruded through a 50 nm
polycarbonate membrane (Avanti Polar Lipids, USA). SUVs (final concentration: 1.1 mM)
were mixed with the respective DNA duplexes or nanostructures (final concentration: 0.5 µM)
in TE20 buffer. The mixture was encapsulated into surfactant-stabilised water-in-oil droplets
via the aqueous inlet of a microfluidic T-junction device. The oil phase contained HFE-7500
fluorinated oil (3M, Germany) with 1.4 wt% perfluoropolyether-polyethylene glycol (PFPE-
PEG) block-copolymer fluorosurfactants (Ran Biotechnologies, Inc., USA) and 10.5 mM
PFPE-carboxylic acid (Krytox, MW: 7,000–7,500 g mol−1, DuPont, Germany). Under these
conditions, SUVs fuse at the droplet periphery and form a spherical supported lipid bilayer
(droplet-stabilised GUV or dsGUV). The attachment of DNA structures was then monitored
with optical microscopy. For details see [189–191].
4.2.5 Confocal fluorescence imaging
Confocal fluorescence imaging was performed to monitor the attachment of the DNA du-
plexes and nanostructures to lipid membranes of dsGUVs. For this purpose, a Leica SP5 con-
focal laser scanning microscope (Leica Microsystems GmbH, Germany) was used, equipped
with an argon and a white light laser as well as a 40x water immersion objective (HC PL
APO 40x/1.10 w, CORR CS2, Leica Microsystems GmbH, Germany). The pinhole aperture
was set to one Airy Unit and experiments were performed at room temperature. Recorded
images were brightness- and contrast-adjusted, and analysed with ImageJ (NIH, USA).
4.2.6 Dynamic light scattering
Dynamic light scattering measurements were performed on a Zetasizer Nano ZSP (Malvern
Panalytical) with an excitation wavelength of 633 nm. The refractive index of DNA was set
to 1.46 [192]. Water was selected as the dispersant in the software. DNA nanostructures
were measured at 25 ◦C and a concentration of 1 µM in TE20 buffer.

4.3 Results & Discussion 53
4.3 Results & Discussion
4.3.1 Sequence-dependence of cholesterol-tagged ssDNA aggregation
Most commonly, the cholesterol moiety is connected to the 3’ end of ssDNA via a triethylene
glycol (TEG) linker as shown in Fig. 4.1. This linker is covalently bound to the 3’ oxygen
of the phosphate atom of the terminal nucleotide. The fully stretched length of the linker
is ≈ 2 nm and of the cholesterol is ≈ 1.7 nm which was determined from their chemical
structures in ChemiBio3D Ultra (PerkinElmer).
HO
O
O
O
O N
H
O
O
O
CH3
CH3
P
OH
O
O
O
5'
N
N
N
N
NH2
O
≈ 2.0 nm
≈ 1.
7 nm
3’ terminal
nucleotide
TEG linker Cholesterol
Fig. 4.1 Chemical structure of cholesterol modified to a DNA 3’ end. Cholesterol (green
ellipsoid) is covalently bound to a phosphate group at the ssDNA 3’ end via a TEG linker. A
terminal nucleotide is shown as an example.
As non-denaturing polyacrylamide gel electrophoresis is able to precisely resolve differ-
ences in molecular size and conformation in a quick and cost-efficient manner, it represents
an ideal tool to visualise cholesterol-mediated interactions of chol-DNA molecules. To probe
the aggregation behaviour of chol-DNA, three different sequences (a, b, c; for sequences
see Table 4.1) with mixed nucleotides were analysed with non-denaturing 10 % PAGE (see
Fig. 4.2). In order to assure that the observed aggregation behaviour is not an artefact of the
specific production batch of the chol-DNA, three separate production batches were ordered
and compared for each chol-DNA sequence.
Table 4.1 DNA sequences used to show sequence-dependent chol-DNA aggregation.
DNA strand Sequence (5’ to 3’)
a (-CholTEG) AAAACGCTAAGCCACCTTTAGATCCAAA(-CholTEG)
b (-CholTEG) AAACTCCCGGAGTCCGCTGCTGATCAAA(-CholTEG)
c (-CholTEG) GGATCTAAAGGACTTCTATCAAAGACGGGACGACTCCGGGAG(-CholTEG)
The gel reveals a different aggregation behaviour for each sequence ranging from smeared
bands, indicating transient interactions between DNA strands (a), to complete aggregation in
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Fig. 4.2 Sequence dependence of cholesterol-modified ssDNA. PAGE analysis of three
different ssDNA sequences (a, b, c) with and without cholesterol tag. Numbers indicate dif-
ferent production batches ordered three months apart from each other from IDT (28.10.2014,
29.01.2015, and 29.04.2015, respectively). For sequences see Table 4.1.
the gel pocket (b), or a mixture of defined bands (indicating monomeric DNA strands) and
aggregation (c). Importantly, no difference between production batches is observed. This
illustrates that the behaviour of cholesterol-modified ssDNA is purely sequence-dependent.
To determine the origin of the sequence-dependent behaviour, we first verified if any sec-
ondary structure or multimer formation could have been the cause. For this purpose, we tested
if the particular, unmodified DNA sequences showed secondary structure formation using the
web-based nucleic acid structure prediction tool NUPACK [38]. Calculations were performed
at a temperature of 18 ◦C and a DNA concentration of 8 µM with 50 mM NaCl and 11 mM
MgCl2. Except for the additional NaCl, these parameters match the experimental conditions
chol-DNA strands were subjected to during PAGE (see Section 4.2). While sequence (a) was
predicted to exclusively remain monomeric, both sequences (b) and (c) showed tendencies
to form multimeric structures (Fig. 4.3). We analysed other DNA sequences, and even with
relatively low predicted dimerisation tendencies, they also aggregated in the gel pockets if
modified with cholesterol (see Fig. A.1 in the Appendix). Such tendency to form multimeric
structures could explain their aggregation behaviour once modified with cholesterol.
To test if we can prevent aggregation by reducing multimer formation, we altered one specific
base which aided dimerisation in sequence (b) (black arrow in Fig. 4.3b). By changing it from
guanine to adenine, terming the resulting sequence (b*), the amount of monomeric structures
predicted by NUPACK increased from 45 % to 93 % (Figs. 4.4a,b). PAGE analysis of
sequence (b) and (b*) showed that aggregation in the pocket is completely averted (Fig. 4.4c).
However, a remaining long smear still indicates transient cholesterol-mediated interactions.
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Although sequences with tendencies to form dimers or multimers were identified to be prone
to significant aggregation once modified with cholesterol, even without or low multimerisa-
tion, cholesterol-mediated interactions were still present, like the smear of sequence (a) in
Fig. 4.2, or the smear of sequence (b*). We therefore set out to further determine indicators
for the sequence-dependent aggregation. For this purpose, we tested poly-thymine (poly-T)
sequences as they represent the most simplified DNA sequences and are not prone to stable
secondary structure formation [193]. At the same time, we probed the dependence on the
length of the sequence, as this could for example influence the formation of micelles. The
gel in Fig. 4.5a compares cholesterol-modified poly-T sequences ranging from 20 to 50
nucleotides, which are relevant lengths for the assembly of DNA nanostructures [35].
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Fig. 4.5 PAGE and MD simulation of cholesterol-modified poly-T ssDNA. (a) PAGE of poly-
T sequences ranging from 20 to 50 thymine bases are shown without and with a cholesterol
modification at the 3’ end. (b) Snapshots of all-atom MD simulation of cholesterol-modified
30 thymine ssDNA (30T) at the beginning (0 µs) and end (0.5 µs) of two independent
simulation runs starting from the same initial configuration. The ssDNA wraps around the
cholesterol group in both simulation runs. Water and ions are not shown for clarity. For an
image sequence throughout the simulation see Fig. A.2 in the Appendix. A movie of the
simulation can be found in the Supplementary Information of the published article [194].
As expected, the longer the DNA strand, the slower the migration in the gel due to the
increasing hydrodynamic radius. Furthermore, chol-DNA strands are slightly shifted to
shorter run lengths compared to the corresponding unmodified strand due to the increased
hydrodynamic radius attributed to the cholesterol group. Notably, all cholesterol-modified
strands form similarly sharp bands as unmodified ones showing no aggregation nor transient
interactions at all. This indicates that neither the interaction between the chol-DNA strands
nor the interaction of the cholesterol group with the gel matrix has a significant effect on the
migration of the DNA.
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To gain insight into the molecular interactions of the ssDNA with the cholesterol tag, we
collaborated with the group of A. Aksimentiev at the University of Illinois at Urbana-
Champaign, who performed all-atom MD simulations. An atomistic model of the cholesterol
conjugated to a 30 thymine (30T) long ssDNA strand was built in explicit water, and extensive
equilibrium MD simulations were performed at ambient temperature, pressure, and ionic
concentrations comparable to those used in experiments (see Section 4.2). The snapshots in
Fig. 4.5b illustrate that throughout the 0.5 µs simulation, the cholesterol group gets completely
wrapped by the ssDNA, with the hydrophobic DNA bases facing the cholesterol moiety (see
Fig. A.2 in the Appendix). A second, independent simulation, starting from the same initial
configuration, yielded a similar result. We postulate that by wrapping around the cholesterol,
the ssDNA effectively shields the cholesterol’s hydrophobicity preventing intermolecular
cholesterol-mediated interactions which agrees with the sharp bands observed in Fig. 4.5a.
The simulations furthermore show that the bases immediately adjacent to the cholesterol
tag also interact with it first (Fig. A.2 in the Appendix). This indicates that these terminal
bases could have a more significant contribution to the sequence-dependent behaviour. We
therefore placed special emphasis on the three bases adjacent to the cholesterol tag and altered
these while maintaining the rest of the sequence to be thymine bases. PAGE results show no
significant difference between three terminal thymine, adenine or cytosine bases (Fig. 4.6a).
However, terminal guanine nucleotides induced transient intermolecular interactions, visible
as a completely smeared band (GGG). In contrast, all unmodified DNA strands showed no
aggregation nor transient interactions. This demonstrates that multiple terminal guanine
bases can lead to transient cholesterol-mediated interactions between the chol-DNA strands.
We then chose a sequence with mixed nucleotides that did not show any aggregation nor
transient interactions even when modified with cholesterol (see sequence AAA in Fig. 4.6b).
To determine the influence of the terminal bases we altered them to either TAT or GCG.
Interestingly, this significantly affected the aggregation behaviour with a long smear for
terminal TAT and both a smear and aggregation in the pocket for terminal GCG (see Fig. 4.6b).
In order to verify that these differences only originate from the DNA sequence, we compared
the synthesised oligonucleotides with terminal TAT and GCG from different suppliers (IDT
or biomers.net) but no significant difference was observed between them (see Fig. 4.6b). We
furthermore verified if the storage conditions of the particular sample could have induced
the observed differences. Chol-DNA strands from IDT were acquired and diluted in Milli-Q
water less than three weeks before the experiment. Chol-DNA strands from biomers.net
were acquired dry in two aliquots from the same production batch for each DNA sequence.
The ‘Biomers 1’ aliquots were dissolved to 100 µM in Milli-Q water 3 years and 11 months
prior the experiment. ‘Biomers 2’ aliquots were stored dry at −20 ◦C and only dissolved
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Fig. 4.6 Influence of terminal bases on chol-DNA aggregation. (a) Comparison of poly-T chol-
DNA sequences containing different terminal bases. (b) Comparison of different terminal
bases on a mixed DNA sequence shows a sequence-dependent aggregation behaviour of the
cholesterol-modified strands but not of the unmodified strands. The behaviour is independent
of supplier (IDT or Biomers) and storage conditions (Biomers 1 or Biomers 2). (c) NUPACK
secondary structures calculations of the analysed DNA sequences. Dimer formation was
below 0.7 % for all sequences.
two months prior the experiment. Once diluted in water, all chol-DNA strands were stored
at 4 ◦C. Again, no significant difference was observed. Lastly, we also confirmed that the
unmodified strands all result in sharp bands without any smears or signs of aggregation.
As shown before, tendencies to form multimeric structures could have caused the observed
differences in aggregation. However, analysis with NUPACK reveals that over 99 % of the
strands are predicted to be monomeric for all three sequences (Fig. 4.6c). This indicates
that multimerisation is only partly responsible and other factors contribute to the sequence-
dependent aggregation behaviour of chol-DNA. Additionally, all secondary structures of the
monomers had a similarly low free energy of ≈ 1 kBT. This indicates that multimerisation
and secondary structure formation, as predicted by NUPACK for the unmodified sequences,
do not provide a complete explanation for the sequence-dependent aggregation behaviour.
4.3 Results & Discussion 59
Our PAGE analysis of the sequence-dependent aggregation of cholesterol-modified ssDNA
has shown that poly-T sequences can successfully inhibit cholesterol-mediated molecular
interactions. This happens most likely due to the ssDNA wrapping around the cholesterol
moiety, as indicated by MD simulations. Furthermore, sequences with certain tendencies
to form dimers or multimers led to significant aggregation and should be avoided. While
terminal thymines prevented aggregation best, the aggregation behaviour of mixed DNA
sequences originates most likely from a more complex interplay of secondary structure
formation and multimerisation. It has been shown that cholesterol and its esters can form
stable complexes with DNA duplexes [195]. Furthermore, inter-cholesterol hydrophobic
interactions have been demonstrated to stabilise nucleic acid complexes by up to 13 ◦C
for duplexes and 30 ◦C for triplexes [196]. Such interactions could decrease the melting
temperature of secondary structures thereby inducing the observed sequence-dependent
aggregation of chol-DNA. Consequently, experiments involving cholesterol-modified ssDNA
require careful consideration of the DNA sequence.
4.3.2 Shielding cholesterol group by an adjacent ssDNA overhang
As applications for cholesterol-modified DNA commonly involve double-stranded DNA, we
investigated the cholesterol-mediated aggregation of a DNA duplex with a single cholesterol
tag. Furthermore, we wanted to explore if the previously observed cholesterol-ssDNA
interaction can be utilised to control aggregation simply by the design of the complementary,
unmodified DNA strand. To test this, the clustering chol-DNA strand (sequence b in Fig. 4.2
and Table 4.1) was hybridised to complementary strands of various lengths ranging from 6
nucleotides shorter (−6) than the chol-DNA strand to a 10 nt ssDNA overhang adjacent to
the cholesterol (for sequences see Table A.4 in the Appendix). PAGE results in Fig. 4.7a
show that while the cholesterol-modified ssDNA strand (ss chol) aggregates in the pocket,
hybridisation to a complementary strand eliminated these aggregates in all cases. A feasible
explanation is that the previously demonstrated multimerisation tendencies of sequence (b)
are inhibited by forming a DNA duplex.
Nevertheless, for complementary strands without overhang (−6 and 0) the bands in the gel
still show long smears, indicating transient interactions either among the DNA duplexes or
with the gel matrix. However, hybridisation with complementary strands with increasing
ssDNA overhangs gradually eliminates these transient interactions. The longer the ssDNA
overhang, the sharper the band of the duplex. A 6 nt overhang on the complementary strand
is sufficient to obtain a clear band in the gel, successfully suppressing aggregation as well as
transient interactions. Longer overhangs (+8 and +10) do not increase the band sharpness
any further. The same aggregation prevention by adjacent ssDNA overhangs was achieved
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Fig. 4.7 Preventing aggregation of hydrophobically modified dsDNA by an adjacent ssDNA
overhang. (a) PAGE analysis of cholesterol-modified ssDNA (ss chol, blue) and its duplex
with a complementary DNA strand (orange) of varying overhang length ranging from −6
to +10 nucleotides with respect to the cholesterol-modified strand. (b) PAGE analysis of
tocopherol-modified ssDNA (red) and its duplex showing reduced aggregation once modified
with a complementary DNA strand (orange) of increasing overhang length.
for tocopherol-modified DNA in a separate experiment (see Fig. 4.7b and Table A.4 in the
Appendix for DNA sequences). In both cases the overhang sequence was chosen randomly.
We again utilised 0.5 µs long all-atom MD simulations to investigate the interaction of the
cholesterol group with the DNA. Without overhang, the cholesterol remains freely accessible
as there is no ssDNA present to wrap around it (Figs. 4.8a,b). This accessibility of the
cholesterol is likely to mediate molecular interactions between modified duplexes giving rise
to the observed smeared gel bands in Fig. 4.7a. In contrast, the simulation of the cholesterol-
modified duplex with a 6 nt overhang shows that the cholesterol is wrapped by the ssDNA
(Figs. 4.8c,d). This observation agrees with the simulation results for the cholesterol-modified
ssDNA. The ssDNA overhang most likely presents a hydrophilic, steric hindrance, effectively
preventing cholesterol-mediated interactions. For each system, an independent simulation
repeat was performed, starting from the same initial configuration, demonstrating a similar
interaction of the ssDNA with the cholesterol group (see image sequences in Fig. A.3 in the
Appendix). The combined results of PAGE and MD simulations show that free cholesterol
modifications are more prone to clustering than ones shielded by adjacent ssDNA.
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Fig. 4.8 Preventing aggregation of hydrophobically modified dsDNA by an adjacent ssDNA
overhang. Instantaneous snapshots of all-atom MD simulations of the DNA duplex with one
cholesterol tag either without overhang (a,b) or with a 6 nt overhang (c,d), each shown at the
beginning (0 µs) and end (0.5 µs) of the equilibrium MD simulation. Close-ups illustrate that
cholesterol is more freely accessible without overhang (b) but shielded by the ssDNA if the
overhang is present (d). For image sequences of simulations see Fig. A.3 in the Appendix.
As the purpose of the cholesterol group is the interaction of DNA with lipid bilayers, we
needed to ensure that the overhang does not impede membrane binding. We therefore incu-
bated artificial, droplet-stabilised giant unilamellar vesicles (dsGUVs, see Section 4.2.4) with
the cholesterol-modified duplex containing a 6 nt overhang. The complementary strand of the
duplex was labelled on the 3’ end with the fluorescent dye Cy3 which facilitated tracing the
location of the DNA duplexes. Imaging the vesicles with confocal fluorescence microscopy
showed bright fluorescent rings, co-localising with the lipid membranes, thereby showing
successful insertion of the cholesterol into the membrane (see Fig. 4.9). This demonstrates
that the presence of the overhang does not inhibit membrane binding.
From these experiments and simulations, we can conclude that the extension of the comple-
mentary DNA strand adjacent to the cholesterol moiety can be used as a universal strategy to
avoid aggregation of cholesterol-tagged DNA duplexes.
Atto488-labelled lipidsCy3-labelled DNA Brightfield
DNA duplex
+ 6 nt overhang
Fig. 4.9 Membrane attachment of shielded DNA duplex. Confocal microscopy images of Cy3-
labelled, cholesterol-modified DNA duplexes (red) containing a 6 nt overhang demonstrating
attachment to membranes of lipid vesicles containing 0.5 mol% ATTO488-labelled lipids
(blue) together with brightfield images of the vesicles. Scale bars denote 50 µm.
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4.3.3 Influence of cholesterol number and linker type on aggregation
After studying cholesterol-modified ssDNA and dsDNA, we investigated the cholesterol-
mediated aggregation of the CP2 DNA nanostructure design as introduced in Chapter 3.
It was important to characterise the influence of cholesterol modifications on the DNA
nanostructure as the gained insights will be helpful to understand and optimise the design for
insertion into lipid bilayers.
As mentioned in Chapter 3, a key feature of the design is an array of 3’ and 5’ ends in the
central region of the DNA nanostructure, allowing for the specific positioning of cholesterol
modifications (see Figs. 4.10a-c). Their strategical placement regarding the DNA’s helical
pitch facilitates that cholesterol modifications should face diagonally away from the structure,
which could aid their accessibility after assembly (as illustrated in Fig. 4.10b). The ssDNA
pathways are point-symmetric to the centre causing an overall symmetry of the design. These
features facilitate the systematic analysis of the cholesterol-mediated interaction between the
DNA nanostructures regarding cholesterol number, linker type, and modification position.
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Fig. 4.10 Overview of cholesterol modification positions and linker types. Side view (a) and
top view (b) of a 3D representation of the DNA nanostructure. Cholesterol modification
positions, specifically the oxygen atoms to which the cholesterol is linked to (compare
Fig. 4.1), are highlighted as green spheres. (c) 2D scheme illustrating the ssDNA pathways
and modification positions within the DNA nanostructure design. Arrows illustrate the trans-
lation from the 2D and to the 3D architecture. (d) Chemical structures of three commercially
available linker types. Colours in c indicate the possible modification positions for each
linker type within the design. For a detailed overview of modification positions and DNA
strand names see Fig. A.4 in the Appendix.
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First, DNA nanostructures were assembled with 1 to 4 cholesterol modifications covalently
bound to the central region of the DNA constructs. At the same time we wanted to determine
if the type of linker employed between the cholesterol and the DNA had an influence on the
cholesterol-mediated interactions. For this purpose, three different commercially available
linker chemistries were tested: 3’ and 5’ end TEG-linkers, and a 5’ hexane (C6) linker (see
Fig. 4.10d). They differ in length, modification position (3’ or 5’), and hydrophobicity with
TEG being less hydrophobic than the C6 chain due to the additional oxygen atoms. PAGE
analysis of DNA nanostructures folded with 1 to 4 cholesterol groups for each linker type
reveals stepwise band shifts to shorter run lengths with each additional cholesterol group for
all linker types (see Fig. 4.11). This can be explained by the increasing hydrodynamic radius
of the nanostructures for each additional cholesterol tag.
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Fig. 4.11 PAGE analysis of DNA constructs assembled with 1 to 4 cholesterol tags for each
linker type. For details on modified DNA strands see Tables A.5 and A.6 in the Appendix.
For 1 to 3 cholesterol groups, monomer bands remain relatively sharp, however, aggrega-
tion in the pockets gradually increases. For 4 cholesterol modifications, all structures show a
smeared, less intense band with a much larger band shift than the previously observed consis-
tent shifts for each cholesterol addition. This suggests that cholesterol-mediated interactions
are now dominating and induce aggregation of the DNA nanostructures.
For all structures folded with cholesterol modifications in the central region of the design,
an additional adenine nucleotide was included prior each cholesterol tag as a spacer (see
Table A.5 in the Appendix). In previously reported work a longer spacer, composed of three
adenine nucleotides prior the cholesterol group, was employed [54]. Here, this spacer was
shortened to one adenine as this allows to position the cholesterol molecules more precisely
on the DNA construct. At the same time, the adenine nucleotide prior the hydrophobic tag
ensured that the attachment chemistry of the cholesterol was homogeneous for all modifica-
tion positions, as it was demonstrated before that this can influence chol-DNA aggregation
(see Fig. 4.6). Lastly, the additional nucleotide still provided the cholesterol anchor with a
slightly increased range which could potentially be beneficial for membrane attachment.
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Nevertheless, we wanted to ensure that this spacer did not have a significant influence on
the observed differences in cholesterol-mediated aggregation. To test if the adenine spacer
affected the folding yield of the DNA nanostructures, we assembled the constructs using DNA
sequences that contained an additional adenine nucleotide but no cholesterol modification.
PAGE analysis shows that the presence of the spacer does not significantly affect the folding
yield of the DNA nanostructures (see Fig. 4.12a). We then folded the structures with 1 to 4
cholesterol modifications (as performed for Fig. 4.11) either with (+A) or without (−A) the
spacer. The results of the subsequent PAGE analysis demonstrate that the additional adenine
did not affect the overall observed trend of increased clustering with additional cholesterol
tags (see Fig. 4.12b). Only for 3 cholesterol modifications a slight difference between the
extent of the monomer band smear was observed, however, the band was sharper when the
spacer was included. Therefore, the single adenine spacer was still included in the design for
all further experiments involving centrally positioned cholesterol tags.
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Fig. 4.12 Influence of additional adenine spacer on DNA nanostructure assembly. (a) PAGE
analysis of DNA nanostructures assembled with additional adenine spacers at the 3’ (red
marker) or 5’ ends (yellow marker) but without cholesterol modifications. (b) Comparison of
DNA nanostructures assembled with 1 to 4 cholesterol-TEG modifications with (+A) and
without (−A) adenine spacer. The first lane after the ladder shows a DNA nanostructure that
did not undergo a folding protocol but was simply mixed together at room temperature.
4.3.4 Influence of the cholesterol modification position
Next, the influence of the cholesterol modification position was studied. For this, DNA
nanostructures were assembled with cholesterol modifications either at the central region, or
the end. Figure 4.13 shows the PAGE analysis of DNA nanostructures folded with 1 or 2
TEG-linked cholesterol groups (1C and 2C, respectively). While a single cholesterol tag in
the central region shifts the monomer band, as discussed above, it does not change the band
intensity nor induce aggregation. However, addition of a single cholesterol to the end of the
design reduces the monomer band intensity to ≈ 35 % (compared to 77 % if on the side),
while dimer and multimer intensities increased by 19 % and 23 %, respectively (Fig. 4.13a).
Similar cholesterol-mediated dimerisation has been reported for a DNA cube construct [174].
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Fig. 4.13 Influence of modification position on DNA nanostructure aggregation. PAGE
comparing DNA nanostructures modified with one (a) or two (b) cholesterol tags at different
locations. Band intensities are normalised to the sum per lane. (c) PAGE illustrating that the
position-dependent aggregation is even more pronounced when structures are folded in 1 M
LiCl, 25 mM HEPES, pH 8. For DNA strands see Fig. A.4 and Table A.5 in the Appendix.
Two central cholesterol modifications at opposing sides also yield a sharp monomer band
(see Fig. 4.13b). This contrasts with two cholesterol tags placed at the end of the structure
causing a smeared monomer band with reduced intensity while the dimer band increases.
Furthermore, placing two cholesterol tags right next to each other at the same location results
in a significantly smeared monomer band.
These results suggest that aggregation not only depends on the number of cholesterol tags but
also on their modification position. Particularly cholesterol at the end of the structure induces
dimerisation or even aggregation. When folded in a monovalent salt solution such as 1 M
LiCl, aggregation of end-modified structures is even more pronounced. While two central
cholesterol modifications induce only very slight aggregation, most structures form only
dimers or multimers for cholesterol modifications placed at the end (see Fig. 4.13c). This
aggregation happens in a similar fashion as if base-stacking interactions are not prevented
on one side of the DNA nanostructure, as demonstrated in Fig. 3.3a. The observed effects
for end-modified structures are therefore possibly a combination of cholesterol-mediated
interactions which are further stabilised by base-stacking interactions between the ssDNA
overhangs. This indicates that the additional cholesterol-mediated interactions could enhance
weaker molecular interactions already present in the design which should be taken into
account in the design process.
4.3.5 Controlling cholesterol-mediated aggregation of DNA constructs
Having studied the cholesterol-mediated aggregation of our DNA construct, we then inves-
tigated if the previously observed cholesterol-ssDNA interaction can be applied to prevent
aggregation of the DNA nanostructures. Similar to how cholesterol-mediated interactions
could be prevented with an adjacent ssDNA overhang for the tagged DNA duplex, such over-
hangs can be introduced in the DNA nanostructure to control aggregation by ‘shielding’ the
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cholesterol. For this purpose, we extended the 5’ ends in the central region of the design by
2, 4 or 6 thymine nucleotides to obtain ssDNA overhangs adjacent to the central 3’-modified
cholesterol tags (Fig. 4.14a). A 3D model representation of the DNA nanostructure provides
an illustration of the location of the overhangs and cholesterol modifications (Figs. 4.14b,c).
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Fig. 4.14 Controlling cholesterol-mediated DNA nanostructure aggregation by ssDNA over-
hangs. (a) 2D scheme illustrating the positions of cholesterol tags (green) and ssDNA
overhangs (orange). (b,c) 3D model of the DNA nanostructure including four 6 nt overhangs
shown from top with four cholesterol modifications (b) or from the side with overhangs only
(c). (d) PAGE of DNA constructs assembled with four 3’ TEG-linked cholesterol groups and
increasing ssDNA overhang length (+0 to +6 nt) or number of 6 nt overhangs adjacent to the
cholesterol. Band intensity graphs are normalised to the +6 nt monomer band intensity and
visualise the increasing run length and band sharpness when cholesterol tags are shielded.
As 4 central cholesterol modifications consistently induced aggregation, we assembled
DNA nanostructures with 4 cholesterol tags without and with 2, 4, or 6 nt overhangs adjacent
to all cholesterol groups, to test if aggregation can successfully be prevented. Structures
without ssDNA overhangs again demonstrated clustering in PAGE, however, with increasing
overhang lengths the initially smeared band gradually shifts to longer run lengths while
increasing in band sharpness and intensity (Fig. 4.14d). This behaviour signifies a gradually
decreasing hydrodynamic radius as well as increasing structural homogeneity, both indicative
of successful aggregation suppression. An overhang length of 6 nt was sufficient to achieve
a sharp monomer band, consistent with the results of the DNA duplex studies (compare
Fig. 4.7). Varying the number of 6 nt overhangs furthermore showed that while one overhang
was insufficient, already from two overhangs onwards a significantly sharper monomer band
was observed suggesting successful aggregation prevention (Fig. 4.14d). This agrees with
previous observations as it effectively reduces the system to two diagonally placed cholesterol
modifications which generally did not show signs of cholesterol-mediated interactions.
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Fig. 4.15 Influence of ssDNA overhangs on DNA nanostructure assembly without and with
cholesterol. (a) PAGE analysis of DNA nanostructures assembled with four overhangs of
various lengths (+0 to +6 nt). (b,c) Histograms of monomer, dimer and multimer band
intensities determined from a and normalised to the sum per lane (b) or absolute (c). (d)
PAGE of DNA nanostructures with four 6 nt overhangs and increasing number of cholesterol
modifications. (e,f) Histograms of monomer, dimer and multimer band intensities determined
from d and normalised to the sum per lane (e) or absolute (f).
As a control, we confirmed that the added ssDNA overhangs do not interfere with the
assembly of the DNA constructs. PAGE analysis shows slight shifts to shorter run lengths
for increasing overhang lengths, as expected (Fig. 4.15a). At the same time, normalised
band intensities remain approximately the same (Fig. 4.15b). Assuming a linear relationship
between number of nucleotides and band intensity (as more staining dye can intercalate into
the DNA), the observed slight increase for the absolute monomer intensities can be explained
by the increasing DNA nanostructure size due to the additional overhang length (Fig. 4.15c).
DNA structures that are folded with all four 6 nt overhangs, now also produced consistent
band shifts for each additional cholesterol (Fig. 4.15d) without significant changes to the in-
tensity of the monomer band (Figs. 4.15e,f). In conclusion, PAGE results suggest that ssDNA
overhangs adjacent to cholesterol modifications can prevent cholesterol-mediated molecular
interactions without significantly affecting the folding yield of the DNA nanostructures.
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To show that the observed gel electrophoresis results are representative for the aggregation
behaviour of the DNA constructs in solution, we performed DLS measurements. While DNA
nanostructures without cholesterol groups showed no aggregation, modification with four
cholesterol tags led to significant aggregation with diameters exceeding 1,000 nm (Fig. 4.16).
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Fig. 4.16 DLS analysis of DNA nanostructures without and with four cholesterol tags
demonstrating reduced aggregation if +2, +4, and +6 nt overhangs are employed. Histograms
represent the average volume distribution of five measurements (error bars denote SD).
Upon addition of ssDNA overhangs, aggregation is gradually reduced with increasing
overhang lengths, consistent with the PAGE experiments. Due to the non-spherical design
of the DNA nanostructure, the contrasting interface with the surrounding water without or
with hydrophobic cholesterol modifications (potentially affecting the hydrodynamic radius),
and the polydispersity of the samples due to multimerisation and either complete or partial
aggregation, reporting absolute sizes using DLS could be misleading which is why we only
employed it to indicate the observed trend of reduced aggregation. In conclusion, DLS
results confirm that our observed effects from non-denaturing PAGE are representative for
the cholesterol-mediated aggregation behaviour of DNA nanostructures in solution.
4.4 Conclusion 69
Lastly, we ensured that DNA nanostructures with 4 cholesterol tags shielded by adjacent 6 nt
overhangs, still bind to lipid bilayers. Analogous to experiments performed with the shielded
DNA duplex, confocal microscopy of dsGUVs containing Cy3-labelled DNA nanostructures
revealed that membrane attachment was not inhibited by the ssDNA overhangs (Fig. 4.17).
DNA nanostructure
+ 6 nt overhangs
Atto488-labelled lipidsCy3-labelled DNA Brightfield
Fig. 4.17 Membrane attachment of shielded DNA nanostructures. Confocal microscopy
images of Cy3-labelled, cholesterol-modified DNA nanostructures (red) with four 6 nt
overhangs demonstrating attachment to membranes of lipid vesicles containing 0.5 mol%
ATTO488-labelled lipids (blue) together with brightfield images of the vesicles. Scale bars
denote 50 µm. Cy3 labels were incorporated on strands st2 and st4 (see Appendix, Table A.5).
4.4 Conclusion
The detailed analysis of cholesterol-modified ssDNA, dsDNA, and DNA nanostructures
performed in this chapter shows that it is possible to control the aggregation of cholesterol-
modified DNA nanostructures following a few simple design rules.
Cholesterol-modified ssDNA exhibits a sequence-dependent aggregation behaviour, indepen-
dent of the production batch, supplier, or storage conditions. Sequences prone to forming
dimers or multimers generally showed significant aggregation and should be avoided by
optimising the sequences using structure prediction tools such as NUPACK [38]. Terminal
thymine nucleotides generally avoided aggregation best, thus we recommend incorporating a
poly-T section to precede the cholesterol moiety if the DNA sequence can be chosen freely.
Our atomistic MD simulations of poly-T chol-DNA showed interactions of the hydrophobic
nucleobases with the hydrophobic cholesterol moiety causing the ssDNA to wrap around the
cholesterol group. For mixed DNA sequences, the behaviour is more complex. Consequently,
experiments involving chol-DNA require careful consideration of the DNA sequence.
We further demonstrated that the incorporation of cholesterol tags into DNA nanostructures
can be successfully analysed with non-denaturing PAGE with a visible shift for each addi-
tional cholesterol group. While nanostructure clustering does not significantly depend on the
DNA-cholesterol linker type, it is the number and location of the hydrophobic tags that proved
70 Controlling aggregation of cholesterol-modified DNA nanostructures
to be the governing factors. The fact that DNA nanostructures with the same number of
cholesterol tags can behave significantly different in PAGE suggests that interactions between
the nanostructures rather than with the polyacrylamide gel matrix are governing. This is
further supported by the DLS measurements performed in solution. The interactions between
cholesterol-modified DNA strands described here can only be studied in non-denaturing
conditions as earlier published results showed that surfactants can mask cholesterol-mediated
aggregation [81]. Therefore, studying interactions between hydrophobically modified DNA
nanostructures requires non-denaturing gel electrophoresis to accurately judge and precisely
adjust aggregation of designs with a higher number of cholesterol tags.
Most importantly, we demonstrated that the hydrophobic interactions of cholesterol-tagged
DNA can be easily controlled by incorporating an ssDNA overhang adjacent to the hydropho-
bic group. In agreement with the MD simulations, the ssDNA overhang most likely presents a
steric hindrance, effectively preventing cholesterol-mediated aggregation. Due to the flexible
nature of the ssDNA overhang, it does not impede insertion of the cholesterol-tagged DNA
into a lipid bilayer membrane as we showed with confocal fluorescence imaging. Adjust-
ing the length of the overhang can be utilised to precisely tune the degree of hydrophobic
interaction. This allows for controlling cholesterol interactions simply by the rational design
of the ssDNA overhang. The method also avoids the necessity of multi-unit membrane
incorporation strategies and the use of surfactants, thereby circumventing the drawbacks of
these strategies. Furthermore, it enables to increase the number of cholesterol modifications
per DNA nanostructure, thereby facilitating enhanced membrane interaction.
The results of this study present a guide to control and prevent aggregation of cholesterol-
modified ssDNA, dsDNA, and DNA nanostructures using simple DNA design rules and no
additional components. This novel, cost-efficient, and easy-to-implement strategy to control
aggregation of cholesterol-modified DNA nanostructures can readily be applied to existing
designs without significant modifications. Additionally, it is not limited to cholesterol but
can be applied to other hydrophobic modifications as already demonstrated for tocopherol.
The gained knowledge on the aggregation behaviour of the CP2 DNA nanostructure, once
modified with cholesterol, will be the basis for subsequent applications presented in this
thesis, particularly the design of the DNA-based lipid scramblase in Chapter 6. However,
the method to prevent aggregation using ssDNA overhangs was only established after the
work presented in Chapters 5 and 6 was performed. Without this shielding strategy, the DNA
nanostructure modified with two cholesterol tags, diagonally positioned in the central region,
showed the most consistent behaviour regarding high monomer yield and low aggregation
tendency (compare Fig. 4.11). Therefore, this design was predominantly tested in further
experiments presented in the next chapters.
Chapter 5
Dithionite reduction assay on LUVs
Dithionite
Parts of this work previously appeared in:
A. Ohmann, C. Y. Li, C. Maffeo, K. Al Nahas, K. N. Baumann, K. Göpfrich, J. Yoo, U. F.
Keyser, and A. Aksimentiev. ‘A synthetic enzyme built from DNA flips 107 lipids per second
in biological membranes.’ Nature Communications, 9:2426 (2018).

5.1 Introduction 73
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It took a long time to figure out how to get these experiments to work.
– Nadrian C. Seeman
In the previous two chapters we studied the assembly characteristics of the CP2 DNA
nanostructure first without and then with cholesterol modifications. In this chapter we will
build up on this foundation and study if these cholesterol-modified DNA nanostructures can
insert into lipid bilayers and, if so, can induce lipid scrambling between bilayer leaflets.
We will first perform electrophysiological measurements, a strategy that has been previously
successfully employed to verify the membrane-insertion of DNA nanostructures [6, 8, 54, 66–
68, 74]. A voltage is applied across a lipid bilayer and membrane-insertion of the DNA
constructs can be identified by a sudden jump in the current to a stable plateau. With these
experiments we will successfully demonstrate that the cholesterol-modified DNA structures
can indeed insert into lipid bilayers and can therefore be termed ‘DNA nanopores’.
We will then utilise the dithionite reduction assay, as introduced in Chapter 2, to analyse
the lipid scrambling activity of the DNA nanostructures. We will perform the assay as it is
commonly reported in the literature, using lipid vesicles of ~100 to 200 nm in diameter and
detecting the fluorescence signal from a bulk solution using a fluorescence spectrometer [14,
15, 24, 115, 137, 140, 197]. It has never previously been reported that this assay was
employed to investigate scrambling activity of DNA nanostructures. Furthermore, as the
dithionite reduction assay in general was also not established in our group, it was important
to study and understand the fundamental characteristics and parameters that significantly
affect the results of the assay. Such a foundation will prove valuable in the long run, in order
to design targeted experiments and interpret their results more accurately. We will therefore
initially characterise the assay regarding its dependence on the dithionite concentration, NBD
labelling position, lipid composition, vesicle size, and the influence of surfactants.
From these experiments we will determine the optimal assay conditions and perform the
dithionite reduction assay in the presence of cholesterol-modified DNA nanostructures to
gauge if lipid scrambling can be observed. The basic principle will be to compare the
dithionite-induced fluorescence reduction of plain vesicles (top in Fig. 5.1) with vesicles
incubated with DNA nanostructures (bottom in Fig. 5.1). If the DNA nanostructures insert
into the membrane and scramble lipids, a decrease of the normalised fluorescence intensity
to values below 0.5 should be observed.
While we successfully demonstrate attachment of cholesterol-modified DNA nanostructures
to the vesicles, no clear evidence for scrambling activity could be shown in this bulk assay.
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One hypothesis is the low membrane insertion efficiency of the DNA structures, an issue
that has been reported previously [47], and will also be confirmed in the electrophysiology
experiments. We will therefore also attempt to facilitate increased membrane insertion using
surfactants and electroporation.
Dithionite
Dithionite
No scrambling
DNA-induced scrambling
Normalised
fluorescence
intensity
1
1
0.5Δ t
0Δ t
Normalised
fluorescence
intensity
Fig. 5.1 Dithionite assay to determine lipid scrambling activity of DNA nanostructures.
(Top) The lipid vesicles are produced containing a small fraction of NBD-labelled lipids
(highlighted in green). Upon addition of dithionite, only lipids in the outer bilayer leaflet
are fluorescently reduced by dithionite (black circles). When normalising the fluorescence
intensity to its initial value before dithionite addition for each vesicle, it should only be
reduced by dithionite to≈ 0.5 over time in the absence of scrambling activity. (Bottom) DNA
nanostructures can spontaneously insert into the vesicle membrane, potentially inducing and
stabilising a toroidal lipid pore. Upon dithionite addition, the DNA-induced pore facilitates
transport of lipids between the inner and outer bilayer leaflet. NBD-labelled lipids, previously
inaccessible on the vesicle’s inner membrane leaflet, are thereby transported to the outer
leaflet where they are bleached by dithionite, effectively reducing the vesicle’s normalised
fluorescence intensity below 0.5.
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5.2.1 Electrophysiology measurements
The capability of the DNA nanostructure to spontaneously self-insert into a lipid bilayer
was measured with ionic current measurements using solvent-containing, free-standing
membranes. The experimental design and setup were prepared together with Q. van der Spek,
and she conducted the measurements and analysis [198]. Recordings were performed as
described previously [7, 8, 198]. Briefly, a polytetrafluoroethylene (PTFE / Teflon) cuvette
with two reservoirs separated by a hole of ≈ 0.28 mm diameter was employed. To ‘pre-paint’
the aperture, 5 µl of 2 % (20 mg ml−1) 1,2-diphytanoyl-sn-glycero-3-phosphatidylcholine
lipids (DPhPC, Avanti Polar Lipids) dissolved in chloroform were deposited on the aperture
and left to evaporate (typically ~5 min). The reservoirs were then each filled with 5 ml of
1 M KCl, 10 mM Tris at pH 8 and Ag / AgCl electrodes were inserted into the buffer on each
side. Between 0.5 to 1 µl of 1 % DPhPC (10 mg ml−1) in 90 % n-decane (Sigma) and 10 %
butane were applied to a brush made from PTFE tubing. By repeatedly stroking this brush
across the aperture between the reservoirs, a lipid bilayer was formed.
The current signal was amplified using an Axopatch 200B amplifier (Molecular Devices)
and recorded using custom LabVIEW scripts written by Oliver Pambos and modified by Q.
van der Spek [198]. Membrane formation was verified by a sudden drop in current from a
few nA to close to 0 pA. Membranes with a resistance between ~50 to 80 GΩ and an IRMS
noise value between ~3 and 5 pA typically allowed for pore insertion which was verified
with α-hemolysin transmembrane pores in preceding experiments [198, 199].
After stable membrane formation, DNA nanostructures modified with two cholesterol tags
were added to the cis-side at a final concentration between 1 nM and 100 nM. Adding
n-Octylpolyoxyethylene (OPOE) to a final concentration of 0.01 % to the cis-side of the
cuvette significantly improved DNA nanostructure insertion. The trans-side voltage was
typically varied between −100 to +100 mV and a constant voltage in that range was applied
during the recording time until a spontaneous membrane insertion was observed. A sudden
jump in current to a stable level typically signified the insertion of a DNA nanostructure.
Subsequently, the voltage was varied in ±20 mV steps up to ±100 mV to obtain a current-
voltage curve. Data was acquired using a Bessel filter of 1 kHz and a sampling rate of 3 kHz.
Data analysis was carried out in OriginPro 2016.
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5.2.2 Lipid mixtures for dithionite assays
To perform the dithionite reduction assay, lipid vesicles were formed from a variety of lipids
which are listed in Table 5.1. Lipids were purchased as powder and dissolved in chloroform
upon arrival to specific stock concentrations (Cstock in Table 5.1) and stored at −20 ◦C.
Table 5.1 Overview of lipids employed for dithionite assays. POPC was purchased from
Sigma-Aldrich while all other lipids were acquired from Avanti Polar Lipids.
Abbreviation Full lipid name Cstock (mg ml−1) Order #
POPC 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphatidylcholine 150 42773
EColi E. Coli Polar Lipid Extract 10 100600
eggPC L-α-phosphatidylcholine (Egg, Chicken) 5 840051
NBD-DPhPE 1,2-diphytanoyl-sn-glycero-3-phosphoethanolamine- 1 810142
N-(7-nitro-2-1,3-benzoxadiazol-4-yl)
NBD-PC 1-palmitoyl-2-{6-[(7-nitro-2-1,3-benzoxadiazol-4-yl) 1 810130
amino]hexanoyl}-sn-glycero-3-phosphatidylcholine
EColi lipids are a mixture of different lipid types in themselves and will be employed in a
3:1 ratio together with eggPC, as described previously [14]. The different lipid components
are listed in Fig. 5.2a. Furthermore, while eggPC exclusively contains phosphatidylcholine
lipids, it is also a natural lipid mixture. An average distribution of its fatty acids is shown in
Fig. 5.2b.
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Fig. 5.2 Components of lipid mixtures used for dithionite assays. (a) Types of lipids in EColi
polar and a 3:1 mixture of EColi polar and eggPC. PE refers to phosphatidylethanolamine,
PG to phosphatidylglycerol, CA to cardiolipin, and PC to phosphatidylcholine. (b) Average
fatty acid distribution of eggPC. Nomenclature of fatty acid chains refers to the number of
carbon atoms:number of double bonds in the chain. Data for lipid compositions was obtained
from Avanti Polar Lipids [200, 201].
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5.2.3 Vesicle preparation and DLS analysis
Lipid vesicles were prepared from either POPC or a 3:1 mixture of EColi polar extract
and eggPC. As the fluorescent reporter for the dithionite assay, 0.5 wt% (weight percent)
of either NBD-DPhPE or NBD-PC were added to the mixture. Dissolved lipids (typically
between 5 and 15 mg) were added to a round-bottom glass flask (Z302570, Sigma-Aldrich)
and the chloroform storage solution was evaporated initially by gentle blow-drying with
nitrogen followed by 1 hour desiccation under vacuum. Dried lipids were dissolved to a
final concentration of 2 mM in 300 mM KCl, 1 mM EDTA and 20 mM HEPES with the
pH adjusted to 7.4 using HCl (= ‘buffer L’). The lipid solution was then sonicated for 15 to
30 min and stored at 4 ◦C.
Right before extrusion, the stored stock vesicle solution was sonicated again for 5 to 10 min.
Extrusion was performed at room temperature by 15 single passes through a track-etched
polycarbonate membrane (Nuclepore, Whatman) with a given average pore size using an
Avanti Mini-Extruder (Avanti Polar Lipids). Before extrusion, the membrane was lined
by two 10 mm polyester drain disks (WHA230300, Sigma-Aldrich) on each side and pre-
equilibrated with buffer L.
Vesicle sizes were verified with dynamic light scattering (DLS). 100 µl liposome solution
at ≈ 80 µM in buffer L were added to a low volume cuvette (ZEN0040) and placed in a
Zetasizer Nano ZSP (Malvern Panalytical). Samples were measured at 25 ◦C using a lipid
refractive index of 1.470, an absorption of 0.001, and water for the dispersant viscosity.
5.2.4 Dithionite assay with fluorescence spectrometer
Freshly extruded liposomes were diluted in their respective buffer to a final concentration of
≈ 80 µM lipids. 100 µl were added to a low volume quartz cuvette and the emitted fluores-
cence intensity was recorded at 5 Hz over time using a Cary Eclipse (Varian) fluorescence
spectrometer (λexc = 460 nm, λem = 535 nm, 20 nm slit widths) at 23 ◦C. Dithionite (157953,
Sigma-Aldrich) was diluted in 1 M Tris (pH 10 adjusted with HCl) to a concentration of
either 250 mM or 1 M freshly before each experiment unless stated otherwise. Dithionite
reduction assays were performed by recording the fluorescence intensity of the vesicle solu-
tion for 1 to 2 min and then pausing the data acquisition (to avoid a possible reading error
of the device that stops the measurement) to add between 1 and 5 µl dithionite solution to
the cuvette. The whole solution was pipetted up and down twice to facilitate mixing and
data acquisition was continued. This process typically took between 10 and 15 s. The final
dithionite concentration was typically 5 or 40 mM and is indicated for each experiment. For
experiments where vesicles were disrupted such that dithionite can access all lipids, 2 µl of a
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1:100 dilution of TritonTM X-100 were added to the cuvette (pausing acquisition and mixing
was also performed as described above).
Recorded traces were normalised to the averaged initial intensity F0 before dithionite ad-
dition and the normalised intensity F(t)/F0 was plotted over time using OriginPro 2016.
Normalised fluorescence intensity plateaus after dithionite reduction were obtained by aver-
aging over 10 data points before and after the six minute mark.
5.2.5 Preparation of TMEM16F scramblase proteoliposomes
Proteoliposomes were prepared according to a previously described method [14]. Briefly,
human TMEM16F recombinant protein (H00196527, Abnova) pre-diluted in 300 mM KCl,
1 mM EDTA, 35 mM CHAPS, 4 mM glutathione, and 30 mM Tris at pH 8.0, was added at 5 µg
per 1 mg lipids to a freshly sonicated lipid solution as described above. Final concentrations
were 0.5 mM lipids and 15 nM scramblase. CHAPS detergent was subsequently removed
using two to four exchanges of 200 mg Bio-BeadsTM SM-2 resin (Bio-Rad) per 500 µl
lipid-detergent-protein solution over 36 hours at 4 ◦C. After detergent removal liposomes
were extruded at 100 nm at room temperature as described above. Dithionite reduction assays
were subsequently performed in 300 mM KCl, 1 mM EDTA and 30 mM Tris at pH 8.0. A
similar but slightly optimised protocol was published recently [202] which can be of use for
future experiments involving TMEM16 scramblase proteins.
5.2.6 Electroporation of LUVs
A Bio-Rad Gene PulserTM connected to a Bio-Rad Pulse Controller was used together with
electroporation cuvettes with a 1 mm gap size (VWR). 40 µl of 3:1 EColi-eggPC vesicle
solution (extruded at 200 nm) at ≈ 200 µM lipid concentration in buffer L were added to the
electroporation cuvette and exposed to various voltage pulses.
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5.3.1 Electrophysiology verifies lipid bilayer insertion
The purpose of the cholesterol modifications was to facilitate the insertion of the DNA
nanostructures into a lipid bilayer. Successful membrane attachment was already verified in
the previous section by observing a bright ring from the fluorescently labelled DNA structures
in confocal microscopy, a similar approach as in previous work [8, 54, 74]. The next step
was to prove that the cholesterol-modified DNA nanostructures could also insert into the
lipid bilayer in a way that they would fully span across the membrane. Electrophysiology
measurements have previously been employed successfully to demonstrate the insertion
capabilities of hydrophobically modified DNA nanostructures [6, 8, 54, 66, 68, 70, 72, 74].
Solvent-containing bilayers, as the first technique for supported lipid bilayers [203], have
been a proven method for studying the potential of novel proteins [204, 205] or DNA
nanostructures [8, 74] to form membrane-inserted ion channels. In a cuvette made from
polytetrafluoroethylene (PTFE) (see Figs. 5.3a,b) two separated reservoirs are connected
by a central hole of ≈ 0.3 mm diameter. By placing electrodes in each reservoir and
applying a voltage, the current through this aperture can be measured (Fig. 5.3c). Before
membrane formation and without applied bias voltage, the current through the open aperture
is typically in the range of nA. Lipids, dissolved in the organic solvent n-decane, are then
spread (‘painted’) across the aperture using a PTFE ‘brush’ thereby eventually forming a
lipid bilayer that seals the opening (Fig. 5.3d). The formation of such a membrane can be
verified by a significant reduction in current as lipid bilayers are almost perfect insulators
(Fig. 5.3f) [204]. CP2 DNA constructs with two central, diagonally-positioned cholesterol
tags (2C) are then added to the cis-side of the cuvette and the current is recorded over time at a
constant voltage (typically 50 to 100 mV). Spontaneous DNA nanostructure insertion is then
observed by a sudden jump in the current to a stable conductance level (Figs. 5.3e,g). Similar
to previous observations for a comparable DNA nanostructure [54], voltage-gating (sudden
jumps between current levels at high voltages) and closure of the DNA-induced channel to a
low-conductance level (voltage-switching) are observed (Fig. 5.3g). These characteristics
further verify that the current jump is caused by a DNA nanostructure insertion.
Once an insertion step was observed, the voltage was reset to 0 V and a current-voltage curve
(IV curve) was recorded by varying the voltage in ± 20 mV steps. In a well-sealed, plain
lipid bilayer the current barely varies with the voltage staying close to 0 pA (see Fig. 5.4a).
However, if a DNA nanostructure is inserted, the current changes linearly with the voltage
to a much higher degree (see Fig. 5.4b), describing ohmic behaviour similar to previously
reported membrane-inserted DNA nanostructures [54, 175].
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Fig. 5.3 Electrophysiology measurements to determine membrane insertion of DNA nano-
structures. Top (a) and side (b) view of PTFE cuvette. (c) Schematic drawing of current
measurement setup. The current across a central aperture (dashed rectangle) connecting two
buffer-filled reservoirs is recorded. At an open aperture, and without an applied bias voltage,
the current is in the low nA range. (d) Lipids, dissolved in n-decane, are spread across the
aperture, eventually forming a lipid bilayer that seals the hole. (e) DNA nanostructures with
two cholesterol modifications added to the cis-side of the cuvette can self-insert into the
lipid bilayer, creating a passage for ions by acting as a DNA nanopore. (f) Current trace of
a sealed bilayer. While the large size of the membrane allows for a low, residual current
flow, the average current is typically ≤ 5 pA even at an applied voltage of 100 mV. (g)
Current recording illustrating a current jump at constant voltage signifying the insertion of a
DNA nanostructure. The trace also shows jumps between current levels (voltage-gating) and
closure of the DNA nanopore to a stable, low-conductance level (voltage-switching).
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Fig. 5.4 Electrophysiological measurements of membrane-inserted DNA nanostructures. (a)
Current-voltage trace of a sealed lipid bilayer without insertion of a DNA nanostructure.
(b) Current-voltage trace of a lipid bilayer containing an inserted DNA nanostructure. (c)
Conductance histogram of 26 insertion steps observed for DNA nanostructures across multi-
ple different lipid bilayers and experiments. The mean conductance was determined to be
0.70 ± 0.14 nS (mean ± SD). The measurement buffer was 1 M KCl, 10 mM Tris at pH 8.
Over multiple lipid bilayers and experiments, insertion steps of the DNA nanostructure
have been observed. The conductance levels determined from these insertion steps are plotted
in Fig. 5.4c showing a mean conductance of 0.70 ± 0.14 nS (mean ± SD). The measured
conductances fall well within the range determined for a similarly-sized DNA nanostructure
published previously [54]. However, multiple experiments needed to be carried out and
only in some of them DNA nanostructure insertion was observed. Given the comparatively
large surface area of the aperture of ≈ 0.07 mm2 (diameter equals ≈ 0.3 mm [198]) the
insertion efficiency is rather low, a previously reported problem for artificial DNA-made ion
channels [47]. Nevertheless, these experiments confirm that the CP2 DNA design modified
with two cholesterols (2C) can insert into lipid bilayers. Furthermore, the results show that
this DNA nanostructure can induce ionic currents across lipid bilayers thereby mimicking
the function of naturally occurring protein ion channels.
5.3.2 Characteristics of the dithionite assay
To initially understand how the dithionite assay works and which parameters are crucial,
vesicles have been formed from POPC lipids containing 0.5 wt% of NBD-DPhPE (see
Fig. 5.9a for chemical structure) and extruded through membranes with a pore size of
200 nm. The vesicles were then diluted and analysed using a fluorometer (for details see
Section 5.2.4). NBD is hereby excited with a laser and its emitted fluorescence is detected
at a 90◦ angle over time. Figure 5.5a shows the absorption and emission spectrum of NBD-
DPhPE in chloroform as stated by the supplier. To verify that these characteristics of NBD-
DPhPE remain similar when inside a vesicle’s membrane in aqueous solution, the emission
spectrum of the above described vesicle suspension (80 µM final lipid concentration) was
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recorded using an excitation wavelength of 460 nm (Fig. 5.5b). The maximum emission was
determined at 535 nm, matching the value stated by the supplier. Therefore, NBD excitation
was performed at 460 nm and emission was recorded at 535 nm for all measurements.
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Fig. 5.5 Fluorescence spectra of NBD-DPhPE. (a) Absorption (blue) and emission (red)
spectrum of NBD-DPhPE at 1 µg ml−1 in chloroform. Data provided by Avanti Polar Lipids.
Image modified after [206]. (b) Emission spectrum from a suspension of POPC vesicles
containing 0.5 wt% NBD-DPhPE. Data was recorded at 80 µM lipid concentration diluted in
buffer L with an excitation wavelength of 460 nm. Trace represents the average of 3 separate
scans and has been smoothed by adjacent averaging over 7 data points. Indicated values
represent the wavelength of the respective local maximum.
Dithionite was then added to the vesicle solution to fluorescently reduce NBD-labelled
lipids in the outer bilayer leaflet. Typical traces of the normalised fluorescence intensity
observed in a dithionite reduction assay are displayed in Fig. 5.6. An initial plateau is
followed by a rapid decrease in fluorescence intensity upon dithionite addition (50 mM final
concentration) at t = 2 min. This fluorescence reduction plateaus at ~0.7 and is followed by a
slow continuing decrease to ~0.6 in the time between 3 and 30 min. The initial plateau at 0.7
is higher than the expected value of ≈ 0.5 which is most likely connected to multilamellarity
of the vesicles which we will discuss in Section 5.3.4. At 30 min the surfactant Triton X-100
was added, disrupting the vesicles such that all lipids are now accessible to be bleached by
dithionite leading again to a rapid decrease in fluorescence. Variations in the reduction rates
are most likely related to different mixing times of the solutions in the sample. Apart from
this, the traces are very reproducible in multiple experiments.
A close-up of the initial rapid decrease in fluorescence is shown in Fig. 5.7a. To avoid
a possible error by the device (occasionally induced by the pipette tip blocking the laser
pathway), data acquisition was paused during dithionite addition. This resulted in a sudden
jump between two data points (indicated by the arrow in Fig. 5.7a). As the added dithionite
solution was typically less than 5 % of the total volume of the solution, this jump is partially
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Fig. 5.6 Dithionite reduction assay on lipid vesicles. Dithionite addition induces a sudden
decrease in fluorescence intensity due to bleaching of NBD lipids in the vesicles’ outer
bilayer leaflet. Triton X-100 addition disrupts the vesicles enabling dithionite to access lipids
inside the vesicles causing a further fluorescence reduction. Traces represent independent
experiments performed using the same vesicle stock solution but always fresh dithionite.
explained by sample dilution but predominantly caused by the dithionite reduction already
being initiated for a brief moment before data acquisition was resumed. Dithionite has
been shown to decompose in aqueous solutions due to air oxidation [207]. Therefore, a
crucial element for repeatable results is that dithionite was prepared freshly every time before
addition [138, 139, 208–210]. Figure 5.7b illustrates the effect of using dithionite solution
5 days after preparation resulting in a much slower fluorescence decrease. The decomposition
has also been shown to happen more rapidly at low pH [24, 211]. Therefore, dithionite powder
was always first prepared in 1 M Tris solution adjusted to pH 10 before it was diluted further,
consistent with previously reported experimental procedures [24, 138, 208, 209].
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Fig. 5.7 Effect of old dithionite and NBD photobleaching. Graphs highlighting the effect on
the fluorescence intensity of NBD vesicles if dithionite is (a) freshly prepared, (b) 5 days
old, or (c) if no dithionite was added to the solution. Inset in c shows a larger time scale to
illustrate the effect of photobleaching.
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Lastly, no dithionite was added to the vesicle solution to determine the effect of photobleach-
ing on the NBD dye during the measurement. At longer time scales an initial decrease by
~5 % within the first 20 min followed by a stable plateau is observed (inset in Fig. 5.7c).
However, at relevant time scales for the dithionite assay, photobleaching had no significant
effect on the fluorescence intensity (see Fig. 5.7c).
In order to correctly understand and interpret the results of the dithionite assay, the influence
of its components was studied separately. Table 5.2 presents an overview of the explored
conditions for five different parameters.
Table 5.2 Overview of tested conditions for dithionite assay.
Parameter Tested conditions
Dithionite concentration (mM) 2, 4, 6, 8, 10, 50
NBD labelling position head-labelled, tail-labelled
Lipid composition POPC, 3:1 EColi-eggPC
Extrusion pore size (nm) 30, 100, 200, 400, 1000
OPOE concentration (%) 0.005 to 0.2
5.3.3 Influence of dithionite concentration
Previous reports in the literature typically employed final dithionite concentrations ranging
from 3 to 60 mM [14, 24, 115, 131, 132, 137–141], with 10 and 20 mM being the most
frequently used. In the previous section, 50 mM dithionite was employed which is on the
high end of the spectrum. To investigate the influence of the dithionite concentration the
assay was performed multiple times, each with a different final concentration of dithionite
added to the solution (Fig. 5.8). The graph shows that for increasing concentrations the rate
of fluorescence reduction is sped up, as expected. The decay traces (starting with the first
point once data acquisition after dithionite addition was resumed) are well described by a
single exponential which yields the characteristic decay times ⟨τ⟩ (see inset in Fig. 5.8a).
At longer time scales the traces show a continuing decrease in fluorescence even after the
initial exponential reduction (see Fig. 5.8b). Approximating the traces between 10 and 30 min
with a linear fit yielded a percental decrease of fluorescence intensity ranging from ~10 to
25 % per hour (inset in Fig. 5.8b). In data obtained previously by Malvezzi et al., similar rates
of ~17 % per hour were observed, although at 40 mM dithionite concentration and a different
lipid mixture (EColi-eggPC which will be discussed in the next section) [14]. These rates
are higher than the ones determined for photobleaching (compare Fig. 5.7c). Furthermore,
their increase with increasing dithionite concentration indicates that this could be related
5.3 Results & Discussion 85
1.0
0.6
0.9
0.8
0.7
0 10 20 30
Time (min)
10 mM
8 mM
6 mM
4 mM
2 mM
50 mM
[Dithionite]
%
 d
ec
re
as
e 
/ h
ou
r
0 10
[Dithionite] (mM)
10
20
0
F(
t) 
/ F
0
1.0
0.6
0.9
0.8
0.7
F(
t) 
/ F
0
1 2 3 4
Time (min)
5
10 mM
8 mM
6 mM
4 mM
2 mM
50 mM
[Dithionite]
1 10 100
[Dithionite] (mM)
< 
τ 
> 
(m
in
)
0
1.5
1.0
0.5
a b
100
Fig. 5.8 Dithionite assay of POPC-NBD LUVs at different dithionite concentrations. (a)
Normalised intensity over time upon addition of final dithionite concentrations ranging from
2 to 50 mM. Inset shows the time constants ⟨τ⟩ obtained from single exponential fits to the
traces from the point the acquisition was resumed after dithionite addition. (b) Longer time
scale to illustrate the concentration-dependent fluorescence decrease over time even after the
initial rapid reduction. Inset shows the percentage decrease per hour from a linear fit to the
trace between 10 and 30 min.
to dithionite permeating through the membrane of the vesicles at a low rate. A previous
study reported 5 mM dithionite to be an optimal concentration to observe NBD reduction
in the outer bilayer leaflet without affecting NBD lipids in the inner bilayer leaflet [141].
However, another study that many of the here presented protocols are based on, employed
40 mM dithionite to observe more rapid reduction kinetics [14]. For further experiments we
will therefore be either employing 5 or 40 mM final dithionite concentration which will be
indicated for each experiment. However, the dithionite concentration will be the same within
each set of experiments. It is important to note that even concentrations of as low as 0.5 mM
have been reported to be sufficient to completely reduce NBD, however, longer time scales
are required (~1–3 min compared to < 1 min for ≥ 10 mM dithionite) [24]. Ultimately, at
sufficiently short time scales (≤ 5 min) varying the dithionite concentration between 5 and
40 mM should only slightly affect the value where the fluorescence intensity plateaus at, but
predominantly the reduction kinetics.
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5.3.4 NBD labelling position, vesicle size & lipid composition
In the dithionite assay, the readout is provided by the NBD-labelled reporter lipids. The
labelling position could therefore have an influence on the measured results. To test this,
lipid vesicles were formed from POPC lipids with 0.5 wt% fluorescently labelled lipids with
the NBD tag located either on the lipid headgroup (head*, Figs. 5.9a,c) or on a fatty acid
chain via a C6 linker (tail*, Figs. 5.9b,d).
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Fig. 5.9 Chemical structures of NBD-labelled lipids. (a) Head-labelled 16:0 NBD-DPhPE
(head*) (b) 16:0-06:0 NBD-PC labelled with NBD on one of the fatty acid chains via a C6
linker (tail*). (c,d) 3D representations of the respective lipids (Colour code: C = green, H =
white, O = red, N = blue, P = purple). Images taken from [206] and [212], respectively.
To simultaneously test the influence of the vesicle size, these vesicles were then extruded
through polycarbonate membranes with different pore sizes ranging from 30 nm to 1 µm.
Subsequently, a dithionite assay was performed and the emitted bulk fluorescence intensity
was recorded. Figures 5.10a,b show the normalised fluorescence intensity before and after
dithionite addition for POPC vesicles with either head-labelled (head*) or tail-labelled (tail*)
NBD lipids. For all vesicle sizes and both reporter lipids, a rapid decrease in fluorescence is
observed after dithionite addition (2 µl at 250 mM) at ~1.5 min, levelling off to rather stable
plateaus with only a slight remaining decrease. The scatter plot in Fig. 5.10d compares the
average fluorescence intensity at 6 min across different vesicle sizes. If every vesicle in the
solution is unilamellar, one would expect the fluorescence intensity to approach a value of
≈ 0.5 as for each vesicle only lipids in the outer bilayer leaflet are fluorescently reduced. This
is only the case for the smallest POPC vesicles with the NBD tag at the fatty acid chain. For
all other vesicles, the intensity levels off at higher values, with ~0.8 for the largest vesicles.
In general, the larger the vesicles, the higher the plateau. A possible explanation could be an
increasing proportion of multilamellar vesicles in the solution for larger vesicles as only the
NBD lipids in the furthest outer bilayer leaflet are reduced by dithionite while membranes
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Fig. 5.10 Dithionite assay dependence on vesicle size, labelling position, and lipid type.
Graphs displaying dithionite reduction assays of vesicles extruded at different membrane pore
sizes and composed of POPC and a head-labelled NBD lipid (a), or POPC and a tail-labelled
NBD lipid (b), or a mixture of EColi and eggPC and a tail-labelled NBD lipid (c). Final
dithionite concentration was 5 mM. (d,e) Scatter plots comparing the normalised intensity
at 6 min across different vesicle sizes for POPC (d) and EColi-eggPC vesicles (e). Light
coloured data points refer to either a repeated measurement of the same extruded vesicle
batch, or a measurement of a second extrusion from the same stock lipid batch.
inside are unaffected. While another explanation could be that NBD lipids aggregate and
are therefore less accessible by dithionite, the fact that the bleaching plateaus scale with the
vesicle size makes multilamellarity the more plausible explanation.
Size-dependent fluorescence reduction plateaus were observed for both head- and tail-labelled
lipids with a comparable trend (see Fig. 5.10d). The most significant deviation between the
two labels occurred for vesicles extruded at 30 nm. This could suggest that for small vesicles
the labelling position has a more significant influence, with tail-labelled lipids being closer
to a value of 0.5. However, the deviations between extrusion batches are of a comparable
degree. This suggests that the labelling position might not have a significant influence on
the specific fluorescence intensity value once a plateau after dithionite addition is reached.
However, determining the rates of fluorescence reduction by fitting with a single exponential
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reveals faster kinetics (lower ⟨τ⟩) for tail-labelled reporter NBD lipids (see Fig. 5.11). This
is surprising given that NBD labelled at the lipid headgroup should be easier or at least
similarly accessible to be bleached by dithionite than the NBD labelled at the fatty acid chain
(compare Fig. 2.9 in Chapter 2). However, choosing a lipid reporter with a faster fluorescence
reduction rate is more desirable, as this allows to study faster lipid scrambling rates as the
dithionite reduction rate would be less rate-limiting. Therefore, tail-labelled NBD-PC (tail*)
lipids were used as the reporter lipid for further experiments.
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Fig. 5.11 Time constants ⟨τ⟩ for different NBD lipids and lipid mixtures. Values were
obtained from single exponential fits to the traces shown in Figs. 5.10a-c from the point the
acquisition was resumed after dithionite addition until the five minute mark.
To gauge the robustness of the assay, deviations between performing measurement repeats
of the same vesicle solution after extrusion (squares in Fig. 5.10d) and deviations between two
separately extruded vesicle solutions (triangles in Fig. 5.10d) were analysed. The results show
that the error between two measurements of the same sample after extrusion is comparatively
small (≤ 1 %), however, the error between different extrusions at the same pore size is much
more relevant (≤ 9 %). This could also be an explanation for the deviations observed between
differently labelled lipids supporting the conclusion that the position of the fluorescent label
only has a minor influence on the fluorescence intensity plateau.
Lastly, the influence of the vesicle’s lipid composition was investigated. Therefore, the same
experiments were repeated with vesicles composed of a 3:1 mixture of EColi and eggPC
together with the tail-labelled NBD lipids. Remarkably, for all extrusion sizes except 30 nm,
the fluorescence intensity plateaued almost exactly at 0.5 (see Figs. 5.10c,e) suggesting
a very high degree of unilamellarity. Furthermore, the difference between two separately
extruded vesicle batches was below 1 % for vesicles with a diameter ≥ 100 nm showing
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much better reproducibility than what was observed for POPC vesicles. However, for the
smallest vesicles surprisingly a value of ≈ 0.4 was reached, lower than the expected value
of 0.5. This can be explained by the fact that a fluorescence reduction to 0.5 would only
take place if the amount of lipids in the inner and outer bilayer leaflet was approximately
the same. However, for vesicles of small diameter, the asymmetry in lipid amount between
the bilayer leaflets starts to become relevant. This hypothesis can be verified by geometrical
estimations of how many lipids are able to fit in the inner and outer bilayer leaflets depending
on the vesicle size. The amount of lipids in the bilayer leaflets can be estimated in two ways:
a) Via the surface area of the inner and outer bilayer leaflet divided by the area of a lipid.
b) Via the volume of the inner and outer bilayer leaflet divided by the volume of a lipid.
With dV being the outer diameter of the vesicle and dB being the bilayer thickness, the
following equations yield the number of lipids in the inner (Ni) and outer (No) bilayer leaflet:
Via area of a lipid:
No =
π
AL
dv2
Ni =
π
AL
(dV −2dB)2
Via volume of a lipid:
No =
π
6VL
[
dV 3− (dV −dB)3
]
Ni =
π
6VL
[
(dV −dB)3− (dV −2dB)3
] (5.1)
To estimate the asymmetry of the number of lipids between the inner and outer bilayer leaflet,
POPC lipids can be used as an example as their structure within fully hydrated lipid bilayers
has been well characterised previously [213] with the data shown in Table 5.3.
Table 5.3 Dimensions of POPC lipids and membranes. Values have been taken from [213]
and VL has been calculated via VL = 12dB AL.
Bilayer thickness dB 3.680 nm
Area of a lipid AL 0.683 nm2
Volume of a lipid VL 1.257 nm3
Using these values for POPC lipids, the graphs in Fig. 5.12a plot the total number N of lipids
in a vesicle of diameter dV calculated from the sum of No and Ni either via the surface area or
the volume of the bilayer leaflets. The numbers of lipids per vesicle agree very well between
calculations via surface area or via volume and deviations fall below 1 % already for vesicle
diameters above ~35 nm.
90 Dithionite reduction assay on LUVs
0.5
0.4
0.3
0.2
0.1
0.0
101 105102 104103
0.5
0.4
0.3
0.2
0.1
0.0
101 105102 104103
0.15
0.10
0.05
0.0010 1000100
101
105
107
109
1011
103
101 105102 104103
104
103
10 20 30
Li
pi
ds
 p
er
 v
es
ic
le
, N
Li
pi
ds
 p
er
 v
es
ic
le
, N
Vesicle diameter (nm)
Vesicle diameter (nm)
10 100 1000
0.5
0.4
0.3
0.2
0.1
0.0
Vesicle diameter (nm) Vesicle diameter (nm)
Vesicle diameter (nm) Vesicle diameter (nm)
N
i /
 N
N
i /
 N
D
ev
ia
tio
n 
fro
m
 0
.5
D
ev
ia
tio
n 
fro
m
 0
.5
a b c
Via area
Via volume
Average
Via area
Via volume
Average
Fig. 5.12 Estimations on lipid asymmetry between the bilayer leaflets of POPC membranes.
(a) Total number of lipids per vesicle (N) as a sum of No and Ni calculated either via the
surface area (red) or the volume (blue) of the bilayer leaflets using Equations 5.1. (b) Ratio
between the number of lipids in the inner bilayer leaflet (Ni) and the total number of lipids
per vesicle (N). Black line represents the average of both calculations. (c) Deviation from an
ideal value of 0.5 depending on the vesicle size. Bottom graphs highlight the lower end of
the vesicle sizes (shaded areas in top row) where lipid bilayer asymmetry is most relevant.
In a dithionite assay, the value of the fluorescence plateau after dithionite addition depends
on how many lipids remain inaccessible to dithionite. Given the assumptions that
• spontaneous lipid flipping happens at much longer time scales than the experiment,
• NBD-labelled lipids are distributed homogeneously within the overall lipid mixture,
• dithionite does not permeate through the membrane at the time scale of the experiment,
• and all vesicles are unilamellar,
these fluorescence intensity values should be equal to the ratio of lipids on the inner bilayer
leaflet over the total number of lipids in that vesicle. Using Equations 5.1, this ratio can be
calculated depending on the vesicle diameter which is plotted in Fig. 5.12b. Here, estimations
performed via the area and the volume differ more significantly only reducing to less than
1 % for vesicles above ~200 nm which is why their average for the purpose of this estimation
is plotted as well. Figure 5.12c allows for a direct quantification of the expected deviation
from an ideal value of 0.5 induced by asymmetric lipid distribution between the bilayer lipids.
For vesicles above ~200 nm this deviation falls below 2 % and below 1 % for vesicles above
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~400 nm in diameter. This means that for vesicles above these diameters measurement errors
become more relevant than deviations in membrane asymmetry.
Using Equations 5.1, the experimentally determined fluorescence intensity plateaus shown
in Fig. 5.10e can be well explained by the asymmetry in the number of lipids between the
inner and outer bilayer leaflet (Fig. 5.13). Although the dimensions of POPC lipids were
used for the estimations, they agree very well with the experimental results obtained from
the EColi-eggPC mixture. Calculations via volume match the data better as calculations via
area seem to overestimate the asymmetry in lipid distribution between the bilayer leaflets.
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Fig. 5.13 Comparison of membrane asymmetry estimations with dithionite reduction experi-
ments. For the calculations, the vesicle diameter dV was assumed to be equal to the extrusion
pore size. Data points from EColi-eggPC vesicles are the same as shown in Fig. 5.10e.
The fact that POPC vesicles do not agree well with the estimated asymmetry values can
most likely be explained by the high degree of multilamellarity, as discussed above. In turn,
vesicles formed from 3:1 EColi-eggPC seem to possess a very high degree of unilamellarity.
The results would even suggest that this mixture can be used to form unilamellar vesicles
up to 1 µm in diameter simply via extrusion. To verify this, DLS measurements have been
performed to determine the actual size of the vesicles after extrusion (Fig. 5.14). Interestingly,
vesicles formed from EColi-eggPC seem to adopt a preferred size of ~150 to 200 nm in
diameter as extrusions at larger pore sizes did not affect the vesicle diameter. This is in
contrast to POPC vesicles where the average diameter can yield larger values of ~450 nm
or even ≥ 500 nm when extruded at 400 nm or 1,000 nm, respectively. The preferred size
of EColi-eggPC vesicles could explain the high degree of unilamellarity determined from
dithionite experiments, as unilamellarity is typically observed for vesicles below 200 nm in
diameter [214, 215]. Unfortunately, this therefore rules out the EColi-eggPC mixture as a
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simple way to form larger unilamellar vesicles. The increased amount of multilamellarity
determined for POPC vesicles even below 200 nm could possibly be reduced by a higher
number of passes through the porous membrane during extrusion. Nevertheless, the EColi-
eggPC mixture performed superior in forming highly unilamellar vesicles.
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Fig. 5.14 Diameter of lipid vesicles extruded at different pore sizes measured with DLS.
Extrusion pore sizes are indicated as dotted lines. Extrusions were performed from the same
unextruded stock vesicle batch for both EColi-eggPC + tail* (red) and POPC + tail* (blue).
In conclusion, no significant difference between NBD labelling positions regarding
the reached fluorescence plateau after dithionite addition was observed. However, lipid
composition and vesicle size had a significant influence which is most likely related to the
vesicles’ lamellarity. Although POPC vesicles extruded at 30 nm yielded values close to 0.5,
for such small vesicles a value of 0.4 would be expected due to the increased asymmetric
distribution of lipids between the bilayer leaflets. As all other vesicle sizes yielded even higher
fluorescence intensities it can be concluded that POPC vesicles of all sizes demonstrated a
measurable degree of multilamellarity in the performed experiments. One possible reason
could be that 15 single passes through the extrusion membrane was insufficient to form
unilamellar POPC vesicles. Doubling the number of passes could yield a more uniform and
unilamellar vesicle distribution. In contrast, EColi-eggPC vesicles showed a very high degree
of unilamellarity as fluorescence intensity plateaus agreed very well with the estimated trend
based on the lipid distribution between bilayer leaflets of unilamellar vesicles. Here, smaller
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vesicles yield greater deviations from 0.5 but already for an extrusion pore size of 200 nm this
reduced to less than 1 %. Furthermore, results were very reproducible for that lipid mixture
and that size range. Therefore, vesicles formed from EColi-eggPC at a size of 200 nm are
ideal for performing dithionite reduction experiments.
Lastly, the results in this section also demonstrate that the dithionite reduction assay is
excellent at determining if vesicles are unilamellar. This has been successfully employed by
another member of our group to demonstrate unilamellarity at the single-vesicle level of giant
unilamellar vesicles formed on a microfluidic chip [216]. However, for bulk measurements
on vesicles with diameters below 1 µm it is recommended to accompany the assay with DLS
measurements to verify the correct vesicle formation and size.
5.3.5 Influence of OPOE concentration on dithionite assay
Surfactants have previously been employed to aid the insertion of membrane proteins and
DNA nanostructures into lipid bilayers [204, 217–219], particularly poly(ethylene glycol)
octyl ether (OPOE) [67, 72, 79, 217, 220]. The critical micelle concentration (CMC) of
OPOE is 0.23 % (≈ 6.6 mM) [217], however, for applying this surfactant to the dithionite
assay, it was necessary to ensure that the surfactant does not affect the spontaneous lipid
flip-flop activity in membranes of lipid vesicles already at concentrations below the CMC.
Furthermore, as the dithionite assay requires that dithionite does not permeate through the
vesicles’ membranes, it was crucial to verify that the membrane integrity was still maintained.
To reduce mixing effects where the OPOE concentration would temporarily be much higher
than intended, 1 % OPOE solution was pre-diluted in buffer L to a volume of 96 µl and only
then 4 µl of vesicle solution was added to yield the intended final surfactant concentration.
Figure 5.15a shows the results of the dithionite assay performed at final concentrations of
OPOE ranging from 0.005 to 0.2 %. For low concentrations (≤ 0.01 %) no change compared
to the control without OPOE was determined. However, from concentrations of 0.05 % and
higher, the reached fluorescence plateau started to decrease rapidly with increasing OPOE
concentration (see Fig. 5.15b). This shows that already concentrations below the CMC
can affect the results of the dithionite assay. It is however unclear, if the mechanism in the
intermediate concentration range (~0.1 %) that facilitates further dithionite reduction, is
based on an increased spontaneous lipid flip-flop rate or dithionite permeating through the
vesicle membrane. Nevertheless, OPOE concentrations of 0.01 % or less represent a suitable
range to try to aid DNA nanostructure insertion without inducing additional lipid scrambling
activity on their own.
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Fig. 5.15 Influence of OPOE on dithionite assay. (a) Dithionite assay performed in the
presence of varying concentrations of OPOE. Vesicles were formed from a 3:1 EColi-eggPC
mixture with NBD-PC reporter lipids extruded at 200 nm. Final lipid concentration was
80 µM and final dithionite concentration 40 mM. (b) Normalised fluorescence intensity at
3 min. Dotted line indicates the critical micelle concentration of OPOE.
5.3.6 TMEM16F protein scramblase assay
Having studied the influence of the different components on the dithionite assay, it was
beneficial to establish a positive control to show that we can detect scrambling activity with
this method. This meant to incorporate a known scramblase protein into the vesicle membrane
and observe a significantly higher intensity reduction as compared to vesicles without
scramblase. Although there has been some initial controversy whether the transmembrane
protein TMEM16F solely regulates phospholipid scrambling or is a phospholipid scramblase
itself [95, 117, 221], recent studies confirmed the scrambling activity of TMEM16F itself [21,
114, 119, 121, 222, 223]. We therefore purchased human TMEM16F recombinant protein
and formed proteoliposomes according to a previously described method [14]. The protocol
required the addition of the zwitterionic detergent CHAPS to facilitate protein insertion.
However, as seen in the previous section with OPOE, at sufficient concentrations surfactants
can destabilise the membrane leading to a false-positive result regarding scrambling activity.
Therefore, it was important to first verify without scramblase protein that CHAPS can be
sufficiently removed such that it does not interfere with the dithionite assay. CHAPS was
added to freshly sonicated lipids (either POPC or 3:1 EColi:eggPC) and gradually removed
using two or four exchanges of Bio-BeadsTM resin. Subsequently, vesicles were extruded
and a dithionite reduction assay was performed (saturated colours in Figs. 5.16a-c). As a
control, no CHAPS was added to one part of the sonicated lipids but all other steps were
performed analogously (pale colours in Figs. 5.16a-c).
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Fig. 5.16 Effect of CHAPS and TMEM16F scramblase on dithionite assay. (a,b) Dithionite
reduction assay with (saturated colours) or without (pale colours) CHAPS performed on
POPC (a) or 3:1 EColi:eggPC (b) vesicles. All samples were treated with 2 or 4 exchanges of
Bio-Beads beforehand. Final dithionite concentration was 40 mM. (c) Bar chart comparing
the normalised intensities at 6 min of traces shown in a,b. (d) Dithionite assay performed
without (light blue) and with (dark blue) addition of TMEM16F scramblase protein.
The results consistently showed a shift to lower fluorescence intensities for lipids that had
been treated with CHAPS compared to lipids that had not. Using 4 exchanges of Bio-Beads
had a measurable improvement on removing the surfactant as the fluorescence reduction
shifted again closer to 0.5. Vesicles formed from POPC without CHAPS show a similar
behaviour as discussed in Section 5.3.4, in that they only approach values above 0.5 indicating
some degree of multilamellarity (Fig. 5.16a). When CHAPS had been added to the lipids the
fluorescence reduced to ~0.4, suggesting that dithionite can access an increased amount of
NBD-labelled lipids. In contrast, vesicles formed from EColi-eggPC show again a more con-
sistent behaviour approaching values closer to 0.5 in all cases (Fig. 5.16b). This furthermore
confirms that EColi-eggPC vesicles are better suited to perform the dithionite reduction assay
as they show greater reproducibility and resilience against surfactants. A comparison of the
normalised intensity values at 6 min illustrates that the vesicles formed from EColi-eggPC,
treated with CHAPS, and followed by 4 exchanges of Bio-Beads, approached 0.5 the closest
and were therefore deemed the best system (Fig. 5.16c).
To obtain a positive control for scrambling activity, the known scramblase TMEM16F was
added to freshly sonicated lipids together with CHAPS. After detergent removal and ex-
trusion, the dithionite assay was performed. The results show a slightly decreased plateau
at ≈ 0.4 after dithionite reduction (Fig. 5.16d). However, the control prepared in parallel
without scramblase protein yielded a value of ≈ 0.43, reducing the effect of the scramblase
to a difference of only 0.03. Although TMEM16F is calcium-activated [95], addition of
calcium ions did not significantly affect these results. Furthermore, even without Ca2+ ions,
the fluorescence intensity for a similar scramblase protein (afTMEM16) was shown to still
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decrease to values below 0.3 [14]. Therefore, the results are not indicative of lipid scrambling
activity given the possible deviations that can occur in the extrusion and detergent removal
steps. Multiple reasons could explain the negligible influence of the scramblase:
• Too few scramblase protein was added.
• Incorporation into the membrane was too inefficient.
• Bio-Beads filtered scramblase out before membrane incorporation occurred.
• Protein not stable or not active.
The last reason could be the most likely as subsequent to these experiments the company
informed us that no tests were ever performed to verify the biological activity of the provided
protein. This interpretation is also supported by the fact that previously published work does
not mention any scramblase protein supplier but rather that the researchers or a collaborator
expressed the protein themselves. Due to this difficulty of obtaining a functioning scramblase
protein, it was not possible to establish a positive scrambling control.
5.3.7 Bulk dithionite reduction assay with DNA nanostructures
Despite the lack of a positive control using a natural scramblase protein, we attempted to
determine the possible scrambling activity of membrane-inserting DNA nanostructures with
this bulk dithionite reduction assay. We initially verified that the DNA nanostructures are
attaching to the lipid vesicles. For this, LUVs (3:1 EColi-eggPC, 0.5 wt% NBD-PC) were
extruded at 200 nm and incubated with DNA nanostructures either without cholesterol or
modified with 1 to 4 cholesterol tags. The DNA nanostructures were of the CP2 design and
prepared as described in Chapter 4 using cholesterol-TEG and an adenine spacer (compare
Fig. 4.11). Subsequent to the incubation with vesicles, DLS size measurements were
performed (see Fig. 5.17). The results show an average vesicle diameter of 179 nm if DNA
nanostructures were not modified with cholesterol (Fig. 5.17b). This agrees with previous
observations that DNA nanostructures lacking hydrophobic modifications are not expected
to attach to vesicles formed from zwitterionic lipids [8, 54, 74]. Once DNA nanostructures
contained cholesterol modifications, an increased vesicle size was observed. The size shift
was slightly larger for structures with only one cholesterol modification which could indicate
a more loose attachment to the vesicle. However, for all constructs containing more than one
cholesterol tag the average vesicle diameter increased by ~20 nm. This is in good agreement
with the expected increase for DNA nanostructures attaching to the vesicles.
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Fig. 5.17 DLS showing attachment of DNA nanostructures to LUVs. (a) DLS size mea-
surements of LUVs extruded at 200 nm and incubated for 1 hour with 500 nM DNA
nanostructures without or with 1 to 4 cholesterol modifications (compare Fig. 4.11). The
final MgCl2 concentration was 5 mM. The Z-average diameter (mean ± SD) is shown in (b).
As structures with only one cholesterol are not expected to form stable membrane inser-
tion [75], the dithionite reduction assay was performed with 0C, 2C, 3C and 4C constructs
only (Fig. 5.18). The traces show an initial rapid decrease to ~0.6, however, no significant
difference between non-membrane-attaching (0C) and membrane-attaching structures (2C,
3C, 4C) is observed. Looking at the initial decay between 1 to 2 min, it seems that 2C
structures show a more significant drop in fluorescence intensity (Fig. 5.18b, top). However,
towards the end of the experiment (at 30 min) the 0C design showed the lowest fluorescence
intensity (Fig. 5.18b, bottom). The comparison of initial intensity reduction levels with final
ones shows only marginal differences between the different DNA nanostructures (Fig. 5.18c).
These variations are within the typical deviations of performing the assay multiple times
(compare Fig. 5.6). Therefore, the data does not provide a clear indication that the DNA
constructs were able to induce lipid scrambling in a significant portion of the vesicles. Further
experiments with the 2C design at a concentration of 100 and 200 nM and in the presence of
0.01 % OPOE still showed comparable results to Fig. 5.18a.
Although the DLS experiments indicated LUV membrane attachment of cholesterol-modified
DNA nanostructures, the bulk dithionite reduction experiments were not able to demonstrate
their scrambling activity. One drawback of this bulk assay is that it requires a relatively
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Fig. 5.18 Dithionite reduction assay with DNA nanostructures. (a) Dithionite reduction
assay of 200 nm vesicles incubated with 100 nM DNA nanostructures without or with 2 to 4
cholesterol modifications. Final dithionite concentration was 40 mM. (b) Graphs focusing on
the normalised fluorescence intensity right after the dithionite reduction (2 min, top) and at the
end of the recording (30 min, bottom). (c) Histogram comparing the normalised fluorescence
intensity averaged over 10 consecutive values (~2 s) at 2 and 30 min (mean ± SD).
efficient insertion of the DNA nanostructures. An adequate proportion of vesicles needs
to have membrane-inserted, lipid scrambling DNA nanostructures to induce a fluorescence
reduction sufficient enough to be detectable in bulk. In order to determine the minimum
number of scrambled lipid vesicles that can be detected, we will use the results of the five
dithionite reduction repeats shown in Fig. 5.6 to estimate the experimental errors. Averaging
over 50 consecutive normalised fluorescence intensity values (~10 s) yields a standard
deviation of ≈ 0.2 % representing the experimental noise (= the systematic error). This value
does not significantly change once the fluorescence reduction plateau is reached (for these
experiments defined as from 6 min onwards). The standard deviation of the fluorescence
intensity averaged over the five experimental repeats is between 0.3 % (at 6 min) and 0.9 %
(at 30 min). Therefore, the total error is on the order of ~1 %.
The electrophysiology experiments, discussed in Section 5.3.1, indicated a very low insertion
efficiency. Only a single or a few insertions were observed on a lipid bilayer area of
≈ 0.07 mm2. In comparison, the surface area of LUVs with a diameter of 100 to 200 nm
is approximately 1,000,000 smaller (see Table 5.4). Assuming the same density of DNA
nanostructures at the membrane surface (both assays were carried out at 100 nM DNA
constructs at some point), an insertion is expected only on approximately every 1,000,000th
vesicle. However, in order to overcome the measurement error of ~1 %, an insertion and
complete lipid scrambling of more than every 100th vesicle is required. Even if DNA
nanostructures would insert more efficiently in the curved membranes of vesicles than in
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planar lipid bilayers, as suggested by a previous report [170], the insertion efficiency would
have to be 10,000 times higher to have an effect in the detectable range.
Table 5.4 Comparison of the membrane area of the planar lipid bilayer used in electrophysiol-
ogy experiments (Aplanar) with the surface area (Avesicle) of large (LUV) or giant unilamellar
vesicles (GUV).
Membrane type Diameter Membrane area Membrane area ratio
µm µm2 Avesicle / Aplanar
Planar 300 70686 1
LUV 0.1 0.03 0.4 × 10−6
LUV 0.2 0.13 1.8 × 10−6
GUV 5 79 0.1 × 10−2
GUV 10 314 0.4 × 10−2
GUV 20 1257 1.8 × 10−2
Due to the low insertion efficiency, the current design of the bulk dithionite assay on LUVs is
most likely not sensitive enough to detect the lipid scrambling activity of DNA nanostructures.
Table 5.4 illustrates that using larger vesicles can enhance the probability for insertion per
vesicle which we will discuss in Chapter 6. However, in the next section we will still employ
LUVs but try to increase the insertion efficiency of DNA constructs using electroporation.
5.3.8 Electroporation to aid DNA nanostructure insertion
One approach to aid the membrane insertion of DNA nanostructures could be to temporarily
disturb the lipid membrane of the vesicles in such a way that the energy barrier for the
DNA nanostructures to insert is lowered. This could be achieved by inducing short-lived
deformations to the vesicles using electric fields. Electroporation is a microbiology technique
in which a strong electrical pulse is applied to create temporary pores in the lipid bilayer
membranes [224, 225]. These pores create passages that are typically used for introducing
molecules like proteins, DNA (transfection) or drugs into a cell [226]. The technique
has previously also been applied to form temporary pores in artificial vesicles [227, 228].
DNA nanostructures that are attached to the vesicle’s membrane but are not yet inserted,
could then spontaneously insert into these temporary pores and stabilise them such that the
nanostructures stay inserted even after the electrical pulse has decayed (see Fig. 5.19).
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a b c
Fig. 5.19 Scheme of electroporation-assisted membrane insertion of DNA nanostructures.
(a) Lipid vesicles with membrane-attached DNA constructs. (b) A strong electrical pulse
induces the formation of temporary membrane pores. While diffusing on the vesicle bilayer,
DNA nanostructures could spontaneously insert into these pores. (c) DNA structures could
stabilise the temporary pores and remain in the membrane after the electrical pulse is over.
To find suitable electroporation conditions, vesicles without DNA constructs were tested
first. The device generates an electric pulse with an exponential decay. The voltage initially
increases rapidly reaching a peak voltage V0 and then decreases over time following
Vt =V0 e−t/τ
with τ = RC
(5.2)
being the time constant which is an expression of the pulse length. R refers to the resistance
and C to the capacitance which are set on the electroporation device. The electrical field is
given by
Et =
Vt
d
=
V0
d
e−
1
RC t (5.3)
with d being the distance between the electrodes. Keeping d and R constant (see Section 5.2)
the electrical field can be modulated by changing the voltage V0 or the capacitance C. While
the voltage alters the field strength, the capacitance can be used to change the duration the
pulse is applied for. These two parameters have been explored in order to find suitable
conditions where membrane pores could potentially form but the vesicles are still intact
afterwards. For this, vesicle solutions were exposed to electric pulses of different voltages
and pulse durations, and afterwards evaluated via DLS size measurements and a dithionite
reduction assay of the same sample to see if the vesicles are still intact (see Fig. 5.20).
While for a capacitance of 1 µF vesicle sizes remained mostly unchanged, for a 3 µF
capacitance larger sizes were observed from applied voltages of 1200 V onwards (Fig. 5.20a).
However, the results of the dithionite assay remained relatively unchanged (Fig. 5.20b). This
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Fig. 5.20 Electroporation of LUVs at different voltages and capacitances. DLS measurements
(a) and dithionite assays (b) of vesicles after exposure to voltage pulses between 0 and
2400 V at capacitances of 1, 3, and 25 µF. For 25 µF only voltages up to 1200 V were tested
(as arcing and scorching of the capillaries was observed above) and the dithionite assay was
repeated n times. Traces for the capacitance of 25 µF represent the average and standard
deviation. Final dithionite concentration was 40 mM.
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is in contrast to using a capacitance of 25 µF where already from 400 V onwards aggregates
were observed and the bleaching plateau in the dithionite assay dropped to lower values than
the 0 V control. The increased size observed for vesicles exposed to high voltages at 3 µF
could indicate vesicle fusion. At the same time, the vesicles seem to remain intact such that
dithionite cannot permeate to their inside as indicated by the results of the dithionite assay
not significantly differing compared to if no voltage was applied (Fig. 5.20b). As vesicle
fusion is a sign for temporary membrane poration [228] which could aid DNA nanostructure
insertion, a pulse of 2400 V at 3 µF was selected as the most promising condition.
To test if electroporation can aid DNA nanostructure insertion, vesicles extruded at 200 nm
were incubated with DNA nanostructures and exposed to an electric pulse. DLS size
analysis of the vesicle suspension, after the voltage pulse was applied, showed larger vesicle
diameters indicating that electroporation and vesicle fusion occurred, as intended (Fig. 5.21a).
Variations in the vesicle size could be caused by different surface potentials at the lipid-buffer
interface due to the presence of the DNA nanostructures.
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Fig. 5.21 Electroporation of LUVs after incubation with DNA nanostructures. (a) DLS size
measurements of EColi-eggPC vesicles after their incubation with different DNA nanostruc-
tures and exposure to either no pulse or a single voltage pulse at 2400 V and 3 µF. As negative
controls, DNA nanostructure buffer (TE20) was added on its own. 6HP structures were
assembled with three cholesterol modifications, as described previously [72]. (b) Dithionite
reduction assay performed on the same vesicle solutions analysed in a. Inset shows a close-up
of the normalised intensity around 0.5. The final dithionite concentration was 40 mM.
After DLS analysis, a dithionite assay was performed. No significant difference in fluores-
cence reduction was observed, whether the DNA constructs were present or not (Fig. 5.21b).
Therefore, although electroporation seemed to have induced vesicle fusion, it did not increase
the insertion efficiency of DNA constructs significantly enough to detect scrambling activity.
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5.4 Conclusion
The aim of the experiments presented in this chapter was to demonstrate the lipid scrambling
activity of cholesterol-modified, membrane-inserted DNA nanostructures. The electro-
physiology measurements showed that the CP2 DNA nanostructure with two cholesterol
modifications is able to spontaneously self-insert into lipid bilayers and act as a synthetic
DNA-built ion channel. The determined conductance of ≈ 0.7 nS was in agreement with
previously determined values for a DNA nanostructure of similar size and modified with two
cholesterol tags [54]. However, our experiments also demonstrated that the DNA nanostruc-
ture insertion efficiency was very low.
As frequently employed in previous research to investigate scrambling activity, the dithionite
reduction assay was performed on suspended, NBD-containing LUVs using a fluorescence
spectrometer. The systematic analysis of the assay parameters revealed that LUVs formed
from POPC are not ideal for the dithionite assay due to a considerable degree of multilamel-
larity. Using a 3:1 EColi:eggPC lipid mixture proved to be far superior as vesicles showed a
more consistent behaviour regarding the dithionite reduction to the expected value. Interest-
ingly, DLS measurements demonstrated that these liposomes seemed to have a preferred size
of ~200 nm in contrast to vesicles formed from POPC. The labelling position of the NBD on
the lipid only had a minor influence in these experiments, however, this could become a more
significant parameter once lipid scrambling activity is observed. The dithionite concentration
significantly influenced the reduction kinetics which is important if scrambling rates need
to be determined. While for long-term measurements higher dithionite concentrations can
lead to lower fluorescence intensity plateaus over time, short-term measurements (a few
minutes) are not significantly affected by that. Lastly, the presence of surfactants, specifically
OPOE, was shown to induce a fluorescence reduction indicative of scrambling activity at
concentrations even below the CMC. Therefore, only low concentrations can be employed
and control experiments are particularly crucial.
Unfortunately, it was not possible to establish a positive control for scrambling activity using
the commercially available TMEM16F scramblase. A possible cause could have been that
the protein was not biologically active. Future experiments would therefore benefit from
expressing a lipid scramblase protein ourselves or to collaborate with another group that
could provide a functioning protein.
For cholesterol-modified DNA nanostructures the results did not show any significant indica-
tion of lipid scrambling activity for multiple different designs even though DLS experiments
suggested attachment of the structures to the vesicles. A possible explanation is the low in-
sertion efficiency of the DNA nanostructures which is in agreement with the results obtained
from the electrophysiology experiments. Our calculations showed that the membrane surface
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area of LUVs with a diameter of ~100 to 200 nm is approximately 106 times smaller than the
membrane area that was employed in the electrophysiology assay. Given the determined low
insertion efficiency, the number of vesicles that demonstrates scrambling activity due to a
membrane-inserted DNA nanostructure is expected to be several orders of magnitude too
low to be detected in the bulk dithionite assay using LUVs. This could also explain why it
was not possible to determine scrambling activity despite attempts to increase the insertion
efficiency by inducing transient membrane pores or vesicle fusion with electroporation.
Nevertheless, the results obtained from the bulk dithionite assays provide a valuable foun-
dation for designing and interpreting future dithionite reduction experiments. While no
lipid scrambling activity of DNA nanostructures could be demonstrated in this chapter, the
question if an undoubtedly membrane-inserted construct can scramble lipids is still open. In
the next chapter, we will address this question by employing molecular dynamics simulations
to determine if our CP2 DNA nanostructure can, in theory, scramble lipids given it is inserted
in a membrane. We will furthermore introduce a strategy to increase the probability for
membrane insertion simply by increasing the size of the vesicles which will additionally
allow to follow the dithionite reduction kinetics at the single-vesicle level.
Chapter 6
A lipid scramblase built from DNA
Parts of this work previously appeared in:
A. Ohmann, C. Y. Li, C. Maffeo, K. Al Nahas, K. N. Baumann, K. Göpfrich, J. Yoo, U. F.
Keyser, and A. Aksimentiev. ‘A synthetic enzyme built from DNA flips 107 lipids per second
in biological membranes.’ Nature Communications, 9:2426 (2018).
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On the molecular scale, you find it’s reasonable to have
a machine that does a million steps per second.
– K. Eric Drexler
In the previous chapter we have introduced the dithionite reduction assay, an established
method to determine lipid scrambling activity in membranes. Although studying the char-
acteristics of the assay provided a valuable foundation, so far we have not achieved our
original aim: to determine if our membrane-inserted DNA nanostructures can induce lipid
scrambling across bilayer leaflets. In this chapter we will use the CP2 DNA nanostructure
modified with two cholesterol tags (2C) as a basis since we have successfully demonstrated
its membrane-insertion capabilities in Chapter 5. An overview of the design with its details
is shown again in Fig. 6.1. Previous experiments on a similar DNA structure have shown that
this number of modifications can be sufficient for membrane insertion [54]. Furthermore,
this minimal design allows to easily switch between a structure that is, in principle, able to
insert into a lipid bilayer (2C) and a structure that should only attach but not insert (1C),
simply by omitting one cholesterol modification in the assembly.
We will first employ atomistic MD simulations to demonstrate that this DNA nanostructure
design indeed scrambles lipids when inserted into a lipid bilayer via two cholesterol anchors.
Similar to the previously described results for a single membrane-spanning DNA duplex [8],
the simulations reveal that the DNA nanostructure induces a toroidal lipid pore. This DNA-
induced lipid pore is then shown to facilitate lipid scrambling on the order of 107 lipids per
second for a single DNA structure.
We will furthermore introduce an improved dithionite reduction assay in order to experi-
mentally demonstrate the lipid scrambling activity of the DNA nanostructures. The elec-
trophysiology measurements discussed in the previous chapter showed that the insertion
efficiency of the DNA constructs is rather low. This could explain why lipid scrambling
was not observed in the bulk dithionite reduction experiments performed on LUVs . Given
the low insertion efficiency, the number of DNA nanostructures per vesicle might not have
been sufficient to achieve insertions on enough vesicles to detect a measurable decrease in
NBD fluorescence with bulk fluorescence spectroscopy. In this chapter, we will discuss the
advantages of employing larger vesicles in order to increase the ratio of DNA structures per
vesicle. We will employ giant unilamellar vesicles (GUVs) with diameters ranging from 5 to
20 µm to perform the dithionite reduction assay which will significantly raise the chances
for membrane insertion compared to the previously employed LUVs (~100 to 200 nm). It
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will further allow us to directly measure scrambling activity on each individual vesicle using
confocal microscopy. To the best of our knowledge, we therefore introduce a novel assay
that allows the direct observation of lipid scrambling activity via monitoring the dithionite
reduction kinetics at the single-vesicle level.
With this combination of atomistic MD simulations and improved dithionite reduction ex-
periments on GUVs, we ultimately demonstrate that our DNA nanostructure can mimic a
fully functional scramblase by facilitating rapid mixing of lipids between bilayer leaflets.
Strikingly, the scrambling activity of our de novo DNA-made enzyme outperforms any known
biological scramblase by several orders of magnitude. This is remarkable given that the
catalytic rates of previous enzymatically active DNA nanostructures fall orders of magnitude
behind natural benchmarks [229, 230].
Lastly, we will test our DNA scramblase on human breast cancer cells. We will use the
Annexin V staining assay which detects the exposure of phosphatidylserine (PS) lipids on the
cell surface, a task performed by lipid scramblases when they are activated during apoptosis.
The results from these experiments indicate that our DNA scramblase can induce apoptosis
in human cancer cells.
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Fig. 6.1 Overview of lipid-scrambling DNA nanostructure. (a) Side and (b) top view of a
3D representation of the assembled CP2 DNA nanostructure with two cholesterol tags (red)
linked to the central 3’ ends via an adenine-TEG spacer (A-TEG, black). (c) 2D schematic
illustrating the pathway of the DNA single strands as well as cholesterol modification
positions. (d) Non-denaturing 10 % PAGE of DNA nanostructures assembled without (0C),
with one (1C), or with two (2C) cholesterol modifications next to a DNA ladder (L).
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6.2.1 All-atom MD simulations of lipid scrambling
MD simulations were performed and analysed by C.-Y. Li, C. Maffeo, J. Yoo and A. Ak-
simentiev at the University of Illinois at Urbana-Champaign. A detailed description of
the methods can be found in the published article and its Supplementary Information [75].
Briefly, the caDNAno design of the DNA nanostructure was converted to an idealised all-atom
representation. The design featured two centrally positioned cholesterol-TEG modifications
(for chemistry see Fig. 4.1) that included an adenine spacer nucleotide (see Fig. 6.1). This
atomistic representation was embedded into a lipid bilayer membrane using a previously
described method [231]. The resulting model was merged with a rectangular volume of elec-
trolyte solution, minimised and equilibrated in the constant number of particles, temperature,
and pressure ensemble. The simulations employed the CHARMM36 parameter set [232] and
were carried out using both NAMD [176] and Anton [233].
6.2.2 Preparation of GUVs using electroformation
Giant unilamellar vesicles were prepared by K. Al Nahas using electroformation via a
Nanion Vesicle Prep Pro. 2-Oleoyl-1-palmitoyl-sn-glycero-3-phosphatidylcholine (POPC;
Sigma-Aldrich) and 1-palmitoyl-2-{6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl}-
sn-glycero-3-phosphatidylcholine (NBD-PC; Avanti Polar Lipids) were dissolved in chlo-
roform and mixed in a weight/weight ratio of 200:1 (POPC:NBD-PC). These lipids were
the same as the POPC:NBD-PC-C6* mixture employed in Chapter 5. 100 µl of the lipid
mixture at 5 mg ml−1 was spin-coated on the conducting surface of an indium tin oxide
(ITO)-coated glass slide (Nanion/VisionTek). Chloroform was evaporated for 1 hour in
a desiccator following which 600 µl of sucrose buffer (100 mM sucrose, 20 mM HEPES
at pH 7.4) was deposited within the O-ring chamber which was subsequently sealed with
another ITO-coated slide (conducting surface facing the other). The electroformation cham-
ber was then connected to the Nanion Vesicle Prep Pro and the electroformation protocol
proceeded in 3 steps:
i. The A/C voltage increased linearly from 0 to 3.2 V peak-to-peak (p-p) at 10 Hz for 1 h,
ii. the voltage stayed at 3.2 V p-p and 10 Hz for 50 min,
iii. the frequency decreased linearly to 4 Hz over 10 min and was maintained for another
20 min.
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The steps were adapted from previous protocols [234, 235]. Electroformation was carried
out at 37 ◦C. Vesicles were stored at 4 ◦C protected from light and not used longer than 36
hours after formation.
6.2.3 Osmolality measurements
A freezing point osmometer (Automatic Micro-Osmometer Type 11, Roebling) was calibrated
at 0 mOsm kg−1 with distilled water and at 300 mOsm kg−1 with a standard solution (Camlab
Limited). A fresh sample was used for each measurement. 100 µl sample was deposited
in a 1.5 ml Eppendorf tube and supercooled. Freezing was automatically initiated by a
metal needle dipping into the solution. Due to the formation of ice crystals the sample’s
temperature rises until an equilibrium between melting and thawing of the ice crystals is
reached and the temperature remains constant for a moment. This temperature is the real
freezing point of the sample which is measured by a high-precision thermistor. From the
deviation of the sample’s freezing point from pure water without any solutes (freezing point
= 0 ◦C), the osmolality of the sample is determined.
6.2.4 Dithionite reduction assay on GUVs
Assembled DNA nanostructures (1 µM) with either one (1C) or two (2C) cholesterol modifi-
cations were mixed with 0.5 % OPOE, pre-diluted in TE20 buffer, in a 7:1 ratio and incubated
for 2 min at room temperature. The mixture was then diluted in glucose buffer (100 mM
glucose, 4 mM MgCl2, 20 mM HEPES titrated to pH 7.4 with KOH) and added to 20 µl
GUV solution at a final concentration of 100 nM DNA nanostructures. Samples were then
incubated for 90 to 120 min on a 1 % BSA-coated glass coverslip within an incubation
chamber (Grace Bio-Labs) at room temperature. This allowed the vesicles to settle to the
bottom due to the density gradient between the intravesicular sucrose and extravesicular
glucose as well as the cholesterol-modified DNA nanostructures to anchor into the lipid
membrane. Dithionite was freshly dissolved in 1 M Tris at pH 10 at a concentration of
1 M and then pre-diluted in 50 mM glucose, 4 mM MgCl2 and 20 mM HEPES pH 7.4 to
a concentration of 15 mM dithionite right before each experiment. To initiate NBD dye
reduction, 30 µl of diluted dithionite solution was carefully added to the incubated vesicles
to a final concentration of ~4.5 mM dithionite at approximately one minute after starting the
image recording. Chambers were covered with a glass slide to prevent evaporation except
when the dithionite solution was added. At all times in the protocol at least 4 mM MgCl2 was
present to keep the DNA nanostructures stable. A detailed overview of the buffer conditions
used throughout the protocol is presented in Table 6.1 in Section 6.3.3.
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Images were acquired on an Olympus FluoView filter-based FV1200F-IX83 laser scanning
microscope using a 60x oil immersion objective (UPLSAPO60XO/1.35). NBD excitation
was performed using a 25 mW 473 nm laser diode at 1 % laser power and emission was
collected between 490 and 525 nm. Cy3 was excited with a 1.5 mW 543 nm HeNe laser at
5 % laser power and emitted light collected between 560 and 660 nm. For statistical analysis
a z-stack (slice thickness 300 nm) was recorded of the field of view before and 35 min after
dithionite addition with separate excitation of the 473 and 543 nm laser lines at a sampling
speed of 2.0 µs pixel−1. For single vesicle fluorescence reduction traces, vesicles of similar
size were kept in focus and images were recorded every 10 s in between the z-stacks while
exciting with both lasers simultaneously. Images were analysed using Fiji [150].
Vesicles were identified and located from the fluorescence signal collected from Cy3-labelled
DNA nanostructures by applying a ring-shaped selection area over the fluorescent ring at
a height close to the equatorial plane. NBD fluorescence intensity for each vesicle was
then determined by measuring the mean grey value of the equivalent area in the respective
images of the NBD emission channel. Values were background-subtracted by measuring and
averaging over three areas without vesicles. Intensities per vesicle were normalised to the
average intensity of the first five data points of each trace.
6.2.5 Dithionite leakage experiments
Several experiments were performed to test if dithionite can leak across the vesicle mem-
brane or through the DNA-induced toroidal pore. 2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-
yl)amino)-2-deoxyglucose (NBD-glucose, Invitrogen) was purchased dry and diluted to a
stock concentration of 30 mM in dimethyl sulfoxide (DMSO). GUVs were then formed from
POPC and NBD-PC but additionally in the presence of 50 µM NBD-glucose. Subsequently,
fluorescence recovery after photobleaching (FRAP) experiments were performed using con-
focal microscopy on several vesicles by excitation of the whole field of view with a 473 nm
laser at high intensity for several frames. Subsequently, the laser intensity was reduced to
the same level as before photobleaching and the fluorescence recovery inside the vesicles
was recorded over time. For data analysis the fluorescence intensity inside the vesicles was
normalised to the fluorescence outside the vesicles before photobleaching.
As a second NBD-labelled probe, Amino-dPEG12-OH (PEG12) or Amino-dPEG24-OH
(PEG24) polyethylene glycol molecules (Quanta Biodesign) were synthesised with suc-
cinimidyl 6-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)hexanoate (NBD-SE; Invitrogen),
an NHS-ester of the fluorescent dye NBD, to form NBD-PEG according to a previously
described protocol [236]. For this, dried NBD-SE and PEG12 (or PEG24) were each di-
luted in 1:1 chloroform:methanol to final concentrations of 10 mg ml−1 (≈ 25 mM) and
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137 mg ml−1 (≈ 128.3 mM), respectively. For the reaction, NBD-SE and PEG12 (or PEG24)
were mixed at a ratio of NBD-SE:PEG of either 1:1, 1:2, or 1:10, and diluted to a final
concentration of ≈ 5 mM NBD-SE in 1:1 chloroform:methanol. The mixture was incubated
for one hour or over night at room temperature under constant movement and protected from
light. The solution was then blow-dried with nitrogen, desiccated for 10 min under vacuum
and subsequently dissolved in 500 µl of 20 mM HEPES (pH 7.4) for a final concentration of
≈ 5 mM NBD-PEG. Successful synthesis was confirmed with thin layer chromatography
(TLC) on silica gel plates (Sigma-Aldrich) using 1:1 chloroform:methanol as the eluent.
Imaging of the TLC plates was performed on a GelDoc-ItTM (UVP) imaging system using
UV excitation.
GUVs were then formed from POPC in the presence of 70 µM NBD-PEG. Vesicles were
diluted in glucose buffer as used for dithionite reduction assays but supplemented with 70 µM
NBD-PEG (to maintain NBD-PEG concentration outside the vesicles), and incubated for
two hours with 2C DNA nanostructures. FRAP experiments were performed and analysed as
described for NBD-glucose above. NBD-PEG24 showed even less membrane permeability
than NBD-PEG12 although not to a significant extent.
6.2.6 Annexin V staining experiments on human cancer cells
MDA-MB-231 cells were acquired from the Biorepository of the Cancer Research UK
Cambridge Institute where the cells were authenticated by multiplex polymerase chain
reaction (PCR) and short tandem repeat (STR) profiling including detection of mouse cell
contamination. Cells were handled and maintained by K. N. Baumann. Cells were cultured
in Dulbecco’s modified Eagle’s medium (DMEM; Sigma-Aldrich) supplemented with 10 %
(v/v) heat-inactivated fetal calf serum (FCS; Thermo Scientific) at 37 ◦C and 5 % CO2. A
concentration of 30,000 cells per 250 µl medium was seeded on a cover glass placed in a
well of a 48-well plate (day 0) and grown for two nights under the same conditions as stated
above. Afterwards, cells were washed once with phosphate-buffered saline (PBS) and then
covered again in fresh medium. DNA nanostructures with two cholesterols and two Cy3
tags were assembled as described in Section 4.2.1 but in PBS at pH 7.4 supplemented with
8 mM MgCl2 instead of TE20 buffer. 120 µl of assembled structures were added to cells
(prepared as described above) in the well plate (final structure concentration 324 nM) and
incubated for one hour at 37 ◦C and 5 % CO2. For control experiments performed in parallel,
only the DNA folding buffer without DNA nanostructures (negative control) or 10 µM of
the apoptosis-inducing agent staurosporine (S5921, Sigma-Aldrich; positive control) was
added, respectively. To stain the cells with FITC-labelled Annexin V as an indicator of PS
exposure, cells were first washed with 500 µl of 1x Annexin V binding buffer (Abcam) and
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then incubated with 500 µl of 1x FITC-labelled Annexin V (Abcam) in binding buffer for
5 min (in accordance with the protocol provided by the manufacturer). To prepare the cells for
fluorescence microscopy imaging, cells were subsequently washed with 500 µl binding buffer
once again and then fixed in 250 µl of 4 % formaldehyde in binding buffer for 15 min on ice,
followed by three washing steps with 250 µl binding buffer before being stored in the fridge
overnight. On day four the cover glasses were transferred onto microscope slides by mounting
them with Mowiol [237]. For this, 6 g of glycerol, 2.4 g of Mowiol powder (Calbiochem)
and 6 ml of distilled water were added to 12 ml of 0.2 M Tris buffer (pH 8.0) and stirred for
four hours. The solution was then left to rest for an additional two hours. Subsequently, the
mixture was incubated for 10 min in a 50 ◦C water bath and finally centrifuged for 15 min
at 5,000 × g. After removing the supernatant, the solution was stored at −20 ◦C before
usage. Images were acquired on the same confocal microscope as described for the dithionite
reduction assay except that a 20x air objective was used (UPLSAPO20X/0.75). Filter set
and laser power for Cy3-labelled DNA nanostructures were kept the same and parameters
used for the NBD dye were applied for imaging FITC-labelled Annexin V as well. Detector
voltages for both channels were kept fixed and were the same for all experiments. Z-stacks
(slice thickness 500 nm) of cells were acquired with separate excitation of the 473 nm and
543 nm laser lines (sampling speed 2.0 µs pixel−1). The brightfield images were obtained
by acquisition of the transmitted light of the 543 nm laser. Analysis was performed using
Fiji [150].
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6.3 Results & Discussion
6.3.1 All-atom MD simulations of lipid scrambling
Having experimentally characterised our cholesterol-modified DNA nanostructures in the
preceding chapters, we employed the all-atom MD method to determine if the structures
induce lipid scrambling when inserted into a lipid bilayer. For this, we collaborated again
with the group of A. Aksimentiev at the University of Illinois at Urbana-Champaign who
performed the MD simulations for us. Following a previously described protocol [231], an
all-atom model of the DNA nanostructure modified with two cholesterol modifications (2C)
embedded in a diphytanoyl phosphatidylethanolamine (DPhPE) membrane and solvated
in 1 M KCl was built. The entire system was first equilibrated for ~230 ns with the DNA
nanostructure constrained to its initial idealised conformation. This allowed for lipids and
water to adopt an equilibrium configuration (see Fig. 6.2a).
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Fig. 6.2 All-atom MD simulation of lipid scrambling induced by the DNA nanostructure.
Snapshots of the microscopic configuration of the simulated system at the beginning (a-c)
and the end (d-f) of the free equilibration simulation. (a,d) Cut-away side view showing
the DNA nanostructure (blue and yellow) embedded in a DPhPE lipid membrane (grey) via
cholesterol tags (red). Lipid headgroups located in the upper and lower leaflet of the bilayer
at 0.2 µs are highlighted using purple and green spheres, respectively. Top view (b,e) and
bottom view (c,f) of the simulated system. The electrolyte solution is not shown for clarity.
White ellipses in e,f highlight DPhPE headgroups that resided in the opposite leaflet of the
bilayer at 0.2 µs. The indicated lipid #51 in e will be used as an example later on.
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The cut-away side view shown in Fig. 6.2a illustrates that the lipid headgroups adopt a
toroidal pore shape around the nanostructure. Such a toroidal pore shape at the lipid-DNA
interface matches previous MD simulation performed on a single membrane-spanning DNA
duplex [8]. Figures 6.2b,c illustrate the lipid headgroups residing at 0.2 µs in the upper
bilayer leaflet (panel b) and lower bilayer leaflet (panel c). The system was then simulated
without any constraints for ~2 µs. Comparison of initial and final configurations illustrates
that throughout the simulation several lipids have completely transferred from one bilayer
leaflet to the other (Figs. 6.2d-f). As the coordinates of all atoms were recorded throughout
the simulation, the trajectory of how the lipids flip from one bilayer leaflet to the other could
be investigated. An example of such a trajectory is depicted in Figure 6.3.
0 µs 0.7 μs 2.2 μs
Fig. 6.3 MD simulation illustrating the trajectory of a flipping lipid. Sequence of microscopic
conformations illustrating spontaneous inter-leaflet transfer of one lipid molecule (highlighted
by the bold depiction; #51 in Fig. 6.2e) during the 2.2 µs MD simulation. For clarity, all
other lipid molecules are shown as a different representation and the electrolyte solution is
not shown. Arrows illustrate the trajectory of the lipid during the simulation.
At 0 µs the toroidal pore has not formed yet, as indicated by the parallel arrangement of
the lipid headgroups. At 0.7 µs the toroidal pore has formed around the DNA nanostructure
and the highlighted lipid diffuses along the DNA-lipid interface to the upper bilayer leaflet
where it still remains at 2.2 µs. This visual inspection of the MD trajectory revealed, that
the lipids diffused from one bilayer leaflet to the other along the walls of the DNA-induced
toroidal lipid pore. The lipids forming the inner surface provide a continuous passage from
one leaflet of the membrane to the other. This diffusive motion of individual lipid molecules
was not correlated, occurred in both transport directions, and produced zero net transport
of lipids from one leaflet to the other, as expected. Further examples of such inter-leaflet
transfer events can be found in the Supplementary Information of [75].
To quantitatively characterise the inter-leaflet transport of lipids, the Z coordinate of each
lipid’s phosphorus atom and its radial distance R from the centre of the DNA nanostructure
was computed as a function of the simulation time. Figure 6.4a shows an example of a typical
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translocation, where a lipid molecule moves from the bottom leaflet (Z < −1.75 nm) to the
top one (Z > 1.75 nm), while approaching the DNA construct (R < 3 nm) during the transfer
process. These values of Z and R match well with the expectations given the geometry of
the lipid bilayer and the DNA nanostructure. As the lipid molecule approaches the DNA
nanostructure, it reorients itself to expose its polar headgroup to the DNA nanostructure
(compare snapshot at 0.7 µs in Fig. 6.3).
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Fig. 6.4 Quantitative analysis of flipped lipids. (a) Graph of the radial distance R relative to
the centre of mass of the nanostructure (left axis) and the Z coordinate of the phosphorus
atoms (right axis) of a lipid molecule (#51, see Fig. 6.2e) undergoing a complete transfer
from the lower to the upper leaflet of the bilayer. Dashed red lines indicate Z-coordinate
thresholds for the upper and lower bilayer leaflet. Data shown were sampled at 0.24 ns and
averaged in 9.6 ns blocks. (b) Cumulative number of inter-leaflet transfer events versus
simulation time. A linear fit (black line) yields the average transfer rate. The error indicates
the estimated standard deviation of the non-linear least squares fit.
An inter-leaflet transfer event, or a flipped lipid, was counted each time the Z coordinate of
a lipid phosphorus atom changes from being less than −1.75 nm to being more than 1.75 nm
or vice versa. Figure 6.4b plots the cumulative number of transfer events versus the simulation
time. A linear fit yields the average transfer rate of 16.7 ± 0.54 lipids per µs. This equates
to a lipid scrambling rate on the order of 107 lipids per second for a single DNA construct.
A slower yet significant spontaneous transfer of lipids was observed in an additional 2 µs
simulation of the same DNA nanostructure embedded in a diphytanoyl phosphatidylcholine
(DPhPC) lipid bilayer (see Supplementary Information of [75]), suggesting that the rate of
lipid transport facilitated by the same nanostructure can be lipid-type dependent.
Quantitative analysis of lipid density within the toroidal pore reveals a rather modest, of the
order of 1 kBT, free energy barrier to inter-leaflet transport (see Fig. A.5 in the Appendix),
which is in accord with our earlier conclusion that transport of lipids occurred via diffusive
motion. Given the general character of such transport, we can expect any membrane-spanning
DNA nanostructures to exhibit lipid scrambling activity as long as they promote the formation
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of a toroidal pore. Indeed, analysis of our previous MD simulations of single duplex [8] and
funnel-like [74] DNA pores revealed an average inter-leaflet transport of 4 and 200 lipids per
µs, respectively. In contrast, no lipid scrambling was observed for a DNA nanostructure that
had a modified DNA backbone and did not allow the toroidal pore to form [68, 231].
6.3.2 Increasing the probability of DNA nanostructure insertion
In the previous section, the MD simulations determined a very high scrambling rate of
107 lipids per second for a single DNA nanostructure. If a comparable rate would also be
observed in experiments, a single, membrane-inserted DNA nanostructure should suffice to
flip most lipids of a vesicle at the typical time scales of the dithionite reduction assay even
in vesicles exceeding 1 µm in diameter (compare number of lipids per vesicle in Fig. 5.12).
As already briefly mentioned in Section 5.3.7, we will discuss in the following that simply
by increasing the vesicle size, the probability of a single membrane insertion per vesicle
increases by an even greater extent as well.
Using the previously introduced membrane parameters (see bilayer thickness dB and volume
of a lipid VL in Table 5.3) and Equations 5.1, the number N of lipids in a vesicle of diameter
dV can be estimated as the sum of lipids in the inner (Ni) and outer bilayer leaflet (No) as
follows:
NLipids per vesicle = Ni +No =
π
6VL
[
dV3− (dV−2dB)3
]
=
π dB
VL
[
dV2−2dB dV + 43 dB
2
]
∝ dV2
(6.1)
The vesicle diameter dV is highlighted in bold to illustrate that the number of lipids per vesicle
has a quadratic dependency on it. In the dithionite reduction assays to detect lipid scrambling
discussed in the previous chapter, typically LUVs with a diameter dV of approximately
100 to 200 nm, a lipid concentration of CLipids ≈ 80 µM, and a DNA concentration of
CDNA ≈ 100 nM were employed. Under the assumptions that
• CLipids and CDNA are kept constant,
• all lipids are used up to form vesicle membranes,
• and all DNA nanostructures homogeneously attach to the vesicles,
we can then estimate the number N of DNA nanostructures per vesicle using
NDNA per vesicle =
CDNA
CLipids
NLipids per vesicle ∝ dV2 (6.2)
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This equation illustrates that the number of DNA nanostructures per vesicle also has a
quadratic dependency on the vesicle diameter dV . Figure 6.5 plots how the ratio of DNA
nanostructures per vesicle increases if vesicles of a larger diameter are employed.
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Fig. 6.5 Estimations of DNA nanostructures per lipid vesicle. Graph illustrating the number
of DNA nanostructures per lipid vesicle of a given diameter dV . Values were calculated
from Equations 6.1 and 6.2 using a lipid concentration of 80 µM and DNA concentration of
100 nM. The vesicle size classification is taken from [238].
From this estimation it becomes apparent that simply by increasing the vesicle diameter
from the previously employed ~100 nm to 10 µm, the chances that a single DNA nanostructure
inserts can be increased 10,000 fold. Changing the system size has furthermore direct
implications for the detection using fluorescently labelled lipids in the dithionite reduction
assay. If a DNA nanostructure inserts in a vesicle and induces lipid scrambling, the absolute
change in fluorescence signal is proportional to the number of NBD-labelled lipids that can
be flipped to the outer membrane leaflet where they are bleached by dithionite. A vesicle of
10 µm in diameter is composed of approximately 10,000 times more lipids than a 100 nm
vesicle. Assuming that a single DNA nanostructure insertion in a vesicle facilitates complete
scrambling of the lipids such that all NBD signal is reduced by dithionite, the absolute change
in fluorescence signal increases 10,000 fold as well. Therefore, simply by increasing the
vesicle size by two orders of magnitude (without changing any other parameter), the insertion
probability of DNA nanostructures as well as the change in fluorescence signal in case of
scrambling activity can be increased by four orders of magnitude each.
It should be noted that these considerations required certain assumptions. In addition to
the ones listed above, we also assumed that a single DNA construct has the same insertion
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efficiency on smaller vesicles than it has on larger vesicles, disregarding the effect of
membrane curvature. Furthermore, the lipid concentration can be less controlled in the
electroformation process to create GUVs. Nevertheless, the fundamental advantages of
employing GUVs can be of several orders of magnitude which makes them a promising
improvement to the assay. Another advantage of using GUVs is that they can be observed via
fluorescence microscopy enabling us to directly verify lipid scrambling at the single-vesicle
level. At the same time, we can confirm the correlation of scrambling with the design and
attachment of our DNA nanostructures. The increased control will also aid in understanding
the results of the dithionite assay making the use of GUVs even more beneficial.
6.3.3 Dithionite assay on giant artificial vesicles
Following the benefits of using larger vesicles discussed in the previous section, it was first
necessary to adapt the experimental protocols of the dithionite reduction assay to GUVs. This
required reconsidering the lipid composition and particularly the buffer conditions which
will be discussed in this section.
For the EColi-eggPC mixture favoured in the previous chapter, the dynamic light scatter-
ing measurements have established that this lipid mixture predominantly forms vesicles
at around 200 nm in diameter. Therefore, for forming GUVs with diameters exceeding
1 µm, this lipid mixture is unsuitable. While vesicles formed from POPC lipids showed a
measurable and variable degree of multilamellarity in the bulk vesicle solutions discussed
in Chapter 5, by using GUVs that can be observed via confocal microscopy, each vesicle
can be analysed individually and multilamellarity can be determined from the fluorescence
intensity and the plateau after dithionite reduction. Furthermore, POPC lipids are ideally
suited for dithionite reduction assays as they show negligible rates of spontaneous flip-flop
in reconstituted vesicles (half times > 1,000 h) [239] and their fatty acid tails are the most
abundant in naturally occurring lipid mixtures [239], making them particularly representative
for biological membranes. Furthermore, POPC lipids minimise the differences in lipid tail
chemistry between the vesicle-forming lipids and the NBD-labelled PC lipids making these
tracer lipids a more accurate representation of the bulk mixture. We therefore formed GUVs
from POPC and trace amounts of NBD-PC (see Section 6.2.2 and Table 5.1).
A crucial requisite for the dithionite assay to yield accurate results indicative of lipid scram-
bling is that dithionite does not permeate inside the lipid vesicles. Osmotic pressure dif-
ferences between the inside and outside of the artificial lipid vesicles have been shown
to potentially induce poration, particularly in giant unilamellar vesicles [240, 241]. Such
temporary passages across the lipid bilayer could allow dithionite to leak into the vesicles.
This could lead to bleaching of NBD lipids on the inner bilayer leaflet which could be falsely
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interpreted as scrambling activity. To avoid this, particular care was taken that artificial
vesicles were not exposed to osmotic pressure differences throughout the dithionite assay.
Knowing the contribution of dithionite to the osmolality of the buffer solutions allows to
account for it appropriately to minimise osmotic pressure differences. As dithionite was
prepared in Tris buffer at a 1:1 molar ratio, first the osmolality of dithionite diluted in Tris
buffer at a 1:1 molar ratio was determined using a freezing point osmometer. A linear
fit to the measured osmolalities of different concentrations of dithionite + Tris in the low
millimolar range yielded a slope of ≈ 4.3 (see Fig. 6.6a). This slope can be interpreted
as the van’t Hoff factor referring to the actual number of particles a dissolved substance
dissociates in. The determined value matches well with a complete dissociation of dithionite
into three ions (2 Na+ + S2O2−4 ) and another ion contributed by Tris. Measuring Tris on
its own yielded a slope of ≈ 1.2. This is slightly above 1 which could be explained by
some additional ions present in the solution which were introduced when adjusting the pH
to 10. This could in turn also explain the slightly higher value than 4 for dithionite + Tris.
Subtraction of the two determined solutions indicates the slope for dithionite on its own,
yielding a value of≈ 3.1 (see Fig. 6.6a). These results confirm that dithionite can be expected
to be fully dissociated at the low millimolar range that will be employed for the dithionite
assay. At higher concentrations (100 mM and 250 mM) dithionite demonstrated incomplete
dissociation (slope of ≈ 2.5, see inset in Fig. 6.6a), however, that concentration range is not
relevant for the here applied protocol of a dithionite reduction assay.
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Fig. 6.6 Osmolality measurements of buffer solutions used in dithionite reduction assays. (a)
Osmolality of Tris and dithionite + Tris (1:1 ratio) at different concentrations. Values for
dithionite only were calculated by subtracting the values for Tris from the dithionite + Tris
mixture. Lines denote linear fits with the intercept fixed at 0 and the slope as indicated. Inset
shows the osmolality at higher concentrations. (b) Columns represent two measurement
repeats and values their mean (for buffer solutions see Table 6.1). Blue bars denote solutions
that giant unilamellar vesicles were in contact with.
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Having determined the contribution of dithionite to the osmolality of the buffer solution, it
could be accounted for by reducing the concentration of glucose in the buffer to maintain an
osmotic balance between inside and outside the vesicles. The bar chart in Fig. 6.6b displays
the determined osmolalities of the buffer solutions involved in the dithionite reduction assay.
The corresponding buffer conditions are listed in Table 6.1. The bars highlighted in blue
are of buffers that vesicles are in contact with. As they show very little difference between
each other, dithionite addition could be assumed to not induce osmotic pressure differences
significant enough to cause dithionite to leak into the vesicles. Additionally, the lack of
dithionite leakage will be experimentally demonstrated by additional control experiments in
the next two sections.
Table 6.1 Buffer solutions used in dithionite reduction assays.
Buffer # Name Buffer conditions
1 HEPES buffer 20 mM HEPES pH 7.4
2 TE20 20 mM MgCl2
(containing DNA nanostructures) 10 mM Tris pH 8.0
1 mM EDTA
3 Dithionite dilution solution 50 mM glucose
20 mM HEPES pH 7.4
4 mM MgCl2
4 Dithionite solution 50 mM glucose
20 mM HEPES pH 7.4
4 mM MgCl2
15 mM dithionite
15 mM Tris pH 10
5 Glucose solution 100 mM glucose
20 mM HEPES pH 7.4
4 mM MgCl2
6 Sucrose solution 100 mM sucrose
(containing lipid vesicles) 20 mM HEPES pH 7.4
7 Incubation solution 7 µl TE20 (#2)
1 µl 0.5 % OPOE in TE20
42 µl glucose solution (#5)
8 Measurement solution 20 µl sucrose solution (#6)
50 µl incubation solution (#7)
30 µl dithionite solution (#4)
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6.3.4 Lipid scrambling on giant artificial vesicles
In order to determine if membrane-inserting DNA nanostructures can facilitate lipid scram-
bling in GUVs, the dithionite reduction assay in this chapter was performed using the 2C
DNA nanostructure design (see Fig. 6.7a). This design is identical to the simulated model dis-
cussed in Section 6.3.1 apart from added Cy3-labels that enabled fluorescence visualisation.
Importantly, the results will be compared to a negative control which follows exactly the same
experimental procedure, except that the DNA nanostructure was only assembled with one
cholesterol anchor (see Fig. 6.7b). Previously, it has been shown experimentally [54, 170]
that one cholesterol tag is not sufficient to produce membrane insertion of similar-sized
DNA nanostructures. Therefore, while this control construct would still attach to the lipid
vesicles, membrane insertion and lipid scrambling are excluded with no other difference in
experimental conditions.
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Fig. 6.7 Schematic illustration of dithionite reduction assay comparing 2C with 1C DNA
nanostructures. POPC (grey) vesicles containing a fraction of NBD-labelled lipids (green)
are incubated with Cy3-labelled DNA constructs. DNA nanostructures assembled with two
cholesterol modifications (2C) allow for membrane insertion to induce lipid scrambling (a)
whereas constructs with only one cholesterol (1C) do not (b). Cy3 labels were incorporated
on strands st2 and st4 (see Table A.5 in the Appendix).
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For the scrambling experiment, the vesicles were incubated in a microscope chamber in the
presence of 100 nM of folded 2C DNA nanostructures at a physiological pH of 7.4 and left
to settle down due to a density gradient between intravesicular sucrose and extravesicular
glucose. After incubation, vesicles were imaged using confocal fluorescence microscopy. A
fluorescent ring was observed in both the NBD and the DNA channel (see Fig. 6.8a). Their
co-localisation (see merged image in Fig. 6.8a) demonstrates successful attachment of DNA
nanostructures to the lipid vesicles [8, 54, 74].
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Fig. 6.8 Dithionite reduction assay on giant unilamellar vesicles. Vesicles were incubated
either with 2C (top) or 1C (bottom) DNA nanostructures. (a,d) Confocal fluorescence
microscopy images of GUVs containing fluorescently labelled NBD lipids (green) and
incubated with Cy3-labelled DNA nanostructures (red) showing the same vesicle before and
35 min after dithionite addition roughly at the equatorial plane. The third column displays a
merged image of the red and green channels. Scale bars are 10 µm. (b,e) Graphs showing
four representative fluorescence intensity traces of NBD fluorescence reduction over time for
2C (b) and 1C (e) designs. Values have been normalised to the initial intensity per vesicle and
aligned to the onset of dithionite reduction. (c,f) Histograms of residual NBD fluorescence
intensity at 35 min after dithionite addition normalised to the initial intensity for each vesicle.
Data were obtained from four (2C) and one (1C) experiments using the same GUV stock
solution. Black arrows in b and c highlight the shifted fluorescence intensity values for 2C
nanostructures in contrast to the 1C control. Data shown were collected from vesicles with a
diameter above 6 µm.
After focusing on one field of view and establishing the initial intensity of NBD and
DNA signals separately, dithionite solution was added (4.5 mM final concentration) while
recording both channels over time. Care was taken not to move vesicles during the dithionite
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addition, and the buffer conditions were optimised to avoid significant osmotic pressure,
as discussed in the previous section. Figure 6.8a shows fluorescence images of a vesicle
incubated with 2C nanostructures taken before and approximately 35 min after dithionite
addition. The NBD signal has completely vanished suggesting that the DNA nanostructures
successfully induced lipid scrambling so that inner-leaflet NBD-lipids could migrate to the
outer layer where they were reduced by dithionite extinguishing any NBD fluorescence. As
the DNA signal was unaffected by dithionite and the nanostructures still remained attached,
the fluorescence intensity in the DNA channel could be used to localise the vesicle membrane
despite the complete loss in fluorescence in the NBD channel. This enabled the acquisition
of intensity traces of different vesicles over time, all showing an exponential decrease in
fluorescence to almost zero (see Fig. 6.8b). About half an hour after dithionite addition
all larger vesicles (d > 6 µm) displayed a reduction in fluorescence of over 87 % with an
average residual fluorescence of only ≈ 5 ± 4 % (n = 7, Fig. 6.8c). Thus, our designed DNA
nanostructures can induce lipid scrambling in biological membranes.
Upon performing the negative control by incubation of vesicles with 1C nanostructures, a
fluorescent ring in the DNA channel before and after dithionite addition indicates membrane
attachment similarly to the results of the 2C design (see Fig. 6.8d). However, the NBD
fluorescence intensity after 35 min remained at ~50 % indicating the absence of scrambling
activity. Example fluorescence intensity traces (Fig. 6.8e) show the expected exponential
decrease plateauing at 48 ± 1 % (n = 7, Fig. 6.8f). Thus, only the outer-leaflet NBD-labelled
lipids have been reduced by dithionite as the 1C DNA nanostructures could not insert into
the membrane and induce lipid scrambling. Another independent set of experiments using
a slightly different protocol for the dithionite reduction assay (but the same final dithionite
concentration), confirmed the difference in the scrambling activity of the 1C and 2C designs
(see Section A.6 in the Appendix).
For smaller vesicles (d < 6 µm) almost all vesicles incubated with the 1C design showed a
fluorescence intensity reduction to the 0.5 value whereas the majority of vesicles incubated
with the 2C design displayed a reduction considerably below the 0.5 value (see Figs. 6.9a,b).
Defining a fluorescence intensity plateau after dithionite reduction of 0.44 as a threshold, more
than 85 % of vesicles incubated with the 2C nanostructures showed an intensity reduction
indicative of lipid scrambling (< 0.44) whereas more than 80 % of vesicles incubated with
1C structures did not (> 0.44).
Analysis of all vesicles shows no clear dependence of the fluorescence plateau after dithionite
reduction on the absolute initial intensity of the vesicle (see Fig. 6.9c). This indicates that
the normalisation did not obscure any possible dependence on the absolute intensity of the
vesicles. Furthermore, for vesicles incubated with 1C structures, the data shows no significant
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dependence of the fluorescence plateau after dithionite reduction on the vesicle’s diameter.
However, for vesicles incubated with 2C nanostructures, all larger vesicles (d > 6 µm) show
a reduction close to 0 whereas for smaller vesicles (d < 6 µm) values have a larger spread
between 0 and 0.5 (see Fig. 6.9d). As discussed in Sections 5.3.7 and 6.3.2, this could
be related to their different surface area which is associated with the probability of DNA
nanostructure insertion per vesicle (compare Table 5.4 in Section 5.3.7).
Lastly, no dependence of the initial absolute fluorescence intensity on the vesicle diameter was
observed (Fig. 6.9e). Therefore, the only distinct feature of the vesicles presented in Fig. 6.8
is their larger size which most likely led to an increased chance for DNA nanostructure
insertion to occur.
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Fig. 6.9 Dependence of scrambling activity on DNA construct, vesicle intensity and vesicle
diameter. (a,b) Histograms of residual, normalised NBD fluorescence intensity at 35 min
after dithionite addition for vesicles incubated with 2C (a) or 1C (b) DNA constructs. Dotted
line indicates the threshold that was set to differentiate scrambling activity (< 0.44) from no
activity (> 0.44). Data for larger vesicles (diameter d > 6 µm, green) are the same as presented
in Figs. 6.8c,f. Data were acquired from the same experiments as those described in Fig. 6.8.
(c,d) Dependence of the normalised fluorescence intensity after dithionite reduction on the
vesicle’s initial absolute fluorescence intensity (c) or its diameter (d). (e) Dependence of the
vesicle’s initial absolute fluorescence intensity on its diameter. Green data points refer to
vesicles with a diameter above 6 µm as plotted in Figs. 6.8c,f. The smallest vesicle included
in the analysis was 2.6 µm in diameter.
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6.3.5 Dithionite leakage through DNA-induced pores
The results presented in the previous section confirmed that DNA nanostructures capable
of membrane insertion induce lipid scrambling (2C) whereas structures that should not
insert, do not (1C). However, an important aspect to verify is that the membrane insertion
of the DNA nanostructures does not create a passage for dithionite to permeate into the
vesicles and bleach NBD lipids on the inner bilayer leaflet even without scrambling activity.
As DNA is negatively charged, permeation of anions through DNA-induced lipid pores is
expected to be much slower than cation permeation due to electrostatic repulsion. Previously
reported simulations of a larger, membrane-inserted DNA nanostructure showed significantly
decreased Cl− ion over K+ ion permeation [231]. In accordance with these results, the
all-atom simulations of our DNA scramblase design similarly reveal a 93 % reduction of
Cl− ion permeation compared to that of K+ ions. In the dithionite reduction assay, the
NBD-reducing dithionite anion S2O2−4 is larger than Cl
− ions and, most importantly, it is
double negatively charged. Therefore, the negative charge of the DNA nanostructure, in
combination with the low ionic strength of the buffer solution used in the experiments, is
expected to present a barrier to dithionite permeation through the toroidal pore.
To experimentally demonstrate the low permeation rate of dithionite through the DNA-
induced toroidal pore, we performed a series of control experiments. The experimental
concept is based on employing a water-soluble NBD-labelled molecule that is present in
solution both inside and outside the vesicles. Upon performing a dithionite reduction assay,
only NBD dye outside the vesicles should be fluorescently reduced if no passages are present
for the dithionite to cross the vesicle membrane (see Fig. 6.10).
Dithionite
NBD
Fig. 6.10 Experimental strategy to probe for dithionite leakage through the 2D DNA nano-
structure. NBD dye is present in the solution inside and outside vesicles incubated with 2C
constructs. If DNA structures do not facilitate permeation of dithionite into the vesicles,
addition of dithionite would only reduce NBD fluorescence outside the vesicles.
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An important aspect of this experimental design is that the NBD-labelled molecule does not
permeate through the vesicle membrane itself (even without any DNA nanostructures present).
According to previously described protocols for bulk dithionite assays on LUVs, NBD-
labelled glucose (NBD-glucose; see Fig. 6.11a) can be used to demonstrate that dithionite
does not permeate inside the vesicles [14]. We therefore formed GUVs as for the dithionite
assay, but this time with NBD-glucose present in solution during the formation. Vesicles were
then incubated in a microscope chamber as for dithionite experiments (except without DNA
structures and dithionite). We then performed fluorescence recovery after photobleaching
(FRAP) experiments using confocal fluorescence microscopy. NBD-glucose inside vesicles
was photobleached by excitation at a high laser power and the fluorescence recovery inside
the vesicles was recorded at certain time points afterwards (see Fig. 6.11b). Already after
~10 min the fluorescence inside the vesicles has significantly recovered (see Fig. 6.11c).
This indicates that under our experimental conditions, NBD-glucose can permeate across
vesicle membranes within minutes even without DNA nanostructures present. A similar
leakage rate of NBD-glucose has been mentioned in previous work [242]. Furthermore, with
a predicted log octanol-water partition coefficient of −0.41, NBD-glucose is only moderately
hydrophilic [243]. We therefore deemed NBD-glucose unsuitable for our purpose of verifying
if dithionite can leak through DNA-induced toroidal pores.
Another reported approach employed NBD-labelled polyethylene glycol (NBD-PEG) [236].
The covalent attachment of the PEG chain was expected to increase the hydrodynamic
radius of the NBD dye, preventing its direct permeation across the membrane or through
DNA-induced toroidal pores. We therefore synthesised a fluorescent probe from NBD-SE
and amino-modified 24-unit polyethylene glycol (see Fig. 6.11d). Successful synthesis was
verified with thin layer chromatography (TLC) where a solvent travels through a silica gel by
capillary action allowing for the separation of different analytes. NBD-SE demonstrates a
shorter migration distance if co-spotted or incubated with varying ratios of NBD-SE:PEG
(1:1, 1:2, 1:10; see Fig. 6.11e). Already at an NBD-SE:PEG ratio of 1:1 a complete shift of
the NBD-SE spot is achieved, indicating successful conjugation to the PEG molecule.
We then formed GUVs in the presence of NBD-PEG and incubated them with 2C DNA
structures, as in the dithionite reduction assay. FRAP experiments show a very slow fluores-
cence recovery rate with a linear slope of ~14 % per hour (Fig. 6.11f). This suggests that,
at the time scale relevant for the dithionite assay, our synthesised NBD-PEG molecules are
essentially membrane impermeable, even in the presence of 2C DNA structures. This makes
NBD-PEG a much better probe for testing dithionite permeability than NBD-glucose.
The same batch of vesicles was then incubated with DNA scramblases, again with NBD-
PEG molecules present inside and outside the vesicles. A dithionite reduction assay was
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Fig. 6.11 Fluorescence recovery after photobleaching of NBD-glucose and NBD-PEG. (a)
Chemical structure of NBD-glucose. (b) Confocal microscopy images of GUVs with NBD-
glucose present inside and outside. Two vesicles are shown before and at various time points
after photobleaching of the NBD dye. Vesicle membranes contained NBD-PC lipids as
described before. (c) Fluorescence intensity traces of the recovery of NBD glucose inside
three vesicles after they have been photobleached. Traces have been normalised to the
fluorescence intensity outside the vesicles before photobleaching. (d) Chemical structures
of NBD-SE and Amino-dPEG24-OH (PEG24), and their reaction to NBD-PEG. (e) Thin
layer chromatography (TLC) analysis verifying the successful conjugation of NBD to PEG.
The second lane refers to a co-spot of NBD-SE and PEG whereas for the subsequent three
lanes both compounds have been incubated at varying ratios over night. This TLC analysis
was performed using PEG12 molecules. (f) Fluorescence recovery after photobleaching of
NBD-PEG inside a POPC GUV that was incubated with 2C DNA nanostructures (NBD-PC
was omitted in the lipid mixture). Normalisation was performed as in c. Red line represents
a linear fit. Note the much longer time scale compared to c. All scale bars denote 5 µm.
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carried out following the same protocol as in our lipid scrambling assays (see Fig. 6.12a).
Monitoring NBD-PEG fluorescence showed that the fluorescence outside the vesicles was
rapidly decreased by dithionite whereas the fluorescence inside the vesicles remained al-
most constant over the 45-minute time scale of the measurement (see Figs. 6.12a-c). The
intensity reduction for a region outside the vesicle follows similar kinetics as observed for
the dithionite reduction in the scrambling assay (see Fig. 6.12c). The NBD fluorescence
intensity inside the vesicle, however, decreases at a much slower rate. This slow decrease is
most likely not explained by photobleaching during the imaging (see Fig. 6.12d). A possible
reason could be that the reduced background fluorescence, due to dithionite reduction outside
the vesicles, could potentially contribute to the slight reduction in fluorescence intensity
inside the vesicles. Alternatively it could be that there is indeed a very low permeation rate
of dithionite into the vesicles. However, these experiments show that dithionite permeation
through the DNA-induced pores is too slow to explain the rapid decrease in fluorescence
observed in our 2C DNA construct experiments. Therefore, we do indeed observe lipid
scrambling induced by the DNA scramblase nanostructures.
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Fig. 6.12 Permeability of dithionite through vesicle membranes incubated with 2C DNA
structures. (a) Confocal microscopy images of POPC GUVs incubated with Cy3-labelled
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are single exponential fits. (d) Absolute fluorescence intensity inside the vesicles analysed in
c imaged for 20 consecutive frames (~90 s) roughly 30 min after dithionite addition.
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6.3.6 Lipid scrambling rates
To determine the lipid scrambling rate of our DNA nanostructures the traces describing
the dithionite-induced fluorescence reduction presented in Fig. 6.8 were each fit with an
exponential decay. For both 1C and 2C structures, traces are well described by a single
exponential decay (see Figs. 6.13a,b). This is in agreement with a previous characterisation
of fully activated biological scramblases that found the dithionite reduction of the NBD dye
to be the rate-limiting factor in the case of rapid scrambling [14]. The exponential fits yielded
characteristic decay times ⟨τ⟩ of ~4 to 8 min. Using Equation 6.1, we approximated the
number of lipids per vesicle Ntotal from the vesicle’s diameter. With
k =
Ntotal
⟨τ⟩ (6.3)
the lipid scrambling rates per vesicle were calculated to be between ~0.7 to 3.7 × 107 s−1
(see Fig. 6.13d). These values are in very good agreement with the simulated scrambling
rates that yielded ~1.7 × 107 s−1 for individual DNA scramblases (see Section 6.3.1). No
additional factor was applied to the number of lipids per vesicle in Equation 6.3 since
Brownian dynamics simulations showed that the scrambling rate does not depend on the ratio
of labelled to unlabelled lipids (see [75] for further details).
Experiments with pore-forming peptides determined lipid flip-flop rates between 1 and
potentially 103 lipids per second per peptide [137, 146]. In vitro experiments on TMEM16
scramblases [14, 121], opsin [15] and rhodopsin [16] have assessed scrambling rates of
> 104 s−1 per scramblase protein under optimal conditions. However, some of these rates
were limited by the dithionite-mediated NBD reduction. Recent atomistic simulations of
the G protein-coupled receptor opsin determined a characteristic time scale of ~33 µs per
lipid translocation event [17]. This corresponds to a possible maximum scrambling rate of
3 × 104 s−1 in the case where dithionite is not the rate-limiting factor. In contrast, we found
the simulated lipid transfer rate induced by our DNA nanostructure to be on the order of
107 s−1, up to three orders of magnitude faster than reported for natural scramblases.
To achieve flip-flop rates equivalent to natural scramblases the free energy barrier for lipid
translocation needs to be lowered from > 20 kcal mol−1 (uncatalysed lipid transfer) to
≈ 7 kcal mol−1 [97]. One reason for the remarkable scrambling rates of our DNA scramblase
is the reduction of the free energy barrier to approximately 1 kBT (≈ 0.6 kcal mol−1 at
room temperature), one order of magnitude lower than accomplished by natural scramblases.
Furthermore, the MD simulations showed that the DNA-induced toroidal lipid pore is stable
for much longer time scales than nanosecond-long, transient water passages that were
previously suggested to allow for spontaneous lipid flipping and flopping [244–246].
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Fig. 6.13 Dithionite reduction rates determined from experiments. (a,b) Single exponential
fits (dotted lines) of dithionite reduction traces (solid lines) shown in Figs. 6.8b,e for 1C and
2C nanostructures, respectively. Fit values ⟨τ⟩ of decay rates are shown in the legend with
the fitting equation below. (c) Graph comparing the characteristic decay times ⟨τ⟩ (error bars
denote fitting error) of the different dithionite reduction traces for 1C and 2C designs. (d)
Scrambling rates approximated from characteristic decay times shown in c via Equation 6.3
with error bars originating from the error of ⟨τ⟩. The number of lipids was calculated via the
volume of a lipid as described in Equations 5.1 using the dimensions listed in Table 5.3.
Our experimentally determined average scrambling rate of ≈ 1.62 × 107 s−1 matches
the simulation results very well, however, these rates can have multiple contributions. While
several structures could insert and scramble lipids at the same time, they might only transiently
insert and therefore not actively contribute for extended periods. Gummadi et al. previously
reported calculations to estimate the mean lifetime ⟨τ⟩ for a freely diffusing phospholipid
to encounter a single, immobile flippase to gauge characteristic flipping times (footnote
in [247]). Their estimations are based on equations regarding diffusion-controlled reactions
on spherical surfaces [248–250]. Sano et al. [249] state (in their Equation 6.1) that the mean
reaction time ⟨τ⟩ for two particles that diffuse on a circle, one particle immobile in the centre
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and the other initially uniformly distributed within the circle, is given by
⟨τ⟩
τQ
=
2
1− d24R2
ln
(
2R
d
)
− 3
2
+
d2
8R2
+
2D
pd
(
1− d
2
4R2
)
(6.4)
with τQ = R2/D being the characteristic time, D the diffusion constant of the diffusing
particle, d the distance at which both particles react with each other, and p measuring the
reactivity once the particles encounter each other at the distance d. R denotes the radius of a
sphere whose surface area equates to the same area as the circle of radius 2R that the particles
are diffusing on. The boundary of the circle is assumed to be perfectly reflective.
We can now use this equation to estimate the mean interaction time for a phospholipid
to be flipped (= captured) once it encounters a DNA-induced toroidal pore. For this, we
first assume a direct absorption upon encounter (p→ ∞) meaning the lipid is flipped upon
reaching the toroidal pore. This simplifies Equation 6.4 to
⟨τ⟩
τQ
≈ 2
1− d24R2
ln
(
2R
d
)
− 3
2
+
d2
8R2
(6.5)
In our case, the encounter distance d equates to the radius of the toroidal pore rp (lipid
headgroups are hereby assumed as point-like). With dV = 2R as the diameter of the lipid
vesicle, and therefore τQ = d2V /4D, the equation can be rewritten to
⟨τ⟩ ≈ d
2
V
4D
 2
1−
(
rp
dV
)2 ln dVrp − 32 + 12
(
rp
dV
)2 (6.6)
In the scramblase experiments, the GUV diameter was in the range of several micrometres
while the radius of the DNA nanostructures (and therefore of the toroidal pores) was only a
few nanometres. As this satisfies the condition of 1≫ r2p /d2V , the equation can ultimately
be simplified to
⟨τ⟩ ≈ d
2
V
2D
(
ln
dV
rp
− 3
4
)
(6.7)
Performing an analogous transformation with Equation 6.2 from Sano et al. [249], we obtain
an expression for the mean reaction time of a pair of freely diffusing particles on a spherical
surface as
⟨τ⟩ ≈ d
2
V
2D
(
ln
dV
rp
− 1
2
)
(6.8)
6.3 Results & Discussion 133
While Equation 6.7 agrees with other previous work [250], it should be noted that neither of
the two equations agree with the equation used for flippase activity presented in a footnote in
Gummadi et al. as their second term in the brackets was −1 which might be an inaccuracy in
the derivation of the equation. Nevertheless, we can now use Equation 6.7 to calculate ⟨τ⟩
for the average diameter of the vesicles used for the determination of scrambling rates (see
Fig. 6.13b) and compare it to the experimentally determined values (see Table 6.2).
Table 6.2 Calculated and experimentally determined scrambling rates. The radius of the
toroidal pore rp was approximated from the transition path of a lipid headgroup at the toroidal
pore determined from calculations of the 2D potential of mean force (see Fig. A.5 in the
Appendix). D denotes the diffusion coefficient of POPC lipids in GUVs [251]. dV is the
average diameter of the vesicles used for 2C rate calculations in Fig. 6.13b. Ntotal refers to
the total number of lipids in a vesicle of diameter dV and was calculated with Equation 6.1. k
is the lipid scrambling rate per scramblase calculated using Equation 6.3.
rp D dV Ntotal Term in ⟨τ⟩calc ⟨τ⟩exp kcalc kexp
nm µm2 s−1 µm 109 equation min min 107 s−1 107 s−1
2.3 7 19.4 3.46 −3/4 3.72 4.15 1.55 1.62
−1/2 3.83 4.15 1.51 1.62
−1 3.60 4.15 1.60 1.62
The calculated mean lifetime is ≈ 3.7 min, which is only slightly lower than the averaged
experimental value of ≈ 4.2 min. Furthermore, the scrambling rate k, defined as in Equa-
tion 6.3, is calculated to be 1.55 × 107 s−1 assuming only a single DNA nanostructure is
active, which agrees very well with the simulated and experimentally observed rates (see
Table 6.2). These values vary only slightly with respect to the second term in the brackets in
Equations 6.7 and 6.8, or the −1 used in Gummadi et al. [247] (compare Table 6.2). While
Equation 6.7 (−3/4) assumes an immobile toroidal pore (= absorbing region), Equation 6.8
(−1/2) assumes two diffusing particles on a spherical surface. A diffusion coefficient of
D = 1 µm2 s−1 was previously reported for a 6-helical DNA nanostructure that was poten-
tially membrane-inserted (6HP design with 3 cholesterol modifications, compare Fig. 3.8
for general design) [78]. Assuming a similar diffusion coefficient for the DNA-induced
toroidal pore, the calculated value for the mean lifetime ⟨τ⟩ will most likely be in between
Equations 6.7 and 6.8. These results together with the calculated low energy barrier for lipid
translocation suggest, that lipid diffusion in our GUVs is not rate limiting even if only one
DNA scramblase is active. If multiple structures scramble lipids simultaneously, a faster
fluorescence reduction would be expected. But in the current assay protocol, the slow kinetics
of the dithionite reduction are ultimately rate limiting.
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6.3.7 DNA scramblase experiments on human cancer cells
To show the potential of our DNA scramblase for in vivo applications, we tested it on human
cells. As discussed in Chapter 2, lipid scrambling is part of the signalling pathway to induce
cell apoptosis. An established method to detect apoptosis in cells is to use a fluorescently
labelled protein called Annexin V which has a high affinity for phosphatidylserine (PS)
lipids [252, 253]. In healthy cells, due to the asymmetric lipid distribution in the the
cell membrane, PS lipids are primarily located in the inner bilayer leaflet [102, 254, 255].
Therefore, Annexin V should not significantly bind to the cell membrane (see Fig. 6.14a).
However, if apoptosis or lipid scrambling is induced, the lipid composition is equilibrated
exposing PS lipids on the cell’s outer bilayer leaflet (see Figs. 6.14b,c). The binding of
fluorescently labelled Annexin V can then be detected via confocal microscopy.
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Fig. 6.14 Annexin V staining experiments on human cancer cells. (a-c) Schematic illustration
of FITC-labelled Annexin V (green) binding assay without apoptosis (a), with chemically
induced apoptosis (b), and DNA scramblase induced apoptosis (c). Phosphatidylserine (PS)
lipids are highlighted in light blue. (d-f) Confocal microscopy images of fixed cells after
incubation with only DNA folding buffer (d), 10 µM staurosporine (e), or with Cy3-labelled
2C DNA scramblases (f). While no Annexin V binding occurs in the negative control,
incubation with DNA scramblases showed cell attachment of the DNA nanostructures (red)
associated with increased Annexin V (green) binding (see merged signal of both channels)
due to PS exposure. All imaging settings were the same for the equivalent images in all
experiments. Corresponding brightfield images illustrate cell locations (scale bar is 20 µm).
To test our DNA scramblases, we employed MDA-MB-231 breast cancer cells as they
naturally possess a low level of PS in the outer membrane leaflet [210]. First, as a negative
control, we incubated the cells with DNA scramblase buffer only. Subsequent staining
with Annexin V and imaging of the fixed cells with confocal microscopy confirmed the
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low amount of Annexin V binding under these conditions (see Fig. 6.14d). Second, as
a positive control, we incubated the cells with the apoptosis-inducing microbial alkaloid
staurosporine which resulted in binding of Annexin V to the cell’s membrane indicated
by bright fluorescent edges (see Fig. 6.14e). No signal was detected in the red channel
illustrating sufficient spectral separation of the FITC dye from the Cy3 channel.
Ultimately, cells were incubated with Cy3-labelled 2C DNA nanostructures where successful
scrambling activity would be indicated by an elevated level of surface-exposed PS resulting
in increased binding of FITC-Annexin V (see Fig. 6.14c). Confocal microscopy images
presented in Fig. 6.14f show not only that the DNA nanostructures attached to the cells but
also that Annexin V binding increased in their vicinity. The recorded fluorescence intensity
is comparable to the positive control performed with the apoptosis-inducing agent. The
elevated level of surface-exposed PS demonstrates that our DNA scramblase is able to induce
lipid scrambling in human cells.
6.4 Conclusion
One of the biggest challenges in determining if our DNA nanostructures can induce lipid
scrambling was their low insertion efficiency. In this chapter, we addressed this issue in two
ways. First, we performed atomistic MD simulations in which we could investigate how our
2C DNA structure interacts with the lipid bilayer when it is membrane inserted. In accor-
dance with our previous work on a membrane-inserted DNA duplex [8], the DNA construct
induces a toroidal DNA-lipid pore that was stable throughout the entire 2.2 µs simulation.
This DNA-stabilised, toroidal pore establishes a pathway for lipid molecules to diffusively
translocate from one bilayer leaflet to the other only needing to cross an energy barrier of
≈ 1 kBT. From these simulations we could furthermore determine a lipid scrambling rate on
the order of 107 lipids per second thereby outperforming biological scramblases by up to
three and reported artificial scramblases by up to six orders of magnitude [97, 131, 132].
Second, we adapted the dithionite reduction assay to giant unilamellar vesicles in the mi-
crometre range. This allowed us to increase the probability for a membrane-inserted DNA
nanostructure by several orders of magnitude while at the same time being able to follow the
lipid scrambling activity of each individual vesicle. To the best of our knowledge, this is the
first demonstration of directly recording the dithionite-induced fluorescence reduction, and
thereby lipid scrambling activity, at the single-vesicle level. Particularly for vesicles larger
than 6 µm in diameter, almost complete fluorescence reduction was observed for all vesicles
incubated with 2C DNA structures, indicating rapid lipid scrambling activity. Importantly,
vesicles incubated with 1C constructs consistently showed an intensity reduction to only
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half, indicating the absence of scrambling activity and no leakage of dithionite into the
vesicles. Controls performed with our synthesised NBD-PEG molecule further verified that
the fluorescence decrease induced by the 2C DNA scramblase design could not be explained
by leakage of dithionite through the membrane, the DNA-induced toroidal pore, or the DNA
construct itself. This demonstrated that we do indeed observe lipid scrambling activity.
The experimentally determined scrambling rates were on the order of 107, agreeing well with
the simulation results. While these rates could have several contributions, e.g. multiple, si-
multaneously inserted structures, the previously determined low insertion efficiency indicates
that most likely only very few of the membrane-attached DNA structures actually contribute
to lipid scrambling activity. Estimations on the characteristic lipid flipping time scales for
a single DNA scramblase (or rather the toroidal pore it induces) confirmed that a single
membrane-inserted structure could potentially be sufficient to explain the experimentally
observed scrambling kinetics. However, ultimately the rate-limiting step in the current assay
design is the dithionite reduction reaction. Therefore, future protocols using higher dithionite
or lower DNA nanostructure concentrations might allow to investigate a regime where lipid
scrambling activity can be differentiated from dithionite reduction kinetics.
Lastly, experiments with human breast cancer cells indicated that, similar to the role of lipid
scramblases in nature, our DNA scramblases can induce cell apoptosis. Future flow cytometry
experiments would be beneficial to further quantify the scrambling and apoptosis-inducing
activity of our DNA nanostructures on cells.
In summary, with our combined approach of all-atom MD simulations and single-vesicle
scrambling experiments, we successfully demonstrated the application of DNA nanotechnol-
ogy to design synthetic lipid scramblases that can even outperform their natural counterparts
by several orders of magnitude.
Chapter 7
Conclusions & Outlook
There are lots and lots of little problems out there, all
of which can probably be solved on the nanometre scale
using these systems or systems derived from them.
– Nadrian C. Seeman
The aim of this thesis was to determine if a DNA-induced toroidal lipid pore facilitates
mixing of lipid molecules between the leaflets of a lipid bilayer. We thereby envisioned to
design and build synthetic mimics of natural lipid scramblase proteins using DNA nanotech-
nology. As previous work demonstrated the feasibility of mimicking protein ion channels
using DNA as a building material, DNA nanotechnology presented itself as an ideal tool
to expand the range of synthetic membrane protein mimics to lipid scramblases. Gaining
control over a cell membrane’s lipid composition has numerous applications in biomedicine
and for therapeutics, making this objective a worthwhile endeavour.
Throughout this thesis, we gradually increased the complexity of the DNA nanostructure
as well as the experimental methods. After a structural analysis of the DNA constructs, we
studied their behaviour once modified with cholesterol, and ultimately investigated their
interaction with lipid membranes on planar bilayers (current measurements), large and giant
unilamellar vesicles (dithionite reduction assays), and via all-atom MD simulations.
In Chapter 3, we introduced the design of our DNA nanostructure consisting of eight ssDNA
strands that self-assemble into four interconnected dsDNA helices. Using a non-scaffolded
DNA nanostructure facilitated an assembly at µM concentrations while minimising DNA
material cost. This is in contrast to DNA origami structures whose concentration is often
limited to the nM range by the viral ssDNA scaffold strand. These fundamental advantages
make our approach scaleable and cost-efficient, two essential aspects for possible future
applications in medicine. The DNA nanostructures consistently showed a high folding
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yield at MgCl2 concentrations above ~5 mM which allowed to work at a broader range of
buffer conditions, another advantage over DNA origami. It was crucial to use a loading
dye without additional EDTA which should always be kept in mind for experiments where
the Mg2+ concentration is an integral parameter. While our AFM measurements lacked
the resolution, TEM imaging enabled us to confirm the correct assembly of the monomeric
DNA nanostructures as their dimensions matched well with the expectations. Four DNA
nanostructure designs have been developed throughout this thesis. Particularly, the CP3 short
and CP4 layouts could be useful alternatives to explore in the future as they exclusively
formed monomeric structures. However, the chosen CP2 design presented the most balanced
layout due to its high folding yield and numerous, centrally located modification positions.
This in-depth analysis of the design and assembly characteristics of the DNA nanostructure
provided a valuable foundation for the rest of the thesis work to build up on.
To insert hydrophilic DNA nanostructures into a lipid bilayer, hydrophobic moieties were
required on the DNA. The commercial availability and compatibility with lipid membranes
made cholesterol the most prominent molecule to anchor DNA into a lipid bilayer. As hy-
drophobic tags typically induce aggregation we needed to better understand this aspect first,
in order to optimise the design of our synthetic lipid scramblase. We therefore characterised
in Chapter 4 the behaviour of cholesterol-modified ssDNA, dsDNA, and DNA nanostructures.
Their transient interactions or complete aggregation could be efficiently analysed using non-
denaturing (native) PAGE. We avoided the use of denaturing gels, as they have been shown
to mask cholesterol-mediated interactions [81]. Our studies revealed a sequence-dependent
aggregation behaviour of cholesterol-modified ssDNA. Particularly the terminal bases preced-
ing the cholesterol modification and tendencies to form dimers or multimers had a significant
influence. This should be prevented by optimising the sequence to minimise secondary
structure formation using a structure prediction tool such as NUPACK [38]. We showed that
preventing stable secondary structure formation, by using poly-T DNA sequences, can avoid
chol-DNA aggregation. All-atom MD simulations were employed to investigate the mode
of action demonstrating that the ssDNA wraps around the cholesterol at the nanosecond
time scale thereby shielding the hydrophobic group. We hypothesised that this interaction
between ssDNA and cholesterol is a mechanism by which cholesterol-mediated aggregation
can be prevented. We proved this hypothesis by controlling the hydrophobically mediated
interaction of a cholesterol-modified DNA duplex by varying the length of an adjacent ssDNA
overhang. A 6 nt overhang was sufficient to prevent cholesterol-mediated aggregation. This
approach also succeeded at shielding tocopherol modifications suggesting that our method is
universally applicable to other types of hydrophobic tags.
The aggregation behaviour of the CP2 DNA constructs was mostly determined by the choles-
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terol number and modification position, and less by the linker chemistry. While up to two
cholesterol modifications showed consistent band shifts in native PAGE, for higher numbers
aggregation dominated. However, we could successfully prevent aggregation both in native
PAGE and DLS experiments in solution using our ssDNA shielding strategy. Importantly,
we verified that the ssDNA overhangs do not inhibit binding to lipid membranes. Here,
the versatile modification positions of the CP2 design were crucial for the systematic study
of cholesterol-mediated aggregation and its prevention. The combination of eight thymine
overhangs to prevent stacking interactions, four cholesterol groups to facilitate membrane
interaction, four ssDNA overhangs to prevent cholesterol-mediated aggregation, and two
Cy3-molecules to allow tracking with fluorescence microscopy, demonstrates the impressive
amount of complexity that can be engineered into such a small DNA structure.
As the ssDNA shielding strategy was only developed at the end of this thesis work, the
2C CP2 design was favoured at that time as it did not tend to aggregate. In Chapter 5, we
then investigated its interaction with planar lipid bilayers and LUVs. Electrophysiology
measurements demonstrated that this design can insert into lipid bilayers and induce ionic
currents across them. We have thereby successfully mimicked the function of natural protein
ion channels. However, these experiments also indicated that the insertion efficiency of these
DNA structures is very low. Next, the bulk dithionite reduction assay on LUVs was employed
to gauge the DNA nanostructure’s lipid scrambling activity. The higher degree of unilamel-
larity rendered vesicles formed from a 3:1 EColi:eggPC lipid mixture superior compared to
POPC. It was even possible to detect the asymmetric lipid distribution across bilayer leaflets
due to geometrical constraints for vesicles smaller than ~100 nm in diameter. Combined
with a second method to confirm vesicle formation (e.g. DLS or confocal microscopy), the
dithionite assay proved to be an excellent tool to determine the unilamellarity of artificial
lipid vesicles which our group already employed in another publication [216].
While the NBD labelling position slightly affected the reduction kinetics, no significant
influence on the reached fluorescence plateaus was observed. Dithionite concentrations
ranging from 10 to 40 mM are ideal if rapid lipid scrambling kinetics are studied in bulk.
However, a concentration of ~5 mM presents a good balance between sufficiently fast kinetics
and low permeation across vesicle membranes which was of great importance in experiments
with GUVs. Final OPOE concentrations of approximately one order of magnitude below
the CMC proved to be acceptable (~0.02 %) but above that membrane permeability was
compromised. If rapid scrambling kinetics are expected, concentrations up to ~0.05 % could
be employed together with appropriate controls in future experiments.
Unfortunately, we could not establish a positive scrambling control using a commercially
available TMEM16F scramblase, possibly due to its lack of biological activity. Collabora-
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tions with other research groups that can provide scramblase proteins would be beneficial
to directly compare natural with synthetic scramblases in the same assay. Also, it was not
possible to detect scrambling activity of various DNA nanostructure designs using the bulk
dithionite assay with LUVs. Given the low DNA nanostructure insertion efficiency and the
small surface area of LUVs, the percentage of vesicles containing membrane-inserted, lipid-
scrambling DNA nanostructures is expected to be significantly too low to be differentiated
from the measurement error. Neither employing OPOE nor electroporation could remedy this
circumstance significantly enough to observe scrambling activity in these bulk experiments.
Nevertheless, the ease of working with LUVs allowed for the characterisation of multiple
assay parameters which aided in optimising the protocols for subsequent experiments.
In Chapter 6, we introduced two ways to analyse the lipid scrambling activity of our DNA
nanostructures despite their low insertion efficiency. With MD simulations of the 2C CP2
nanostructure we could directly study its interaction with the lipid bilayer when membrane-
inserted. Electrostatic forces between the charged DNA and the hydrophilic lipid headgroups
causes the lipids to rearrange forming a toroidal DNA-lipid pore. Stabilised by the DNA
nanostructure, this toroidal lipid pore connects the two bilayer leaflets allowing lipids to
diffusively translocate between the leaflets. Re-analysing previous MD simulations showed
that lipid scrambling activity depends on the size of the DNA nanostructure (DNA duplex [8]
vs. DNA origami porin [74]) while no scrambling activity is observed when a hydrophobic
belt prevented the formation of a continuous toroidal pore [68, 231] (compare Section 6.3.1).
We therefore suggest that any membrane-spanning DNA nanostructure (or hydrophilic object
in general) induces lipid scrambling as long as it allows for the formation of a toroidal lipid
pore whose shape will be the rate-determining factor of the scrambling activity.
Lastly, the simulations established a scrambling rate on the order of 107 lipids per second.
This high scrambling rate could be explained by the low energy barrier of ≈ 1 kBT and the
fact that the toroidal pore completely surrounds the DNA construct. In contrast, natural scram-
blases primarily facilitate lipid translocations through an aqueduct-like pathway, possibly
requiring conformational changes, although the precise mechanisms are still unclear [120].
Adapting the dithionite assay to GUVs was a key experimental development to demonstrate
the lipid scrambling ability of our 2C DNA nanostructure. Raising their chances for a single
insertion per vesicle and directly observing the dithionite assay at the single-vesicle level
were vital advantages. As 1C structures consistently did not scramble lipids, and proving
with our synthesised NBD-PEG molecule that dithionite permeation into the vesicles had
significantly slower kinetics, we could conclusively demonstrate the lipid scrambling activity
of our 2C DNA structures. The experimentally measured scrambling rates and theoretical cal-
culations both make the rates determined from MD simulations plausible, particularly taking
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into consideration the low insertion efficiency of the DNA nanostructures. However, further
experiments should employ higher dithionite or lower DNA concentrations to eventually
enter a regime where the dithionite reduction is not rate-limiting providing further insight
into the scrambling kinetics. Lastly, we demonstrated that our DNA scramblase can induce
the surface exposure of PS-lipids in human cancer cells, a role in the apoptosis mechanism
taken over by lipid scramblases. Future flow cytometry experiments can provide a more
quantitative analysis of the lipid scrambling capabilities of our DNA scramblase in cells.
In summary, in this thesis we introduced a novel strategy to control cholesterol-mediated ag-
gregation with the length of adjacent ssDNA overhangs. This allows for DNA nanostructures
with increased number of hydrophobic tags while maintaining the close structure-function-
relationship enabled by DNA nanotechnology. This will facilitate greater control in inter-
facing DNA nanostructures with lipid bilayers and cell membranes. The higher free energy
gained from more membrane-anchored cholesterol groups could balance the energy penalty
of DNA membrane penetration [74] which could potentially improve insertion efficiencies
of DNA nanostructures, a long-standing problem in the field [47]. We envision that our
easy-to-implement method will expand the design space of membrane-interfacing DNA
nanosystems with applications in research and biomedicine.
We furthermore established an advanced protocol for the dithionite reduction assay that
enables tracing of lipid scrambling activity at the single-vesicle level. Our designed DNA
nanostructure can reproduce the biological function of a scramblase protein by mixing lipids
that reside on opposite leaflets of a biological membrane in vitro and in human cells. Our
synthetic DNA scramblase flips lipids much more rapidly, outperforming biological and
reported artificial scramblases by several orders of magnitude. These exceptional rates are
promoted by a stable DNA-induced toroidal lipid pore directly interconnecting the membrane
leaflets without any substrate specificity or covalent bond formation.
Next steps will focus on gaining control over the scrambling activity by establishing an
activation mechanism and design-specific rates. Modulating the toroidal pore will be key
which could for example be achieved by using a single, membrane-spanning DNA duplex
with internal modifications of varying hydrophobicity. Recent experiments in our group
already showed that this is a promising approach to rationally design DNA scramblases with
different rates. For biomedical applications we envision future designs to be equipped with a
targeting mechanism for membranes of specific cell types. On demand, target cell-specific
lipid scrambling could help patients suffering from impaired scrambling activity, or trigger
phagocytic uptake of PS-exposing intruder cells by macrophages, including cells carrying
cancer-specific plasma membrane antigens. As the mechanism of our DNA scramblase is
independent of the cell-specific apoptosis pathways, it can be applied to a variety of cell
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types. Control over lipid homeostasis with synthetic DNA nanostructures opens up a novel
direction for designing personalised drugs and therapeutics for a variety of health conditions.
Ultimately, the ability to outperform naturally evolved proteins allowed for a glimpse at the
tremendous opportunities yet to be explored in nucleic acid-based nanotechnology.
Summary of key insights gained in this dissertation
• A DNA nanostructure design was devised that assembles under a range of Mg2+-
concentrations with the expected dimensions. The design provides an ideal balance
between high assembly yield and versatile modification options.
• Aggregation of cholesterol-modified ssDNA is sequence-dependent while for DNA
nanostructures, cholesterol number and modification position are the determining
factors. Hydrophobically-mediated interactions can be controlled by the length of
ssDNA overhangs adjacent to the hydrophobic groups allowing for an increased number
of cholesterol tags per DNA nanostructure while preventing aggregation.
• Stable currents are induced by the spontaneous insertion of the 2C CP2 nanostructures
in a lipid bilayer classifying them as ‘DNA-built synthetic ion channels’. However, the
insertion efficiency is very low. The bulk dithionite reduction assay using a fluorometer
is optimised by using a lipid mixture of EColi:eggPC leading to more unilamellar
vesicles. While cholesterol-modified DNA nanostructures attached to the vesicles,
lipid scrambling was not detected, most likely due to their low insertion efficiency.
• MD simulations showed that the DNA construct induces a stable, toroidal DNA-lipid
pore allowing lipids to rapidly diffuse between bilayer leaflets. By adapting the
dithionite assay to GUVs, we experimentally demonstrated lipid scrambling activity of
our 2C DNA scramblase. Both experiments and simulations support a lipid scrambling
rate on the order of 107 lipids per second. This high rate is most likely explained by
the low energy barrier of 1 kBT for lipids to cross between bilayer leaflets and the
fact that the toroidal pore completely surrounds the DNA nanostructure, which is in
contrast to the mode of lipid flipping of natural lipid scramblase proteins. We thereby
pioneered the use of DNA nanotechnology to create artificial lipid scramblases which
can outperform synthetic and natural scramblases by several orders of magnitude.
• Future experiments should focus on controlling scrambling activity by modulating the
size of the toroidal pore or by changing the hydrophilicity of the membrane-inserted
region. With an activation mechanism and cell-targeting capabilities, synthetic DNA-
built scramblases open up exciting opportunities for patient-specific therapeutics.
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Appendix
A.1 Advice and troubleshooting for PAGE
• To prevent gel mixture leakage, place a 1 ml pipette tip behind the spring-loaded clamp in
the casting stand to increase the pressure on the glass plates into the gaskets.
• Filling should be performed quickly. Bubbles formed when pipetting the gel mixture in
usually rise to the top and disappear. It is recommended to fill spacer plates all the way to
the top as it reduces the risk of bubbles in the gel pockets when inserting the comb.
• Leaving the glass pipette in the unused portion of the gel mixture after pouring can be used
as a rough confirmation that polymerisation was successful.
• Polymerisation durations between 1 to 2 hours provided the most consistent results. At
longer durations drying of the gel becomes a factor which starts to deform the gel pockets.
• If the same gel pockets repeatedly show filaments in them, using a new comb or new spacer
plates typically resolves the problem.
• TEMED should be added last to the gel mixture, as it catalyses the polymerisation reaction
and from then onwards the gel starts to rapidly solidify.
• TEMED should be used from small aliquots rather than the stock bottle as oxidation
decreases its catalytic activity. Oxidised TEMED solution has a yellowish colour.
• APS solution is not stable for long periods of time in aqueous solutions and for best results
should be prepared freshly. However, storing frozen aliquots at −20 ◦C and thawing them
upon use has proven sufficient, although aliquots should not be stored longer than 6 months
or until gels show inconsistent polymerisation.
• For best results, polyacrylamide solution should ideally not be older than 12 months.
• Inconsistent polymerisation and band separation is often resolved by using fresh solutions.
• Recommended final concentrations of APS and TEMED are typically 0.05 %. The
here described protocol uses slightly more than that which has proven to facilitate faster
164 Appendix
polymerisation (without clouding of the gel) and might also compensate for degradation of
APS and TEMED allowing them to be stored for longer.
• Many DNA ladders contain mixed DNA sequences for bands referring to the same base
pair length (particularly some ladders from New England Biolabs). Due to the sequence
specificity of PAGE, these will split up, providing a less accurate reference. To avoid this,
the used ladder L: GeneRuler Low Range (Thermo Fisher Scientific) proved a good choice.
• Freshly vortexing the DNA ladder and loading it last typically yields the sharpest bands.
• Many commercially available loading dyes contain SDS or EDTA. Care must be taken that
this does not interfere with the DNA samples upon loading onto the gel.
• The comb should only be taken out after the chamber was filled with running buffer such
that no air bubbles enter the pockets.
• It is highly recommended to clean the glass edges and gel pockets from gel filaments before
loading. Flushing the pockets with the running buffer or air helps to remove particles from
the pockets (pipetting repeatedly with a gel loading tip and about 100 to 150 µl volume).
Applying suction with the pipette upon making contact with a loose particle can aid to
remove it from the pocket. Care must be taken not to poke the bottom of the gel pocket.
• Gel-loading tips are recommended for sample loading. It is best to pipette slowly and
always slightly less than the total volume of prepared sample to avoid air at the end of
the pipette tip which can cause difficulties for ejecting the sample into the gel pocket.
To pipette small volumes, the adapter on 2 and 10 µl Gilson pipettes can be reversed to
accommodate 200 µl tip sizes.
• Running the gel at room temperature and the typical buffer conditions (11 mM MgCl2
present) leads to temperatures of ~30 ◦C (at 100 V for 90 min) or ~37 ◦C (at 200 V
for 45 min) inside the central reservoir. The outer reservoir typically stays below 30 ◦C.
Surrounding the gel chamber with crushed ice some minutes prior the run typically yields
temperatures in the outer chamber reservoir of 18 ◦C before and ~10 ◦C after running
the gel for 90 min at 100 V. Temperatures are higher when two gels are run in parallel.
Temperatures are generally lower for the gel located more centrally rather than the one
closest to the wall of the gel chamber.
• At 100 V and the above described running buffer, the current is typically ~24 mA (for one
gel, double for two gels) at the beginning and decreases to < 15 mA towards the end.
• To avoid possible tearing of the gel slab edges, separate the gel from the glass by passing
with a scalpel once on each side before releasing the gel slab into the staining solution.
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• It is recommended to keep the gel slab always well moistened. A dry gel slab easily tears
or breaks while a wet gel slab can even fold without breaking (but is still prone to tearing).
• The GelRed® staining solution can be used multiple times, especially for PAGE gels that
do not absorb much of the dye. The staining solution should be stored in the dark.
• Rinsing the gel slab with distilled water after staining can improve the signal to noise ratio
as excess dye is removed.
• The UV lamp used for gel imaging requires ~5 min to warm up. This results in a continu-
ously increasing contrast if the gel is imaged multiple times after the lamp is switched on.
To avoid this, switch the lamp on already a few minutes before imaging.
• Gel imaging at various exposure times is recommended as for analysis the bands should
not be saturated but for presentation purposes more intense bands aid contrast.
• The gel slab should be aligned horizontally focussing on the gel pockets (not the bottom
edge of the gel as it can be skewed). Digitally rotating the image after imaging can reduce
the sharpness of the bands.
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A.2 Sequences of DNA nanostructures
Table A.1 Sequences of DNA nanostructures with various ssDNA overhangs included to
prevent stacking interactions.
Name 5’ overhang Double-stranded core sequence (5’ to 3’) 3’ overhang
sc1 CCTTTCCACGAACACAGGGTTGTCCGATCCTATATTACGACTCC -/C/G/A/T/TT/TTT
sc2 -/C/G/A/T/TT/TTT GGGAAGGGGTTCGCAAGTCGCACCCTAAACG
sc3 TCTTATCCTGCATCGAAAGCTCAATCATGCATC -/C/G/A/T/TT/TTT
sc4 -/C/G/A/T/TT/TTT ATGTTGAAGGCTCAGGATGC
st1 -/C/G/A/T/TT/TTT ATCGGACATTCAACATGGAGTCGTGGTGCGACT
st2 TGCGAACAGGATAAGACGTTTAGAATATAGG -/C/G/A/T/TT/TTT
st3 -/C/G/A/T/TT/TTT TTCGATGCCCCTTCCCGATGCATGAAGGGCATCCTGAGCCACCC
st4 TGTGTTCGTGGAATTGAGCT -/C/G/A/T/TT/TTT
Table A.2 DNA strands employed for DNA nanostructures assembled with different number
of TTT overhangs as analysed in Fig. 3.3. For detailed sequences see Table A.3.
TTT overhangs DNA strands with TTT overhangs
0 / 0 —
1 / 0 st1
1 / 1 st1, sc3
2 / 1 st1, sc3, sc1
2 / 2 st1, sc3, sc1, st3
3 / 2 st1, sc3, sc1, st3, sc4
3 / 3 st1, sc3, sc1, st3, sc4, st4
4 / 3 st1, sc3, sc1, st3, sc4, st4, st2
4 / 4 st1, sc3, sc1, st3, sc4, st4, st2, sc2
4 / 0 st1, sc1, sc4, st2
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Table A.3 Sequences of different DNA nanostructure designs.
Design Strand Sequence (5’ to 3’) nt
CP1 U1R1 AAAACGCTAAGCCACCTTTAGATCCAAA 28
U1R2 GGTCGTGCGGACTGTCGAACACCAACGATGCCTGATAGAAGT 42
U2R1 GGATCTAAAGGACTTCTATCAAAGACGGGACGACTCCGGGAG 42
U2R2 GGCATCGTTGGAAAAAATTTCGGATCCA 28
U3R1 AAACTCCCGGAGTCCGCTGCTGATCAAA 28
U3R2 GTCCCGTCTTTGGATCCGAAAGCCATAATATATCGAGACGGG 42
U4R1 GATCAGCAGCGCCCGTCTCGACCGCACGACCTGGCTTAGCGT 42
U4R2 TATATTATGGCAAAAAATGTTCGACAGT 28
CP2 sc1 CCTTTCCACGAACACAGGGTTGTCCGATCCTATATTACGACTCCTTT 47
sc2 TTTGGGAAGGGGTTCGCAAGTCGCACCCTAAACG 34
sc3 TCTTATCCTGCATCGAAAGCTCAATCATGCATCTTT 36
sc4 TTTATGTTGAAGGCTCAGGATGC 23
st1 TTTATCGGACATTCAACATGGAGTCGTGGTGCGACT 36
st2 TGCGAACAGGATAAGACGTTTAGAATATAGGTTT 34
st3 TTTTTCGATGCCCCTTCCCGATGCATGAAGGGCATCCTGAGCCACCC 47
st4 TGTGTTCGTGGAATTGAGCTTTT 23
CP3 sc11 TTTTACCGCGAGGAGCTAGCGGCTTT 26
sc12 TTTAGGTAGCGCCGCTGCGAACGTTT 26
sc21 ATAACCGTGTGAGCCTGACGGTCGGCCAGAGAGGCTCGATTA 42
sc22 AGACATTTCGGCCGGCGTAGACCGGACAGGTATTCATGCAGG 42
st11 CACACGGTTATCCTCGCGGTACGTTCGCAGCCCTGCATGAAT 42
st12 CCGAAATGTCTGGCGCTACCTGCCGCTAGCTTAATCGAGCCT 42
st21 TTTCCGTCAGGCTACCTGTCCGGTTT 26
st22 TTTTCTACGCCGGCTCTGGCCGATTT 26
CP3 sc11 TTTTCGCATCAGGGCACATTGGCTTT 26
short sc12 TTTTGCGGCTAAGACTTGCCAGGTTT 26
sc21 GCCGACGTGTACGGATCTGGCA 22
sc22 GCGACATTGCGGCCGATTCGGA 22
st11 TTTTACACGTCGGCCCTGATGCGACCTGGCAAGTTCCGAATCGGCTTT 48
st12 TTTCGCAATGTCGCCTTAGCCGCAGCCAATGTGCTGCCAGATCCGTTT 48
CP4 sc1 AGTGTCGACAAGACGGCTGTGGCTTGTGTGGTGTGTCAATCCTTCGGACTAG 52
sc2 AGTCACATGCGTAGGTTTCCGCGTTCTCGCCAGGATGAGATTT 43
sc3 TTTAGGGCTGCTAAGTCGT 19
st1 AGCCACAGATGTGACTTGTGTGGTGTGTCTAGTCCGACGACTTAACCTACGC 52
st2 TTTACGCGGAAGCAGCCCTTCTCATCCTCGACACTAAGGATTG 43
st3 CCGTCTTGTGGCGAGATTT 19
6HP sc1 AGCGAACGTGGATTTTGTCCGACATCGGCAAGCTCCCTTTTTCGACTATT 50
sc2 CGAAGATCGTGTTTTTCCACAGTTGATTGCCCTTCACTTTTCCCAGCAGG 50
sc3 TCACCAGTGAGATTTTTGTCGTACCAGGTGCATGGATTTTTGCATTCTAA 50
st1 CCGATGTCGGACTTTTACACGATCTTCGCCTGCTGGGTTTTGGGAGCTTG 50
st2 AATCAACTGTGGTTTTTCTCACTGGTGATTAGAATGCTTTTGTGAAGGGC 50
st3 CCTGGTACGACATTTTTCCACGTTCGCTAATAGTCGATTTTATCCATGCA 50
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Fig. A.1 Analysis of other DNA sequences with dimerisation tendencies. (a) PAGE of one
unmodified and three cholesterol-modified DNA sequences as shown in b and c. Samples
were run on the same gel but space between lanes was omitted as indicated by the dashed
line. (d,e) Probability shading representation of NUPACK free energy calculations of DNA
sequences shown in b and c, respectively, illustrating a tendency for dimerisation.
Table A.4 DNA sequences used for dsDNA aggregation prevention experiments with ssDNA
overhangs. The sequence of the ‘ss’ chol-DNA strand equals sequence (b) analysed previously.
5’ tocopherol-modified ssDNA was purchased from biomers.net covalently linked to the
DNA via an octyl (C8) spacer.
DNA strand Sequence (5’ to 3’)
ss AAACTCCCGGAGTCCGCTGCTGATCAAA
ss chol AAACTCCCGGAGTCCGCTGCTGATCAAA-CholTEG
comp −6 CAGCAGCGGACTCCGGGAGTTT
comp 0 TTTGATCAGCAGCGGACTCCGGGAGTTT
comp +2 CCTTTGATCAGCAGCGGACTCCGGGAGTTT
comp +4 TACCTTTGATCAGCAGCGGACTCCGGGAGTTT
comp +6 ACTACCTTTGATCAGCAGCGGACTCCGGGAGTTT
comp +8 GTACTACCTTTGATCAGCAGCGGACTCCGGGAGTTT
comp +10 TCGTACTACCTTTGATCAGCAGCGGACTCCGGGAGTTT
ss toco TocoC8-ATATATTATGGCAAAAAATGTTCGACAGT
comp 0 ACTGTCGAACATTTTTTGCCATAATATAT
comp +3 ACTGTCGAACATTTTTTGCCATAATATATCTG
comp +6 ACTGTCGAACATTTTTTGCCATAATATATCTGTCA
comp +10 ACTGTCGAACATTTTTTGCCATAATATATCTGTCACTTG
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Fig. A.2 Image sequence of MD simulations of cholesterol-modified 30T ssDNA. Instan-
taneous snapshots of all-atom MD simulations of cholesterol-modified 30 thymine ssDNA
(30T) taken at various time points throughout two independent 0.5 µs long simulation runs
(Run 1 and Run 2) starting from the same initial configuration. The ssDNA wraps around the
cholesterol group throughout both simulation runs. Water and ions are not shown for clarity.
A movie of the simulation can be found in the Supplementary Information of the published
article [194].
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Fig. A.3 Image sequences of MD simulations of cholesterol-modified DNA duplexes. In-
stantaneous snapshots of all-atom MD simulations of the cholesterol-modified DNA duplex
without (a) and with a 6 nt overhang (b) on the complementary strand. For each system two
independent 0.5 µs long simulation runs (Run 1 and Run 2) starting from the same initial
configuration were performed. Water and ions are not shown for clarity. Movies of the
simulations can be found in the Supplementary Information of the published article [194].
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Fig. A.4 Overview of modification positions and DNA strand names for the DNA nanostruc-
ture design. Top (a) and side view (b) of a 3D representation of the DNA nanostructure with
cholesterol modification positions highlighted as green spheres. (c) 2D scheme illustrating
the ssDNA pathways and modification positions within the DNA nanostructure design.
Table A.5 DNA sequences of cholesterol-modified (C) and Cy3-modified (F) strands em-
ployed for the assembly of the CP2 DNA nanostructure.
DNA strand Modification Sequence (5’ to 3’)
sc4C 3’ TEG TTTATGTTGAAGGCTCAGGATGCA
sc2C 3’ TEG TTTGGGAAGGGGTTCGCAAGTCGCACCCTAAACGA
st3C 3’ TEG TTTTTCGATGCCCCTTCCCGATGCATGAAGGGCATCCTGAGCCACCCA
st1C 3’ TEG TTTATCGGACATTCAACATGGAGTCGTGGTGCGACTA
sc1C 5’ TEG / 5’ C6 ACCTTTCCACGAACACAGGGTTGTCCGATCCTATATTACGACTCCTTT
sc3C 5’ TEG / 5’ C6 ATCTTATCCTGCATCGAAAGCTCAATCATGCATCTTT
st4C 5’ TEG / 5’ C6 ATGTGTTCGTGGAATTGAGCTTTT
st2C 5’ TEG / 5’ C6 ATGCGAACAGGATAAGACGTTTAGAATATAGGTTT
sc1C 3’ TEG CCTTTCCACGAACACAGGGTTGTCCGATCCTATATTACGACTCCTTT
st2C 3’ TEG TGCGAACAGGATAAGACGTTTAGAATATAGGTTT
st2F 3’ Cy3 TGCGAACAGGATAAGACGTTTAGAATATAGGTTT
st4F 3’ Cy3 TGTGTTCGTGGAATTGAGCTTTT
Table A.6 DNA sequences employed for DNA nanostructures assembled with different
cholesterol linker types.
Cholesterol number Linker type DNA strands with cholesterol
1 3’ TEG sc4C
2 3’ TEG sc4C, sc2C
3 3’ TEG sc4C, sc2C, st3C
4 3’ TEG sc4C, sc2C, st3C, st1C
1 5’ TEG / 5’ C6 sc1C
2 5’ TEG / 5’ C6 sc1C, sc3C
3 5’ TEG / 5’ C6 sc1C, sc3C, st4C
4 5’ TEG / 5’ C6 sc1C, sc3C, st4C, st2C
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A.5 Additional MD results: Energetics of lipid scrambling
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Fig. A.5 Energetics of lipid scrambling. (a) Two-dimensional potential of mean force
(PMF) for a lipid headgroup near the toroidal pore. The PMF was obtained by Boltzmann
inversion of the average density of lipid phosphorus atoms. To obtain the density, the system
was translated at each frame of the trajectory so that the centre of mass of all lipid atoms
within 2 nm of DNA was at the origin. Following that, a two-dimensional histogram was
constructed by binning the radial- and Z-coordinates of each phosphorus atom during the
2 µs MD trajectory. An approximate transition path for moving a lipid molecule from one
leaflet to the other is drawn as a white line. The transition path was obtained by selecting all
bins with a density greater than 1 % of the maximum and iteratively removing bins from the
edges until a single path of bins remained. (b) Free energy profile along the transition path
for a lipid moving from one leaflet to the other. To compute the free energy profile, all bins
in the 2D histogram were assigned to the nearest transition path bin. The free energy at each
transition path bin was calculated from the Boltzmann-weighted average of the free energies
of its assigned bins from panel a. The contour at zero corresponds to the bin with radial and
Z-coordinates of 59 and −20 Å, respectively.
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A.6 Alternative dithionite reduction protocol
In the alternative experimental protocol, the final concentration of dithionite was similar
(≈ 5 mM), however, the amount of dithionite solution added was greater (see Table A.7).
Table A.7 Alternative protocol of dithionite reduction assay.
Amount Buffer conditions
20 µl GUV solution in 100 mM sucrose, 20 mM HEPES pH 7.4
24.5 µl 100 mM glucose, 20 mM HEPES pH 7.4
0.5 µl 0.5 % OPOE in TE20 buffer
5 µl DNA nanostructures at 1 µM in TE20 buffer
–> Incubation for ≈ 150 min at room temperature
–> Record z-stacks of multiple areas containing vesicles
50 µl 10 mM dithionite in 80 mM glucose, 20 mM HEPES pH 7.4
–> Record z-stacks of multiple areas containing vesicles after 1 hour
100 µl Total volume
The greater amount of added solution caused the vesicles to move upon dithionite addition in
most cases. Therefore, it was rarely possible to compare the intensity before and after addition
for the same vesicle. Alternatively, z-stacks of several areas containing vesicles were acquired
before and one hour after dithionite addition. NBD fluorescence intensities before and after
dithionite addition were determined similarly as described in Section 6.2. Intensity values
were background subtracted and their count was normalised to the highest intensity column
in each graph (see Figs. A.6a,c). The fairly large spread in the intensity distribution can be
explained by the use of a 20x air objective (UPLSAPO20X, NA = 0.75) in these experiments
which resulted in a larger focal volume in z-direction. This caused the fluorescence intensity
to depend on the size meaning that larger vesicles had a higher fluorescence intensity
than smaller ones. However, the data still showed that for vesicles incubated with 2C
nanostructures the highest peak is associated with a complete NBD reduction (red column in
Fig. A.6a) which is in contrast to 1C nanostructure experiments where the highest peak is
located at a much higher remaining fluorescence intensity (Fig. A.6c). A small fraction of
vesicles in the case of 1C nanostructures is completely reduced in their fluorescence which
could be caused by dithionite leakage into the vesicles while they were moved upon dithionite
addition. Fluorescence intensity traces show an exponential decay to almost 0 or to 0.5 for
vesicles incubated with 2C or 1C nanostructures, respectively (see Figs. A.6b,d). Spikes in
intensity are caused by vesicles temporarily being out of focus during image acquisition.
Although the results are comparable to the ones presented in Chapter 6, improvements in the
protocol prevented vesicles from moving, while still not exposing them to an osmotic shock,
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which allowed to normalise the fluorescence intensity reduction for each vesicle making the
overall results much more consistent.
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Fig. A.6 Results of dithionite reduction assays using an alternative protocol. (a,c) Absolute
NBD fluorescence intensities before (green) and ~1 hour after (grey) dithionite addition
of vesicles incubated with 2C (a) or 1C (c) DNA nanostructures. Arrow and red column
highlight the shifted population down to no residual fluorescence. Counts were normalised to
the maximum for each histogram. Number of analysed vesicles is denoted by n. (b,d) NBD
fluorescence intensity traces from vesicles incubated with 2C and 1C nanostructures and
imaging very 5 s over time. Values have been normalised to the initial intensity per vesicle
and aligned to the onset of dithionite reduction. The shifted grey trace in the top graph is
caused by the vesicle entering the field of view only some moments after dithionite addition.
